
<html lang="en"     class="pb-page"  data-request-id="2e371c6a-8171-4149-9261-20b9f303fdc8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm300118s;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-21;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors" /></meta><meta name="dc.Creator" content="Thomas A.  Dineen" /></meta><meta name="dc.Creator" content="Matthew M.  Weiss" /></meta><meta name="dc.Creator" content="Toni  Williamson" /></meta><meta name="dc.Creator" content="Paul  Acton" /></meta><meta name="dc.Creator" content="Safura  Babu-Khan" /></meta><meta name="dc.Creator" content="Michael D.  Bartberger" /></meta><meta name="dc.Creator" content="James  Brown" /></meta><meta name="dc.Creator" content="Kui  Chen" /></meta><meta name="dc.Creator" content="Yuan  Cheng" /></meta><meta name="dc.Creator" content="Martin  Citron" /></meta><meta name="dc.Creator" content="Michael D.  Croghan" /></meta><meta name="dc.Creator" content="Robert T.  Dunn, II" /></meta><meta name="dc.Creator" content="Joel  Esmay" /></meta><meta name="dc.Creator" content="Russell F.  Graceffa" /></meta><meta name="dc.Creator" content="Scott S.  Harried" /></meta><meta name="dc.Creator" content="Dean  Hickman" /></meta><meta name="dc.Creator" content="Stephen A.  Hitchcock" /></meta><meta name="dc.Creator" content="Daniel B.  Horne" /></meta><meta name="dc.Creator" content="Hongbing  Huang" /></meta><meta name="dc.Creator" content="Ronke  Imbeah-Ampiah" /></meta><meta name="dc.Creator" content="Ted  Judd" /></meta><meta name="dc.Creator" content="Matthew R.  Kaller" /></meta><meta name="dc.Creator" content="Charles R.  Kreiman" /></meta><meta name="dc.Creator" content="Daniel S.  La" /></meta><meta name="dc.Creator" content="Vivian  Li" /></meta><meta name="dc.Creator" content="Patricia  Lopez" /></meta><meta name="dc.Creator" content="Steven  Louie" /></meta><meta name="dc.Creator" content="Holger  Monenschein" /></meta><meta name="dc.Creator" content="Thomas T.  Nguyen" /></meta><meta name="dc.Creator" content="Lewis D.  Pennington" /></meta><meta name="dc.Creator" content="Tisha  San Miguel" /></meta><meta name="dc.Creator" content="E. Allen  Sickmier" /></meta><meta name="dc.Creator" content="Hugo M.  Vargas" /></meta><meta name="dc.Creator" content="Robert C.  Wahl" /></meta><meta name="dc.Creator" content="Paul H.  Wen" /></meta><meta name="dc.Creator" content="Douglas A.  Whittington" /></meta><meta name="dc.Creator" content="Stephen  Wood" /></meta><meta name="dc.Creator" content="Qiufen  Xue" /></meta><meta name="dc.Creator" content="Bryant H.  Yang" /></meta><meta name="dc.Creator" content="Vinod F.  Patel" /></meta><meta name="dc.Creator" content="Wenge  Zhong" /></meta><meta name="dc.Description" content="We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords..." /></meta><meta name="Description" content="We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 18, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300118s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300118s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300118s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300118s" /></link>
        
    
    

<title>Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300118s" /></meta><meta property="og:title" content="Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0009.jpeg" /></meta><meta property="og:description" content="We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords compounds (e.g., 1) with sufficient bioavailability and pharmacokinetic profiles to reduce central amyloid-β peptide (Aβ) levels in wild-type rats following oral dosing. In this article, we describe further modifications of the P1-phenyl ring of the hydroxyethylamine series to afford potent, dual BACE1/CYP 3A4 inhibitors which demonstrate improved penetration into the CNS. Several of these compounds caused robust reduction of Aβ levels in rat CSF and brain following oral dosing, and compound 37 exhibited an improved cardiovascular safety profile relative to 1." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300118s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300118s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300118s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300118s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300118s&amp;href=/doi/10.1021/jm300118s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9025-9044</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300119p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3007799" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+A.++Dineen">Thomas A. Dineen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+M.++Weiss">Matthew M. Weiss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Toni++Williamson">Toni Williamson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Acton">Paul Acton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Safura++Babu-Khan">Safura Babu-Khan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Bartberger">Michael D. Bartberger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Brown">James Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kui++Chen">Kui Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuan++Cheng">Yuan Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Citron">Martin Citron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Croghan">Michael D. Croghan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+T.++Dunn%2C++II">Robert T. Dunn, II</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel++Esmay">Joel Esmay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Russell+F.++Graceffa">Russell F. Graceffa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+S.++Harried">Scott S. Harried</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean++Hickman">Dean Hickman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+A.++Hitchcock">Stephen A. Hitchcock</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+B.++Horne">Daniel B. Horne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongbing++Huang">Hongbing Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronke++Imbeah-Ampiah">Ronke Imbeah-Ampiah</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ted++Judd">Ted Judd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+R.++Kaller">Matthew R. Kaller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+R.++Kreiman">Charles R. Kreiman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+S.++La">Daniel S. La</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vivian++Li">Vivian Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia++Lopez">Patricia Lopez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Louie">Steven Louie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Holger++Monenschein">Holger Monenschein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+T.++Nguyen">Thomas T. Nguyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lewis+D.++Pennington">Lewis D. Pennington</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tisha++San+Miguel">Tisha San Miguel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=E.+Allen++Sickmier">E. Allen Sickmier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hugo+M.++Vargas">Hugo M. Vargas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+C.++Wahl">Robert C. Wahl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+H.++Wen">Paul H. Wen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+A.++Whittington">Douglas A. Whittington</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Wood">Stephen Wood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiufen++Xue">Qiufen Xue</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryant+H.++Yang">Bryant H. Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinod+F.++Patel">Vinod F. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenge++Zhong">Wenge Zhong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Chemical Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>‡</sup>Department of Neuroscience, <sup>§</sup>Department of HTS and Molecular Pharmacology, <sup>∥</sup>Molecular Structure, <sup>⊥</sup>Pharmacokinetics and Drug Metabolism, <sup>#</sup>Comparative Biology and Safety Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-444-5352. Fax: 617-621-3907. E-mail: <a href="/cdn-cgi/l/email-protection#7c081815121919123c1d111b1912521f1311"><span class="__cf_email__" data-cfemail="b1c5d5d8dfd4d4dff1d0dcd6d4df9fd2dedc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300118s&amp;href=/doi/10.1021%2Fjm300118s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9025–9044</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 2, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 January 2012</li><li><span class="item_label"><b>Published</b> online</span>18 April 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300118s" title="DOI URL">https://doi.org/10.1021/jm300118s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9025%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThomas%2BA.%2BDineen%252C%2BMatthew%2BM.%2BWeiss%252C%2BToni%2BWilliamson%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D21%26contentID%3Djm300118s%26title%3DDesign%2Band%2BSynthesis%2Bof%2BPotent%252C%2BOrally%2BEfficacious%2BHydroxyethylamine%2BDerived%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B%2528BACE1%2529%2BInhibitors%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9044%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300118s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3513</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300118s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;A. Dineen&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;M. Weiss&quot;},{&quot;first_name&quot;:&quot;Toni&quot;,&quot;last_name&quot;:&quot;Williamson&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Acton&quot;},{&quot;first_name&quot;:&quot;Safura&quot;,&quot;last_name&quot;:&quot;Babu-Khan&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Bartberger&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Kui&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Yuan&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Citron&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Croghan&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;T. Dunn&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;Esmay&quot;},{&quot;first_name&quot;:&quot;Russell&quot;,&quot;last_name&quot;:&quot;F. Graceffa&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;S. Harried&quot;},{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;Hickman&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;A. Hitchcock&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;B. Horne&quot;},{&quot;first_name&quot;:&quot;Hongbing&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Ronke&quot;,&quot;last_name&quot;:&quot;Imbeah-Ampiah&quot;},{&quot;first_name&quot;:&quot;Ted&quot;,&quot;last_name&quot;:&quot;Judd&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;R. Kaller&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;R. Kreiman&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;S. La&quot;},{&quot;first_name&quot;:&quot;Vivian&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;Lopez&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Louie&quot;},{&quot;first_name&quot;:&quot;Holger&quot;,&quot;last_name&quot;:&quot;Monenschein&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;T. Nguyen&quot;},{&quot;first_name&quot;:&quot;Lewis&quot;,&quot;last_name&quot;:&quot;D. Pennington&quot;},{&quot;first_name&quot;:&quot;Tisha&quot;,&quot;last_name&quot;:&quot;San Miguel&quot;},{&quot;first_name&quot;:&quot;E.&quot;,&quot;last_name&quot;:&quot;Allen Sickmier&quot;},{&quot;first_name&quot;:&quot;Hugo&quot;,&quot;last_name&quot;:&quot;M. Vargas&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;C. Wahl&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;H. Wen&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;A. Whittington&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Wood&quot;},{&quot;first_name&quot;:&quot;Qiufen&quot;,&quot;last_name&quot;:&quot;Xue&quot;},{&quot;first_name&quot;:&quot;Bryant&quot;,&quot;last_name&quot;:&quot;H. Yang&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;F. Patel&quot;},{&quot;first_name&quot;:&quot;Wenge&quot;,&quot;last_name&quot;:&quot;Zhong&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9025-9044&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300118s&quot;},&quot;abstract&quot;:&quot;We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords compounds (e.g., 1) with sufficient bioavailability and pharmacokinetic profiles to reduce central amyloid-β peptide (Aβ) levels in wild-type rats following oral dosing. In this article, we describe further modifications of the P1-phenyl ring of the hydroxyethylamine series to afford potent, dual BACE1/CYP 3A4 inhibitors which demonstrate improved penetration into the CNS. Several of these compounds caused robust reduction of Aβ levels in rat CSF and brain following oral dosing, and compound 37 exhibited an improved cardiovascular safety profile relative to 1.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300118s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300118s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300118s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300118s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300118s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300118s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300118s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300118s&amp;href=/doi/10.1021/jm300118s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300118s" /></input><a href="/doi/pdf/10.1021/jm300118s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300118s%26sid%3Dliteratum%253Aachs%26pmid%3D22468684%26genre%3Darticle%26aulast%3DDineen%26date%3D2012%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BPotent%252C%2BOrally%2BEfficacious%2BHydroxyethylamine%2BDerived%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B%2528BACE1%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D21%26spage%3D9025%26epage%3D9044%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jmcmar.2012.55.issue-21/production/jmcmar.2012.55.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords compounds (e.g., <b>1</b>) with sufficient bioavailability and pharmacokinetic profiles to reduce central amyloid-β peptide (Aβ) levels in wild-type rats following oral dosing. In this article, we describe further modifications of the P1-phenyl ring of the hydroxyethylamine series to afford potent, dual BACE1/CYP 3A4 inhibitors which demonstrate improved penetration into the CNS. Several of these compounds caused robust reduction of Aβ levels in rat CSF and brain following oral dosing, and compound <b>37</b> exhibited an improved cardiovascular safety profile relative to <b>1</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/55/21"><issue-title>Alzheimer's Disease</issue-title></a> special issue.</p></div><div class="extra-info-sec articleNote"><h4><span>▽</span> Author Present Address</h4><p class="last">Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>○</span> Author Present Address</h4><p class="last">Envoy Therapeutics, 555 Heritage Drive, Jupiter, Florida 33458, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>◆</span> Author Present Address</h4><p class="last">Sanofi-Aventis, 270 Albany Street, Cambridge, Massachusetts 02139, United States.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">The PDB accession code for the X-ray cocrystal of BACE1 + compound <b>37</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DI2">4DI2</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a terminal neurodegenerative disorder of the brain that begins with mild cognitive and short-term memory impairment that gradually progresses to complete loss of cognitive function and ultimately death.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> While AD is the most common form of dementia in the elderly, affecting more that 5 million people in the U.S. and over 20 million people worldwide, current treatment options are limited and do little to alleviate the symptoms of the disease. As a result, a disease-modifying therapy for AD represents a large and growing unmet medical need.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> A large body of evidence suggests that AD results from the accumulation of β-amyloid peptides, particularly Aβ<sub>40</sub> and Aβ<sub>42</sub>, in the brain. These peptides can aggregate to form toxic, soluble oligomers or further aggregate to form insoluble senile plaques, the histological hallmark of AD.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> While it remains unclear to what extent each of these species contributes to the overall pathology of the disease, the available evidence suggests that inhibition of Aβ formation is an important and direct strategy for therapeutic intervention in AD.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Aβ is generated via initial proteolytic cleavage of membrane-bound amyloid precursor protein (APP) by the aspartyl protease BACE1 (β-site APP cleaving enzyme) to give a soluble <i>N</i>-terminal domain (β-sAPP) and a membrane-bound C-terminal domain (C99). Further processing of C99 by another aspartyl protease, γ-secretase, affords soluble Aβ peptides of varying length. Since its identification as β-secretase in 1999,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> BACE1 has received considerable attention as a therapeutic target in AD research.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> BACE1 knockout mice do not produce Aβ from APP in the brain but are viable, suggesting that targeted inhibition of the BACE1 enzyme would prevent formation of Aβ without significant on-target toxicities.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Given the central role of the enzyme in Aβ formation and the viability of knockout mice, the use of a CNS-penetrant small-molecule inhibitor of BACE1 to reduce Aβ levels in the brain is an attractive approach toward a disease-modifying therapy for AD.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">In previous articles, we have described the synthesis and evaluation of a series of BACE1 inhibitors featuring a hydroxyethylamine (HEA) scaffold as the transition state isostere to bind the critical catalytic aspartic acid residues of the BACE1 enzyme. While select compounds from these series did demonstrate the ability to reduce central Aβ concentrations following peripheral dosing in Sprague–Dawley (SD) rats, the pharmacological effects of these compounds were limited by their low intrinsic stability (as measured in liver microsome preparations) and poor penetration into the CNS as a result of P-glycoprotein (Pgp) mediated efflux.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Consequently, significant CNS access and efficacy required either high doses or codosing with a CYP 3A4 inhibitor. In an effort to obviate these shortcomings, a strategy was adopted wherein CYP inhibitory activities were incorporated into our HEA-derived BACE1 inhibitors, leading to the identification of <b>1</b>, a potent BACE1 inhibitor which demonstrated moderate in vivo clearance and reduced Pgp-mediated efflux (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In the course of evaluating inhibitor <b>1</b> for off-target cardiovascular (CV) liabilities in dog, it was found that this compound exhibited a narrow therapeutic index due to drug-induced tachycardia of an unknown mechanism.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Properties of BACE1 inhibitor <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this article, we report on the design and synthesis of a series of compounds aimed at improving the CV-safety margin of hydroxyethylamine BACE1 inhibitors exemplified by <b>1</b>. Given the uncertainties of the underlying cause of the observed off-target CV effects, our strategy to improve upon this series focused on decreasing the unbound plasma drug concentration required to achieve significant reduction of CNS Aβ. This strategy thus relied on our ability to improve the functional cellular potency of our inhibitors and/or reduce their susceptibility to Pgp-mediated efflux and thereby increase their distribution into the CNS. Our previous work had demonstrated that the highly optimized azachroman ring system was required to maintain potent cellular activities in HEA BACE1 inhibitors which demonstrated suitable properties for CNS penetration.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This work also revealed that the BACE1 enzyme was much more tolerant of modification to the P1-phenyl group, <a href="https://doi.org/10.1021/jm300119p">hence our efforts to improve upon </a><b>1</b><a href="https://doi.org/10.1021/jm300119p"> focused on modifying this region of the inhibitor</a>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In keeping with our previously described strategy to design hydroxyethylamines which demonstrated suitable metabolic stability, we designed compounds incorporating <i>N</i>-containing heterocycles and alkynes, functional groups commonly known to inhibit CYP 3A4.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> This work led to the identification of potent, highly orally efficacious BACE1 inhibitors with CYP 3A4 inhibitory activities, some of which demonstrated significantly improved cardiovascular safety margins relative to <b>1</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds described in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were prepared as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Sulfinyl imine <b>2</b> was treated with a number of different benzyl Grignard reagents to afford sulfinamides <b>4</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Simultaneous deprotection of the <i>tert</i>-butyl sulfinyl and primary <i>tert</i>-butyldimethylsilyl (TBS) ether groups was accomplished by exposure of compounds <b>4</b> to hydrogen chloride in cold ethanol, and the resulting intermediates were reprotected to give the Boc-carbamates <b>5</b>. Dess–Martin oxidation<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> of the primary alcohols to the corresponding aldehydes was followed by sodium triacetoxyborohydride-mediated reductive amination with amine <b>6</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> to afford protected hydroxyethylamines <b>7</b>. Simultaneous removal of the <i>N</i>-Boc and TBS-groups in methanolic hydrochloric acid was followed by direct exposure of the crude amine hydrochlorides to 1-(1<i>H</i>-imidazol-1-yl)-2-methoxyethanone (<b>8</b>) in the presence of Hünig’s base to afford the hydroxyethylamines <b>9</b>. At this point, palladium-catalyzed cross-coupling reactions were used to form the final biaryl products <b>11</b>–<b>30</b>. In the case of compounds <b>22</b>, <b>23</b>, and <b>27</b>, the cross-coupling reactions were performed directly on intermediates <b>7</b> to generate compounds <b>10g</b>–<b>i</b>. Sequential deprotection and acylation, as described above, afforded the corresponding final products.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of P1-Biaryl BACE1 Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) R-MgBr, THF, −70 °C; (b) HCl, 1,4-dioxane-EtOH, −20 °C, Et<sub>3</sub>N, Boc<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, −20 to 23 °C; (c) (i) Dess–Martin periodinane, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 23 °C (ii) <b>6,</b> (EtO)<sub>3</sub>CH, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C; (d) (i) HCl, 1,4-dioxane-CH<sub>3</sub>OH, 40 °C, (ii) <b>8</b>, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C; (e) Ar-SnBu<sub>3</sub> or R-CC-SnBu<sub>3</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, CsF, 1,4-dioxane, 160 °C, μ-wave; (f) Ar-SnBu<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 140 °C, μ-wave; (g) R-CC-ZnCl, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, THF, 120 °C, sealed vessel.</p></p></figure><div class="NLM_p">The compounds described in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were used to evaluate the SAR around the acyl group of the inhibitors, and the synthesis of these compounds is illustrated in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Negishi coupling<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> of aryl bromide <b>5a</b> and 2-thiazolyl zinc bromide in 1,4-dioxane at room temperature afforded biaryl <b>31</b> in 92% yield. Following oxidation of the primary alcohol unit of <b>31</b> with the Dess–Martin periodinane, reductive amination with amine <b>6</b> in the presence of sodium triacetoxyborohydride afforded protected hydroxyethylamine <b>32</b> in 83% yield. Deprotection of the <i>N</i>-Boc and TBS-groups was again accomplished by exposure of <b>32</b> to warm methanolic hydrochloric acid. The crude intermediate amine was directly acylated by treatment with a preformed solution of the appropriate acyl imidazole in dichloromethane at 0 °C to afford inhibitors <b>34</b>–<b>43</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Acetamide Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Pd(P<i>t</i>-Bu<sub>3</sub>)<sub>2</sub> (5 mol %), ZnCl<sub>2</sub> (2 equiv), 2-thiazolyl zinc bromide (1.2 equiv), dioxane, 23 °C; (b) (i) Dess–Martin periodinane, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 23 °C, (ii) <b>6,</b> (EtO)<sub>3</sub>CH, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C; (c) HCl, dioxane-CH<sub>3</sub>OH, 40 °C; (d) carboxylic acid, carbonyl diimidazole, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our efforts to identify HEA-derived BACE1 inhibitors which exhibited improved safety profiles relied extensively upon our previously established SAR.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> As outlined above, our strategy involved the generation of dual potent BACE1/CYP 3A4 inhibitors. Although not ideal, this strategy was deemed necessary so as to maintain sufficiently high drug plasma levels. In addition, to ensure adequate exposure within the CNS, analogues with high permeability and low efflux ratios were targeted. Evaluation of compounds such as <b>1</b>, containing the optimized right-hand side azachroman ring system, had demonstrated that potent inhibitors of both BACE1 and CYP 3A4 could be generated by appropriate substitution of the P1-phenyl ring at the 3- and 4-positions.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Furthermore, incorporation of an ethereal oxygen at the α-position of the acyl group had been shown to attenuate Pgp-mediated efflux.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Upon the basis of these observations, we elected to initiate our studies by keeping the acyl group constant as the α-methoxy acetamide and varying the substituent attached to the P1-phenyl ring to identify inhibitors with enhanced potency and reduced efflux relative to compound <b>1</b>.</div><div class="NLM_p">After extensive screening, we identified a series of biaryl inhibitors which functioned as potent dual BACE1/CYP 3A4 inhibitors. More specifically, it was found that the incorporation of a variety of <i>N</i>-containing heterocycles provided compounds which compared favorably with our previously identified HEA-containing BACE1 inhibitors (i.e., <b>1</b>). As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, a range of hetereocycles were tolerated at this position, and incorporation of pyridyl (<b>11</b>–<b>12</b>), oxazolyl (<b>13</b>), or thiazolyl (<b>15</b>–<b>18</b>) groups generated potent BACE1 inhibitors as measured in both the enzymatic and cellular assays. A notable exception is <i>N</i>-methylimidazole <b>14</b> with reduced potency in the enzymatic assay but inexplicably good potency in the cellular assay. Alkynyl-substitution was also well tolerated, with the terminal aryl acetylene <b>19</b> being roughly 3–5-fold more potent than internal alkyne <b>20</b>. Substitution at the 4-position of the P1-phenyl ring with either the 2-thiazolyl group (<b>21</b>) or terminal alkyne (<b>22</b>) generated less potent inhibitors. Generally, the relative intrinsic metabolic stability within the series could be correlated to the estimated potency of the inhibitors on the CYP 3A4 enzyme. For example, 4-pyridyl compound <b>11</b> was significantly more potent on CYP 3A4 (IC<sub>50</sub> = 160 nM) than the 2-pyridyl regioisomer <b>12</b> (IC<sub>50</sub> = 400 nM), and this difference is reflected in greater turnover of <b>12</b> in human liver microsomes. Further, compounds with estimated IC<sub>50</sub>s on CYP 3A4 below 50 nM demonstrated consistently low microsomal turnover. Overall, inhibitors substituted with a pyridyl group were less metabolically stable than compounds containing other heterocycles examined. While compounds bearing 2-thiazolyl (<b>15</b> and <b>21</b>) or 5-thiazolyl (<b>16</b>) groups demonstrated good intrinsic metabolic stability, 4-thiazolyl substitution (<b>17</b>) generated a compound with high microsomal turnover. Introduction of a methyl group on the thiazole ring, as in 4-methyl-2-thiazolyl analogue <b>18</b>, significantly decreased metabolic stability. Similarly, an internal alkyne (<b>20</b>) was much less stable relative to terminal aryl acetylenes (<b>19</b> and <b>22</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Substituted P1-Phenyl BACE1 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0002.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0003.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were averaged values determined by at least two independent experiments.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Human embryonic kidney cells.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> values were estimated based on a single-concentration experiment. Compound concentration = 3 μM</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Rat liver microsomal (RLM) and human liver microsomal (HLM) clearance. Compound concentration = 1 μM. Microsomal protein concentration = 250 μg/mL.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Apparent permeability measured in parental LLC-PK1 cells. Values are an average of apical to basolateral (A to B) and basolateral to apical (B to A) velocities and are reported as 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Efflux measured in LLC-PK1 cells transfected with either rat MDR1A/1B or human MDR1 and are reported as a ratio of (B to A)/(A to B).</p></div></div><div></div></div><div class="NLM_p">Given that a primary focus of this work was to identify a series of BACE1 inhibitors which demonstrated improved penetration into the CNS, potent inhibitors were also assessed for their passive permeability and potential for Pgp-mediated efflux. Interestingly, as a whole, this series of compounds displayed excellent passive permeability and did not show a tendency for significant Pgp-mediated efflux. Most of the compounds showed higher efflux by rat Pgp relative to the human transporter; however, in most cases, these values were within 3-fold of one another. The three compounds which were recognized and transported by Pgp were the 4-pyridyl, 2-oxazolyl, and <i>N</i>-methylimidazole derivatives (<b>11</b>, <b>13</b>, and <b>14</b>). Compound <b>17</b> showed a moderate potential for rat Pgp-mediated efflux but was less prone to transport by the human transporter.</div><div class="NLM_p">Compounds <b>13</b>, <b>15</b>, <b>16</b>, and <b>19</b> offered the best balance of functional potency and intrinsic metabolic stability, so these compounds were profiled in an acute rat pharmacodynamic model measuring levels of Aβ<sub>40</sub> in rat CSF and brain. Each compound was dosed by oral gavage at 30 mg/kg to male Sprague–Dawley rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). After 4 h, 2-thiazolyl substituted compound <b>15</b> and terminal alkyne <b>19</b> demonstrated robust reduction of Aβ<sub>40</sub> levels in the CSF (75% and 76%, respectively) while oxazole <b>13</b> and 5-thiazolyl isomer <b>16</b> led to a much less pronounced effect of CSF Aβ<sub>40</sub> levels (44% and 27%, respectively). At the 4 h time point, reductions of Aβ<sub>40</sub> levels in the brain were similar to that observed in the CSF for compounds <b>13</b> and <b>19</b> (34% and 68%, respectively), but surprisingly compound <b>15</b> only afforded a 49% reduction in brain Aβ<sub>40</sub> levels. The magnitude of these effects could be correlated with the concentration of inhibitor in the CSF, a surrogate for brain free fraction.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Although all compounds exhibited good total plasma levels (2.5–7 μM) at the 4 h time point, compounds <b>15</b> and <b>19</b> achieved CSF concentrations of greater than 8-fold at their respective in vitro cellular potencies. On the other hand, CSF levels of <b>13</b> were 14 nM, a considerably reduced exposure relative to its in vitro potency, which likely explains the moderate efficacy observed with this inhibitor. Similarly, the modest Aβ reduction observed following oral administration of <b>16</b> can be explained by the low drug levels in the CSF (2 nM). While it is unclear why the concentration of 5-thiazolyl isomer <b>16</b> was low in CSF at the 4 h time point, the lower passive permeability (9.9 × 10<sup>–6</sup> cm/s) and higher Pgp-mediated efflux (efflux ratio<sub>rat</sub> = 8.5) of oxazole <b>13</b> explain the low levels of drug observed in the CSF for this inhibitor.</div><div class="NLM_p">With the knowledge that compounds <b>15</b> and <b>19</b>, featuring 3-(2-thiazolyl)phenyl and 3-(ethynyl)phenyl P1-groups, respectively, produced robust effects in our PD model, we further explored the SAR of dual BACE1/CYP 3A4 inhibitors bearing these groups. We anticipated that by identifying additional compounds with more potent in vivo Aβ reduction in our PD model, we would increase our chances of identifying BACE1 inhibitors with significantly improved cardiovascular safety margins relative to inhibitors like <b>1</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Reduction of CSF Aβ<sub>40</sub> in Wild-Type Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CSF Aβ<sub>40</sub><br /></br>reduction<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center">brain Aβ<sub>40</sub><br /></br>reduction<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center" char="±">CSF compd <br /></br>conc (μM)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">plasma compd <br /></br>conc (μM)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">cell <br /></br>IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="center">34</td><td class="colsep0 rowsep0" align="char" char="±">0.014 ± 0.016</td><td class="colsep0 rowsep0" align="char" char="±">7.08 ± 4.11</td><td class="colsep0 rowsep0" align="center">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="center">49</td><td class="colsep0 rowsep0" align="char" char="±">0.052 ± 0.032</td><td class="colsep0 rowsep0" align="char" char="±">3.27 ± 0.43</td><td class="colsep0 rowsep0" align="center">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="±">0.002 ± 0.003</td><td class="colsep0 rowsep0" align="char" char="±">2.51 ± 1.30</td><td class="colsep0 rowsep0" align="center">8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="center">68</td><td class="colsep0 rowsep0" align="char" char="±">0.078 ± 0.032</td><td class="colsep0 rowsep0" align="char" char="±">3.54 ± 0.48</td><td class="colsep0 rowsep0" align="center">7.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compounds were dosed orally at 30 mg/kg in male Sprague–Dawley rats. <i>n</i> = 5 animals per group.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">CSF and brain Aβ<sub>40</sub> measured at <i>t</i> = 4 h. ND = not determined.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">CSF drug concentration measured at <i>t</i> = 4 h.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Plasma drug concentration measured at <i>t</i> = 4 h.</p></div></div></div><div class="NLM_p">Previous work had demonstrated that the incorporation of a fluorine atom on the P1-phenyl ring can result in significant improvements on the potencies and pharmacokinetic profiles of hydroxyethylamine BACE1 inhibitors,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> so we next examined fluorinated analogues of compounds <b>15</b> and <b>19</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Within the series of compounds containing the 2-thiazolyl moiety, incorporation of a fluorine at the 2 position of the phenyl ring led to a compound (<b>23</b>) with diminished BACE1 potency. Alternatively, compounds containing a fluorine at the 4, 5, or 6 position (<b>24</b>–<b>26</b>) demonstrated similar levels of potency in the enzymatic assay as that shown by the parent compound (<b>15</b>). Of note was compound <b>25</b>, which demonstrated a roughly 3-fold improvement in our enzymatic assay. Similar trends were observed within the acetylene series of compounds. Notably, compound <b>27</b>, which contains a fluorine at the 2-position, showed a modest loss in potency, while the 3-fluoro derivative <b>29</b> showed a small improvement in BACE1 potency. In general, the enzyme-to-cell potency shifts were marginally lower in the fluorinated derivatives (celluar IC<sub>50</sub>/enzyme IC<sub>50</sub> = 1.4–3.8) compared to parent compound <b>15</b> (cellular IC<sub>50</sub>/enzyme IC<sub>50</sub> = 5.5). As was observed with the aryl thiazoles, 4-fluoro substitution in the acetylene series (<b>28</b>) did not lead to appreciable changes in potency. It should be noted that within both series of compounds, introduction of fluorine had no discernible effect on either metabolic stability or efflux potential. It is worth pointing out, however, that compounds substituted with a fluorine at the 6-position (<b>26</b> and <b>30</b>) showed a tendency toward reduced passive permeability relative to their <i>des</i>-fluoro analogues.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. P1-Fluorophenyl BACE1 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0004.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0005.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were averaged values determined by at least two independent experiments.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Human embryonic kidney cells.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Rat liver microsomal (RLM) and human liver microsomal (HLM) clearance. Compound concentration = 1 μM. Microsomal protein concentration = 250 μg/mL.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Apparent permeability measured in parental LLC-PK1 cells. Values are an average of apical to basolateral (A to B) and basolateral to apical (B to A) velocities and are reported as 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Efflux measured in LLC-PK1 cells transfected with either rat MDR1A/1B or human MDR1 and are reported as a ratio of (B to A)/(A to B).</p></div></div><div></div></div><div class="NLM_p">Having established that incorporation of a 2-thiazolyl group onto the 3-position of the P1-phenyl ring of hydroxyethylamine compounds produced potent BACE1 inhibitors with moderate intrinsic metabolic stability, high permeability, and low Pgp-mediated efflux, we next examined systematic variation of the <i>N</i>-acyl group for further optimization. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the <i>N</i>-acetyl analogue (<b>34</b>) displayed increased BACE1 potency but suffered from significantly increased efflux ratios. This supports our previous observations that the Pgp-mediated efflux could be attenuated by incorporating an ethereal oxygen in the amide tether.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Increasing the chain length of the acyl group (<b>35</b>) resulted in a diminished human efflux ratio, but the modestly increased lipophilicity dramatically increased the observed enzyme to cell shift. Alkyl-substitution at the α-position, as in α-methoxypropanamide <b>37</b> and tetrahydrofuran-2-carboxamide epimers <b>41</b> and <b>42</b>, generated compounds with similar potency, stability, and permeability properties as methoxyacetamide <b>15</b>, although α-methoxypropanamide epimer <b>38</b> and α-ethoxypropanamide epimer <b>39</b> were slightly less potent and <b>39</b> was slightly less stable in rat liver microsomes as well. Incorporation of additional oxygenation, as in 2,2-dimethoxyacetamide <b>40</b>, was also tolerated. Addition of a free alcohol to the acetamide (<b>43</b>) resulted in a compound with good potency on the BACE1 enzyme, but this compound suffered from an increased enzyme to cell shift, reduced passive permeability, and elevated efflux ratios.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of the <i>N</i>-Acyl Unit of P1-3-(2-Thiazolyl)phenyl BACE1 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0006.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0007.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were averaged values determined by at least two independent experiments.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Human embryonic kidney cells.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Rat liver microsomal (RLM) and human liver microsomal (HLM) clearance. Compound concentration = 1 μM. Microsomal protein concentration = 250 μg/mL.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Apparent permeability measured in parental LLC-PK1 cells. Values are an average of apical to basolateral (A to B) and basolateral to apical (B to A) velocities and are reported as 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Efflux measured in LLC-PK1 cells transfected with either rat MDR1A/1B or human MDR1 and are reported as a ratio of (B to A)/(A to B).</p></div></div><div></div></div><div class="NLM_p">An X-ray cocrystal structure of BACE1 with compound <b>37</b> is represented in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As expected,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> the azachroman and neopentyl groups of the molecule occupy the S1′ and S2′ regions of BACE1, respectively, and the hydroxyethylamine unit engages in hydrogen bonding interactions with the catalytic aspartic acid residues, Asp32 and Asp228. While the phenyl group of the inhibitor occupies the S1 region of BACE1 as observed previously, the crystal structure indicates that the preferred <i>meta</i>-orientation of the 2-thiazolyl group allows it to fill the S3 pocket. This observation is consistent with the higher BACE1 potency of P1 <i>meta</i>-substituted inhibitors (e.g., <b>15</b> and <b>19</b>) relative to their <i>para</i>-substituted counterparts (<b>21</b> and <b>22</b>, respectively). Additionally, the methoxyacetamide unit of <b>37</b> appears to bind differently than the corresponding group of inhibitor <b>1</b>. In the latter compound, a bidentate interaction occurs between the methoxy and carbonyl groups of the acetamide with Thr72.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In the case of <b>37</b>, only the carbonyl of the acetamide engages Thr72, while the methoxy group hydrogen bonds to Thr232 via a water molecule. The different orientation of the methoxy group observed in the crystal structure of <b>37</b> and BACE1 may occur to accommodate the binding of the 2-thiazolyl group in the S3 pocket.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structure of BACE1 complexed with <b>37</b>. (a) Interactions of <b>37</b> with the BACE1 enzyme and extension of the <i>meta</i>-thiazole unit into S3. (b) Interactions of the methoxyacetamide group with BACE1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Model for Reduction of CNS Aβ Levels</h3><div class="NLM_p">Studies with potent BACE1 inhibitors in rats had demonstrated that the extent of Aβ-reduction in the brain and CSF could be correlated with the concentrations of inhibitor in the CSF, a surrogate measurement for unbound drug in the brain. Within an acute setting, the dosing of peripherally restricted BACE1 inhibitors resulted in reduced plasma Aβ concentrations; however, the levels of Aβ in the brain and CSF remained unperturbed.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Although distribution of a compound into the CNS is governed by a number of complex factors, compounds with moderate-to-high passive permeability (≥10 × 10<sup>–6</sup> cm/s) and low transporter-mediated (e.g., Pgp) efflux (efflux ratios <3) generally have a better likelihood of achieving good CNS exposures.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Most of the compounds featuring either a 2-thiazolyl-phenyl or ethynylphenyl P1 group that we examined exhibited low (<3) rat and human efflux ratios. Exceptions to this trend are straight-chain alkyl amides <b>34</b> and <b>35</b> and hydroxypropanamide <b>43</b>. These analogues displayed higher human and rat efflux ratios (generally >3) that are likely to decrease CNS penetration. Of the methoxyacetamides examined, only the oxazole <b>13</b> and the 6-fluorophenyl derivatives <b>26</b> and <b>30</b> exhibited low passive permeabilities (<15 × 10<sup>–6</sup> cm/s), and all but one of the acyl analogues examined in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> (hydroxypropanamide <b>43</b>) showed good passive permeability. On the basis of these considerations, a select group of compounds from Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were evaluated further in the acute rat pharmacodynamic model (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In general it was found that compounds that achieved CSF concentrations at or over their functional IC<sub>50</sub>s resulted in robust reduction (60–76%) of CSF Aβ<sub>40</sub> levels. As mentioned above, Pgp-mediated efflux can limit the exposure of compounds in the CNS, and this trend is exemplified by acetamide <b>34</b>, a compound with good passive permability but which is susceptible to active transport by Pgp. Dosed orally at 30 mg/kg, this compound achieved only low levels (0.002 μM) in the CSF at the 4 h time point despite plasma concentrations of ca. 5.06 μM. As a result, <b>34</b> produced no measurable change in CSF Aβ<sub>40</sub> levels. In contrast, (<i>R</i>)-2-methoxypropanamide <b>37</b> displayed similar passive permeability but did not appear to be a substrate for Pgp-mediated efflux. Despite lower plasma concentrations (3.11 μM), <b>37</b> achieved 42-fold higher CSF levels (0.085 μM) than <b>34</b>, producing a robust 69% reduction in CSF Aβ 4 h after oral dosing.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Reduction of CSF Aβ in Sprague–Dawley Rats<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CSF Aβ<sub>40</sub><br /></br>reduction<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center">brain Aβ<sub>40</sub><br /></br>reduction<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center" char="±">CSF compd <br /></br>conc (μM)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">plasma compd <br /></br>conc (μM)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">rat Pgp-efflux <br /></br>ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="center">49</td><td class="colsep0 rowsep0" align="char" char="±">0.052 ± 0.032</td><td class="colsep0 rowsep0" align="char" char="±">3.27 ± 0.43</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="center">68</td><td class="colsep0 rowsep0" align="char" char="±">0.078 ± 0.032</td><td class="colsep0 rowsep0" align="char" char="±">3.54 ± 0.48</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="center">45</td><td class="colsep0 rowsep0" align="char" char="±">0.035 ± 0.018</td><td class="colsep0 rowsep0" align="char" char="±">11.7 ± 1.53</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="±">0.002 ± 0.003</td><td class="colsep0 rowsep0" align="char" char="±">5.06 ± 1.06</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="center">59</td><td class="colsep0 rowsep0" align="char" char="±">0.085 ± 0.022</td><td class="colsep0 rowsep0" align="char" char="±">3.11 ± 0.18</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="char" char="±">0.046 ± 0.046</td><td class="colsep0 rowsep0" align="char" char="±">4.18 ± 1.99</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Compounds were dosed orally at 30 mg/kg in male Sprague–Dawley rats. <i>n</i> = 5 animals per group.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">CSF and brain Aβ<sub>40</sub> measured at <i>t</i> = 4 h. ND = not determined.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">CSF drug concentration measured at <i>t</i> = 4 h.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Plasma drug concentration measured at <i>t</i> = 4 h.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Pharmacokinetic Profiles in Rat</h3><div class="NLM_p">The pharmacokinetic properties of a group of these compounds were assessed in rat following both intravenous (iv) and oral (po) dosing. As summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, thiazole-containing compounds <b>15</b>, <b>25</b>, and <b>37</b> and aryl acetylene <b>19</b> displayed moderate clearance (0.71–1.46 L/h/kg) and half-lives (ca. 5–9 h) in male Sprague–Dawley rats when dosed iv. As a consequence of their CYP 3A4 inhibitory activities, these compounds each demonstrated high plasma exposure following a 10 mg/kg oral dose in addition to excellent bioavailabilities (>100%). Compound <b>37</b> had a particularly high AUC<sub>0→∞</sub> of 34470 ng·h/mL, and the thiazole-containing compounds showed similar plasma protein binding in the range of 96.3–98.6%.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Plasma Protein Binding and Pharmacokinetic Parameters in Male Sprague–Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">iv<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">po<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub><br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0→∞</sub><br /></br>(ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><br /></br>(ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>max</sub><br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><br /></br>(%)</th><th class="colsep0 rowsep0" align="center">plasma protein <br /></br>binding (%)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="char" char=".">2.19</td><td class="colsep0 rowsep0" align="char" char=".">8.96</td><td class="colsep0 rowsep0" align="char" char=".">9030</td><td class="colsep0 rowsep0" align="char" char=".">1887</td><td class="colsep0 rowsep0" align="char" char=".">3.33</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="center">96.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">1.54</td><td class="colsep0 rowsep0" align="char" char=".">5.30</td><td class="colsep0 rowsep0" align="char" char=".">24250</td><td class="colsep0 rowsep0" align="char" char=".">4863</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">1.03</td><td class="colsep0 rowsep0" align="char" char=".">1.92</td><td class="colsep0 rowsep0" align="char" char=".">8.81</td><td class="colsep0 rowsep0" align="char" char=".">5335</td><td class="colsep0 rowsep0" align="char" char=".">4440</td><td class="colsep0 rowsep0" align="char" char=".">4.00</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="center">98.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="char" char=".">1.22</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char=".">34770</td><td class="colsep0 rowsep0" align="char" char=".">5290</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char=".">297</td><td class="colsep0 rowsep0" align="center">98.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Dosed iv at 2 mg/kg as a solution in DMSO.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Dosed po at 10 mg/kg as an aqueous suspension in 1% Tween 80 in 2% HMPC.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">ND = not determined.</p></div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Determination of In Vivo Plasma EC<sub>50</sub> for Central Aβ<sub>40</sub> Reduction</h3><div class="NLM_p">On the basis of their favorable pharmacokinetic and pharmacodynamic properties, compounds <b>15</b> and <b>37</b> were further evaluated in dose–response studies at a 4 h time point. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, the total plasma concentrations required to produce a 50% reduction in CSF Aβ<sub>40</sub> for both compounds were determined to be very similar and in the low single-digit micromolar range (EC<sub>50, total</sub> = 1.85 μM for <b>15</b>; EC<sub>50, total</sub> = 1.62 μM for <b>37</b>). When corrected for plasma protein binding at these concentrations, the effective unbound plasma concentrations were found to be in the low nanomolar range (EC<sub>50, unbound</sub> = 6.6 nM and 13.5 nM for <b>15</b> and <b>37</b>, respectively). Compounds <b>15</b> and <b>37</b> produced robust reductions in CSF Aβ<sub>40</sub> at significantly lower unbound plasma concentrations than those required for compounds such as <b>1</b> (EC<sub>50, unbound</sub> = 176 nM), likely as a result of reduced Pgp-mediated efflux and consequently higher CNS exposures. Therefore, this series represented a substantial advantage over earlier HEA BACE1 inhibitors in terms of efficacy in our rat pharmacodynamic model.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Effective Concentrations in Plasma for CSF Aβ<sub>40</sub> Reduction in Male Sprague–Dawley Rats 4 h after Oral Dosing<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50, total</sub> for CSF <br /></br>Aβ<sub>40</sub> reduction (μM)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50, unbound</sub> for CSF <br /></br>Aβ<sub>40</sub> reduction (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">1.85</td><td class="colsep0 rowsep0" align="char" char=".">0.0066</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">1.62</td><td class="colsep0 rowsep0" align="char" char=".">0.0135</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Each compound was dosed at 10, 30, and 100 mg/kg, po as an aqueous suspension in 1% Tween 80 in 2% HMPC. Plasma drug concentrations and CSF Aβ<sub>40</sub> concentrations measured at <i>t</i> = 4 h. For each group, <i>n</i> = 5.</p></div></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Pharmacokinetic Profile and Cardiovascular Safety Evaluation of Inhibitor <b>37</b> in Male Beagle Dogs</h3><div class="NLM_p">To study the cardiovascular profile of <b>37</b> in an anesthetized dog model, we first determined the pharmacokinetic parameters of this compound in dogs. Upon intravenous administration to male beagles, <b>37</b> displayed moderate clearance (0.23 L/h/kg) and <i>V</i><sub>ss</sub> (0.586 L/kg), resulting in a short half-life of 2.8 h (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). On the basis of this information, compound <b>37</b> was administered intravenously as a series of three 60 min infusions at doses of 1.5, 5, and 20 mg/kg to two chloralose-anesthetized dogs; blood samples were taken throughout the infusion period to quantify exposure. At the end of each infusion period, the unbound plasma concentrations increased in a dose-dependent manner and were determined (average) to be 37.5, 219, and 793 nM, respectively. No significant effects on mean arterial pressure, heart rate, cardiac output, or systemic vascular resistance were observed by the end of the second infusion, at which point unbound plasma concentrations of <b>37</b> were ca. 16-fold over the effective unbound plasma concentration for a 50% reduction in CSF Aβ in the acute rat pharmacodynamic model. Upon infusion of the high dose, concentrations of <b>37</b> were ca. 60-fold over the EC<sub>50,unbound</sub>, and reductions in mean arterial pressure (15%) and systemic vascular resistance (43%) were observed along with reflex tachycardia (50%). The wider safety margin represented a significant improvement in CV safety for <b>37</b> compared to lead compound <b>1</b>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Plasma Protein Binding and Pharmacokinetic Parameters of <b>37</b> in Male Beagle Dogs<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0→∞</sub><br /></br>(ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">CL <br /></br>(L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub><br /></br>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub><br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char=".">plasma protein <br /></br>binding (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">11970</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">2.82</td><td class="colsep0 rowsep0" align="char" char=".">98.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Dosed iv at 2 mg/kg as a solution in 5% propylene glycol, 95% D5W at pH = 4.0.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Dual BACE1/CYP 3A4 inhibitors were prepared via modification of the hydroxyethylamine scaffold to incorporate <i>N</i>-heterocyclic or alkynyl groups at the 3-position of a P1-phenyl ring. α-Alkoxy acetamides bearing 2-thiazolyl or ethynyl groups on the P1-phenyl ring provided the best balance of functional potency, intrinsic metabolic stability, high passive permeability, and low efflux ratios. By virtue of their CYP 3A4-inhibiting properties, these compounds exhibited good pharmacokinetic profiles in both rat and dog. When dosed orally in an acute rat pharmacodynamic model, several compounds were shown to produce robust decreases in CSF and brain Aβ<sub>40</sub> levels following a single 30 mg/kg dose. More rigorous dose–response efficacy studies demostrated that compounds <b>15</b> and <b>37</b> reduced CSF Aβ<sub>40</sub> levels by 50% at effective unbound plasma concentrations in the range of 6–13 nM. Compound <b>37</b> was further profiled in an anesthetized dog model for cardiovascular hazard identification and was found to produce no significant changes in cardiovascular function at concentrations exceeding 16-fold the effective unbound plasma concentration required for 50% reduction of CSF Aβ<sub>40</sub> levels in rats, a significant improvement over BACE1 inhibitors exemplified by <b>1</b>. Further studies describing pharmacodynamic and toxicology studies of these compounds will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> BACE1 Enzymatic Assay</h3><div class="NLM_p last">BACE1 enzymatic activity was determined by the enhancement of fluorescence intensity upon enzymatic cleavage of the fluorescence resonance energy transfer substrate. The BACE1 recognition and cleavage sequence of the substrate is derived from the reported literature,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and the fluorophore and quencher dyes are attached to side chain of Lys residues at the termini of the substrate peptide. The human recombinant BACE1<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> assay was performed in 50 mM acetate, pH 4.5/8% DMSO/100 μM Genepol/0.002% Brij-35. In dose–response IC<sub>50</sub> assays, 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 60 min at room temperature. Subsequently, the substrate was added to initiate the reaction. After 60 min at room temperature, the reaction was stopped by addition of 0.1 M Tris base to raise the pH above the enzyme active range, and the increase of fluorescence intensity was measured on Safire II microplate reader (Tecan, Männedorf, Switzerland).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Cell-Based Assay</h3><div class="NLM_p last">Human embryonic kidney cells (HEK293) stably expressing APP<sub>SW</sub> were plated at a density of 100K cells/well in 96-well plates (Costar). The cells were cultivated for 6 h at 37 °C and 5% CO<sub>2</sub> in DMEM supplemented with 10% FBS. Cells were incubated overnight with test compounds at concentrations ranging from 0.0005 to 10 μM. Following incubation with the test compounds, the conditioned media was collected and the Aβ40 levels were determined using a sandwich ELISA. The IC<sub>50</sub> was calculated from the percent of control Aβ40 as a function of the concentration of the test compound. The sandwich ELISA to detect Aβ40 was performed in 96-well microtiter plates, which were precoated with goat antirabbit IgG (Pierce). The capture and detection antibody pair that was used to detect Aβ40 from cell supernatants consists of affinity purified pAβ40 (Invitrogen) and biotinylated 6E10 (Covance), respectively. Conditioned media was incubated with capture antibody overnight at 4 °C, followed by washing. The detecting antibody incubation was for 3 h at 4 °C, again followed by the wash steps as described previously. The plate was developed using Delfia reagents (Streptavidin–Europium and Enhancement solution (Perkin-Elmer)), and time-resolved fluorescence was measured on an EnVision multilabel plate reader (Perkin-Elmer).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Permeability Assay</h3><div class="NLM_p">The wild-type cell line LLC-PK1 (porcine renal epithelial cells, WT-LLC-PK1) was purchased from American Type Culture Collection (ATCC, Manassass, VA). Transfections of WT-LLC-PK1 cells with human <i>MDR</i>1 gene (hMDR1-LLC-PK1) and rat <i>mdr1a</i> gene (rMdr1a-LLC-PK1) were generated. Cells were grown in Medium 199 supplemented with 10% fetal bovine serum.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Cells were seeded onto matrigel-coated transwell filter membranes at a density of 90000 cells/well. Media change was performed on day 3. Compound incubations were performed 5–6 days post seeding. All cultures were incubated at 37 °C in a humidified (95% relative humidity) atmosphere of 5% CO<sub>2</sub>/95% air.</div><div class="NLM_p">Prior to the transport experiment,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> culture medium was aspirated from both apical and basolateral wells and cells were rinsed with warmed (37 °C) Hank’s balanced salt solution supplemented with 10 mM Hepes at pH 7.4 (HHBSS, Invitrogen, Grand Island, NY). HHBSS was removed from wells prior to dosing with test drugs at 5 μM in transport buffer (HHBSS containing 0.1% bovine serum albumin). Then 150 μL of transport buffer were added to receiver chambers prior to dosing in triplicate to apical or basolateral chambers. The dosed transwell plates containing the cell monolayers were incubated for 2 h at 37 °C on a shaking platform. At the end of the incubation period, 100 μL samples were collected from receiver reservoirs and analyzed by LC-MS/MS on an API4000 (Applied Biosystem, Foster City, CA) triple quadruple mass spectrometer interfaced with turbo IonSpray operated in positive mode using Analyst 1.4.2 software.</div><div class="NLM_p last">The apparent permeability coefficient (<i>P</i><sub>app</sub>) of all tested agents was estimated from the slope of a plot of cumulative amount of the agent versus time based on the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/jm-2012-00118s_m001.gif" alt="" /></img></span>where d<i>Q</i>/d<i>t</i> is the penetration rate of the agent (ng/s), <i>A</i> is the surface area of the cell layer on the Transwell (0.11 cm<sup>2</sup>), and <i>C</i><sub>0</sub> is the initial concentration of the test compound (ng/mL). Efflux ratio (ER) was calculated from the basolateral-to-apical permeability divided by the apical-to-basolateral permeability: ER = <i>P</i><sub>app</sub> B > A/<i>P</i><sub>app</sub> A > B.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> X-Ray Crystal Structure</h3><div class="NLM_p last">The catalytic domain of human BACE1 (residues 14–453) was overexpressed in <i>Escherichia coli</i> and refolded from inclusion bodies following a procedure described previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Purified protein was concentrated to ∼8 mg/mL and 0.5 mM compound <b>37</b> was added to the sample, which was allowed to incubate on ice for 2 h. BACE1 was crystallized by hanging drop vapor diffusion at room temperature by mixing 1.0 uL of protein solution with 1.0 uL of reservoir solution containing 16% PEG 8000 and 0.1 M sodium citrate (pH 5.0). Diffraction data were collected at the Advanced Light Source, beamline 5.0.2, using λ = 1.0000 Å and an ADSC Q315R CCD detector. Data were reduced using HKL2000.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The crystals belong to the space group <i>P</i>2<sub>1</sub> with approximate unit cell dimensions of <i>a</i> = 82.7 Å, <i>b</i> = 104.8 Å, and <i>c</i> = 103.9 Å. The structure was solved by molecular replacement using PHASER<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and employing a human BACE1 structure with the same space group (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DUY">3DUY</a>) as a search model. The structure was refined with REFMAC5, and model building was performed with COOT.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Data collection and refinement statistics appear in the <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Pharmacodynamic Assay</h3><div class="NLM_p last">Male Sprague–Dawley rats (175–200 g) were purchased from Harlan and were maintained on a 12 h light/dark cycle with unrestricted access to food and water until use. Rats were administered compound by oral gavage at the appropriate dose. Rats were euthanized with CO<sub>2</sub> inhalation for 2 min, and cisterna magna was quickly exposed by removing the skin and muscle above it. CSF (50–100 μL) was collected with a 30 gauge needle through the dura membrane covering the cisterna magna. Blood was withdrawn by cardiac puncture and plasma obtained by centrifugation for drug exposures. Brains were removed and, along with the CSF, immediately frozen on dry ice and stored at −80 °C until use. The frozen brains were subsequently homogenized in 10 volumes of (w/v) of 0.5% Triton X-100 in TBS with protease inhibitors. The homogenates were centrifuged at 100000 rpm for 30 min at 4 °C. The supernatants were analyzed for Aβ40 levels by immunoassay as follows: Meso Scale 96-well avidin plates were coated with Biotin-4G8 (Covance) and detected with ruthenium-labeled Fab specific for Aβ40. Plates were read in MSD Sector6000 imager according to manufacturer’s recommended protocol (Meso Scale Discovery, Inc.). Aβ40 concentrations were plotted using Graphpad Prism and analyzed by one-way ANOVA followed by Dunnett’s multiple comparison analysis to compare drug-treated animals to vehicle-treated controls.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> CYP3A4 Inhibition Assay</h3><div class="NLM_p last">Pooled human liver microsomes (0.1 mg/mL) were incubated at 37 °C in a phosphate buffer (pH 7.4) with the selective CYP3A substrate midazolam at a concentration of 2.5 μM in the presence and absence of test compound (at about a 3 μM concentration). The reaction was started with the addition of NADPH (1 mM final concentration). Incubations were stopped after 10 min by the addition of organic solvent and 1-hydroxymidazolam. Metabolite formation was measured by HPLC-MS. The ability of the test compound to inhibit the activity of CYP3A4 was determined. Estimated IC<sub>50</sub>s were calculated based on the ratio of the concentration of metabolite in the presence of test compound to the concentration of metabolite in the absence of test compound.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Chemistry</h3><div class="NLM_p last">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Sulfinyl imine <b>2</b> and azachroman <b>6</b> were prepared as described in ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>. Benzyl Grignard reagents were purchased from Rieke Metals, Inc. as solutions in ether. Anhydrous solvents were obtained from Aldrich or EM Science and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. All microwave assisted reactions were conducted with a Smith synthesizer from Personal Chemistry, Uppsala, Sweden. Silica gel chromatography was performed using either glass columns packed with silica gel (230–400 mesh, EMD Chemicals, Gibbstown, NJ) or prepacked silica gel cartridges (Biotage or ISCO). <sup>1</sup>H NMR spectra were recorded on a Bruker AV-400 (400 MHz) spectrometer at ambient temperature or on a Varian 400 MHz spectrometer. Chemical shifts are reported in parts per million (ppm, δ units) downfield from tetramethylsilane. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and number of protons. Purity for final compounds was greater than 95% unless otherwise noted and was measured using Agilent 1100 series high performance liquid chromatography (HPLC) systems with UV detection at 254 nm (system A, Agilent Zorbax Eclipse XDB-C8 4.6 mm ×150 mm, 5 μm, 5–100% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 15 min at 1.5 mL/min; system B, Waters Xterra 4.6 mm ×150 mm, 3.5 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 15 min at 1.0 mL/min). Exact mass confirmation was performed on an Agilent 1100 series high performance liquid chromatography (HPLC) system (Santa Clara, CA, USA) by flow injection analysis, eluting with a binary solvent system A and B (A, water with 0.1% FA; B, ACN with 0.1% FA) under isocratic conditions (50% A/50% B) at 0.2 mL/min with MS detection by an Agilent G1969A time-of-flight (TOF) mass spectrometer (Santa Clara, CA, USA).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-1-(3-Bromophenyl)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>4a</b>)</h3><div class="NLM_p last">A 2 L flask was charged with (<i>S</i>,<i>E</i>)-<i>N</i>-((<i>S</i>)-2,3-bis(<i>tert</i>-butyldimethylsilyloxy)propylidene)-2-methylpropane-2-sulfinamide (<b>2</b>) (50.00 g, 119 mmol) and THF (300 mL), and the resulting solution was cooled to −65 °C. (3-Bromobenzyl)magnesium chloride (948 mL of a 0.25 M solution in diethyl ether, 237 mmol) was added dropwise via cannula over 2.5 h such that the internal temperature did not rise above −60 °C. The resulting yellow slurry was stirred for 2 h at −65 °C, at which time TLC analysis indicated consumption of the starting material. The reaction mixture was warmed −25 °C, at which point a saturated aq ammonium chloride solution (200 mL) was added. The resulting white solids were dissolved upon the addition of water (150 mL). The mixture was warmed to room temperature, and the layers were separated. The aqueous layer was extracted with ethyl acetate (250 mL). The organic layers were combined, and the combined solution was dried over sodium sulfate, filtered, and concentrated to afford a yellow oil. The crude product was purified by chromatography on silica gel (0–10% EtOAc/hexane) to afford (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-1-(3-bromophenyl)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>4a</b>) as a pale-yellow oil that formed a waxy solid upon standing at room temperature. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.29–7.36 (m, 2 H), 7.12 (ddd, <i>J</i> = 15.43, 7.65, 7.53 Hz, 2 H), 4.18 (ddd, <i>J</i> = 8.16, 5.90, 2.51 Hz, 1 H), 3.71–3.80 (m, 1 H), 3.67 (dd, <i>J</i> = 10.29, 5.77 Hz, 1 H), 3.49–3.60 (m, 2 H), 2.90 (dd, <i>J</i> = 14.05, 4.02 Hz, 1 H), 2.58 (dd, <i>J</i> = 13.80, 10.79 Hz, 1 H), 0.99 (s, 9 H), 0.94 (s, 9 H), 0.93 (s, 9 H), 0.18 (s, 3 H), 0.07–0.14 (m, 6 H), 0.01 (s, 3 H). MS <i>m</i>/<i>z</i> = 592.2 [M + H]<sup>+</sup>. Calcd for C<sub>26</sub>H<sub>51</sub>BrNO<sub>3</sub>SSi<sub>2</sub>: 592.2.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-3,4-Bis(<i>tert</i>-butyldimethylsilyloxy)-1-(3-chloro-5-fluorophenyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>4b</b>)</h3><div class="NLM_p last">The title compound was prepared via a method analogous to the preparation of compound <b>4a</b> using (3-chloro-5-fluorobenzyl)magnesium chloride, giving a pale-yellow oil (24.0 g, 71% yield). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 6.96 (s, 1 H), 6.91 (dt, <i>J</i> = 8.40, 2.08 Hz, 1 H), 6.78 (dt, <i>J</i> = 9.21, 1.75 Hz, 1 H), 4.19 (ddd, <i>J</i> = 8.51, 5.88, 2.41 Hz, 1 H), 3.62–3.82 (m, 2 H), 3.43–3.62 (m, 2 H), 2.90 (dd, <i>J</i> = 14.10, 3.73 Hz, 1 H), 2.58 (dd, <i>J</i> = 14.10, 10.60 Hz, 1 H), 1.01 (s, 9 H), 0.94 (s, 9 H), 0.93 (s, 9 H), 0.19 (s, 3 H), 0.07–0.15 (m, 9 H).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-3,4-Bis(<i>tert</i>-butyldimethylsilyloxy)-1-(3-chloro-4-fluorophenyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>4c</b>)</h3><div class="NLM_p last">The title compound was prepared via a method analogous to the preparation of compound <b>4a</b> using (3-chloro-4-fluorobenzyl)magnesium bromide, giving a pale yellow oil (1.4 g, 80% yield). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 7.14–7.22 (m, 1 H), 6.96–7.08 (m, 2 H), 4.12–4.22 (m, 1 H), 3.51–3.79 (m, 4 H), 2.88 (dd, <i>J</i> = 14.25, 3.58 Hz, 1 H), 2.56 (dd, <i>J</i> = 14.10, 10.45 Hz, 1 H), 1.00 (s, 9 H), 0.94 (s, 9 H), 0.93 (s, 9 H), 0.18 (s, 3 H), 0.06–0.14 (m, 9 H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-3,4-Bis(<i>tert</i>-butyldimethylsilyloxy)-1-(5-chloro-2-fluorophenyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>4d</b>)</h3><div class="NLM_p last">The title compound was prepared via a method analogous to the preparation of compound <b>4a</b> using (5-chloro-2-fluorobenzyl)magnesium bromide, giving a pale-yellow oil (4.0 g, 63% yield). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 7.05–7.19 (m, 2 H), 6.82–6.98 (m, 1 H), 4.22 (ddd, <i>J</i> = 8.37, 5.88, 2.27 Hz, 1 H), 3.75 (ddd, <i>J</i> = 10.19, 4.71, 2.34 Hz, 1 H), 3.47–3.72 (m, 3 H), 2.65–2.88 (m, 2 H), 1.27 (s, 9 H), 0.97 (s, 9 H), 0.94 (s, 9 H), 0.20 (s, 3 H), 0.08–0.14 (m, 9 H).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-3,4-Bis(<i>tert</i>-butyldimethylsilyloxy)-1-(4-chlorophenyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>4e</b>)</h3><div class="NLM_p last">The title compound was prepared via a method analogous to the preparation of compound <b>4a</b> using 4-chlorobenzylmagnesium chloride, giving a pale-yellow oil (86 g, 77% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.23 (d, <i>J</i> = 8.53 Hz, 2 H), 7.03–7.13 (m, 2 H), 4.12–4.21 (m, 1 H), 3.70–3.82 (m, 1 H), 3.67 (dd, <i>J</i> = 10.04, 5.52 Hz, 1 H), 3.48–3.61 (m, 2 H), 2.89 (dd, <i>J</i> = 14.56, 4.02 Hz, 1 H), 2.60 (dd, <i>J</i> = 14.05, 10.54 Hz, 1 H), 0.98 (s, 9 H), 0.94 (s, 9 H), 0.93 (s, 9 H), 0.18 (s, 3 H), 0.07–0.13 (m, 9 H).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-3,4-Bis(<i>tert</i>-butyldimethylsilyloxy)-1-(3-chloro-2-fluorophenyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>4f</b>)</h3><div class="NLM_p last">The title compound was prepared via a method analogous to the preparation of compound <b>4a</b> using (3-chloro-2-fluorobenzyl)magnesium bromide, giving a pale-yellow oil (24.5 g, 77% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.29 (ddd, <i>J</i> = 7.97, 7.09, 1.76 Hz, 1 H), 7.14–7.22 (m, 1 H), 7.03–7.10 (m, 1 H), 4.13 (ddd, <i>J</i> = 7.87, 5.72, 2.15 Hz, 1 H), 3.59–3.77 (m, 4 H), 2.84–2.91 (m, 2 H), 0.94 (s, 9 H), 0.94 (s, 9 H), 0.90 (s, 9 H), 0.17 (s, 3 H), 0.13 (s, 3 H), 0.12 (s, 6 H).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-1-(3-Bromophenyl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4 Hydroxybutan-2-ylcarbamate (<b>5a</b>)</h3><div class="NLM_p last">A solution of (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-1-(3-bromophenyl)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>4a</b>) (5.00 g, 8.43 mmol) in ethanol (60 mL) at −40 °C was added hydrogen chloride (10.5 mL of a 4N solution in 1,4-dioxane, 42.2 mmol) dropwise over 3 min such that the maintained the temperature did not rise above −35 °C. The reaction was briefly warmed to −5 °C to dissolve the white precipitate that had formed, and then the resulting homogeneous solution was maintained at −20 °C for 16 h. After this time, <i>N</i>,<i>N</i>-diisopropylethylamine (10.3 mL, 59.0 mmol) and di-<i>tert</i>-butyl dicarbonate (3.68 g, 16.9 mmol) were added in sequence, and the reaction was warmed to 23 °C. After stirring for 30 min, the reaction mixture was diluted with dichloromethane (100 mL) and poured into a 50% aq ammonium chloride solution (500 mL). The layers were separated, and the aqueous layer was extracted with dichloromethane (3 × 100 mL). The organic layers were combined, and the combined solution was washed with water (100 mL), washed with brine (100 mL), dried over sodium sulfate, filtered, and concentrated. Purification of the crude product by chromatography on silica gel (0–25% EtOAc/Hexane) afforded <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-1-(3-bromophenyl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4 hydroxybutan-2-ylcarbamate (<b>5a</b>) (2.75 g, 68.7% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.32–7.39 (m, 2 H), 7.09–7.20 (m, 2 H), 4.67 (d, <i>J</i> = 8.51 Hz, 1 H), 4.02–4.24 (m, 1 H), 3.93 (br s, 1 H), 3.69–3.77 (m, 2 H), 3.59–3.68 (m, 1 H), 2.99 (dd, <i>J</i> = 14.28, 4.40 Hz, 1 H), 2.69 (dd, <i>J</i> = 13.55, 9.54 Hz, 1 H), 1.37 (s, 9 H), 0.94 (s, 9 H), 0.11 (d, <i>J</i> = 1.86 Hz, 6 H).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(3-chloro-5-fluorophenyl)-4 Hydroxybutan-2-ylcarbamate (<b>5b</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>4b</b> via a method analogous to the preparation of compound <b>5a</b>, giving a colorless oil (36.0 g, 88% yield). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 7.00 (s, 1 H), 6.94 (dt, <i>J</i> = 8.48, 2.05 Hz, 1 H), 6.84 (d, <i>J</i> = 9.35 Hz, 1 H), 4.68 (d, <i>J</i> = 8.92 Hz, 1 H), 3.99–4.24 (m, 1 H), 3.91 (tt, <i>J</i> = 9.59, 5.02 Hz, 1 H), 3.57–3.80 (m, 2 H), 2.99 (dd, <i>J</i> = 14.25, 4.17 Hz, 1 H), 2.60–2.75 (m, 1 H), 2.37 (br s, 1 H), 1.36 (s, 9 H), 1.19 (s, 9 H), 0.11 (s, 6 H).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(3-chloro-4-fluorophenyl)-4 Hydroxybutan-2-ylcarbamate (<b>5c</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>4c</b> via a method analogous to the preparation of compound <b>5a</b>, giving a colorless oil (0.49 g, 84% yield). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 7.24 (d, <i>J</i> = 7.45 Hz, 1 H), 6.99–7.12 (m, 2 H), 4.67 (d, <i>J</i> = 8.77 Hz, 1 H), 3.83–3.97 (m, <i>J</i> = 9.37, 9.37, 4.71, 4.46 Hz, 1 H), 3.58–3.79 (m, 3 H), 2.98 (dd, <i>J</i> = 14.18, 4.24 Hz, 1 H), 2.65 (dd, <i>J</i> = 14.18, 10.08 Hz, 1 H), 2.40 (t, <i>J</i> = 6.07 Hz, 1 H), 1.36 (s, 9 H), 0.90–0.95 (m, 9 H), 0.07–0.15 (m, 6 H). MS <i>m</i>/<i>z</i> = 470.1 [M + Na]<sup>+</sup>. Calcd for C<sub>21</sub>H<sub>35</sub>ClFNNaO<sub>4</sub>Si: 470.1.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(5-chloro-2-fluorophenyl)-4 hydroxybutan-2-ylcarbamate (<b>5d</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>4d</b> via a method analogous to the preparation of compound <b>5a</b>, giving a colorless oil (2.9 g, 92% yield). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 7.06–7.25 (m, 2 H), 6.97 (t, <i>J</i> = 8.99 Hz, 1 H), 4.77 (d, <i>J</i> = 9.06 Hz, 1 H), 4.00–4.31 (m, 1 H), 3.84–4.00 (m, 1 H), 3.56–3.85 (m, 2 H), 3.01 (dd, <i>J</i> = 14.47, 3.65 Hz, 1 H), 2.52–2.82 (m, 1 H), 2.32 (t, <i>J</i> = 6.14 Hz, 1 H), 1.36 (s, 9 H), 0.94 (s, 9 H), 0.12 (s, 6 H).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(4-chlorophenyl)-4 hydroxybutan-2-ylcarbamate (<b>5e</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>4e</b> via a method analogous to the preparation of compound <b>5a</b>, giving a colorless oil (17.8 g, 84% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.22–7.33 (m, 2 H), 7.14 (d, <i>J</i> = 8.41 Hz, 2 H), 4.66 (d, <i>J</i> = 8.41 Hz, 1 H), 3.87–4.01 (m, 1 H), 3.51–3.78 (m, 2 H), 2.98 (dd, <i>J</i> = 14.18, 4.40 Hz, 1 H), 2.68 (dd, <i>J</i> = 13.40, 10.07 Hz, 1 H), 2.39 (br s, 1 H), 1.31–1.42 (m, 9 H), 0.93 (s, 9 H), 0.11 (s, 6 H).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(3-chloro-2-fluorophenyl)-4 hydroxybutan-2-ylcarbamate (<b>5f</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>4f</b> via a method analogous to the preparation of compound <b>5a</b>, giving a colorless oil (17.1 g, 88% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.31 (t, <i>J</i> = 7.29 Hz, 1 H), 7.15–7.25 (m, 1 H), 7.01–7.12 (m, 1 H), 5.16 (d, <i>J</i> = 9.29 Hz, 1 H), 3.98–4.16 (m, 1 H), 3.84–3.97 (m, 1 H), 3.75 (q, <i>J</i> = 4.86 Hz, 1 H), 3.52–3.63 (m, 1 H), 3.03 (dd, <i>J</i> = 13.30, 2.93 Hz, 1 H), 2.87 (t, <i>J</i> = 5.82 Hz, 1 H), 2.66 (t, <i>J</i> = 12.52 Hz, 1 H), 1.27 (br s, 9 H), 0.93 (s, 9 H), 0.11 (s, 6 H).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-1-(3-Bromophenyl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7a</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-1-(3-bromophenyl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-oxobutan-2-ylcarbamate (<b>5a</b>) (0.68 g, 1.4 mmol) and (<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridin]-4′-amine (<b>6</b>) (0.37 g, 1.4 mmol) in dichloromethane (10 mL) was treated with trimethyl orthoformate (1.3 mL, 12 mmol). The solution was stirred for 1 h,  then sodium triacetoxyborohydride (1.2 g, 5.8 mmol) was added, and the resulting mixture was stirred for an additional hour. The reaction mixture was diluted with dichloromethane (25 mL) and saturated aq Rochelle’s salt solution (50 mL). The biphasic mixture was stirred vigorously for 1 h, and then the layers were separated. The aq layer was extracted with dichloromethane (2 × 25 mL). The organic extracts were combined, and the combined solution was washed with water, washed with brine, dried over sodium sulfate, filtered, and concentrated. The crude product was purified by chromatography on silica gel (0–30% EtOAc/Hexane) to afford <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-1-(3-bromophenyl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7a</b>) (0.845 g, 82% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.89 (br s, 1 H), 7.57 (br s, 1 H), 7.37 (s, 2 H), 7.10–7.21 (m, 2 H), 3.75–4.10 (m, 3 H), 2.87–3.00 (m, 1 H), 2.81 (d, <i>J</i> = 7.82 Hz, 2 H), 2.50–2.66 (m, 1 H), 2.29–2.47 (m, 2 H), 2.17–2.29 (m, 1 H), 2.04–2.15 (m, 1 H), 1.92–2.03 (m, 1 H), 1.65–1.82 (m, 1 H), 1.39 (br s, 9 H), 0.90 (s, 18 H), 0.83–0.89 (m, 6 H), 0.07 (br s, 3 H), 0.05 (br s, 3 H). MS <i>m</i>/<i>z</i> = 716.2 [M + H]<sup>+</sup>. Calcd for C<sub>37</sub>H<sub>59</sub>BrN<sub>3</sub>O<sub>4</sub>Si: 716.4.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(3-chloro-5-fluorophenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7b</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>5b</b> and <b>6</b> via a method analogous to the preparation of <b>7a</b>, giving a white solid (2.3 g, 99% yield). MS <i>m</i>/<i>z</i> = 690.2 [M + H]<sup>+</sup>. Calcd for C<sub>37</sub>H<sub>58</sub>ClFN<sub>3</sub>O<sub>4</sub>Si: 690.4.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(3-chloro-4-fluorophenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7c</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>5c</b> and <b>6</b> via a method analogous to the preparation of <b>7a</b>, giving a white solid (3.8 g, 83% yield). MS <i>m</i>/<i>z</i> = 690.3 [M + H]<sup>+</sup>. Calcd for C<sub>37</sub>H<sub>58</sub>ClFN<sub>3</sub>O<sub>4</sub>Si: 690.4.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(5-chloro-2-fluorophenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7d</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>5d</b> and <b>6</b> via a method analogous to the preparation of <b>7a</b>, giving a white solid (0.13 g, 78% yield). MS <i>m</i>/<i>z</i> = 690.3 [M + H]<sup>+</sup>. Calcd for C<sub>37</sub>H<sub>58</sub>ClFN<sub>3</sub>O<sub>4</sub>Si: 690.4.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(4-chlorophenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7e</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>5e</b> and <b>6</b> via a method analogous to the preparation of <b>7a</b>, giving a white solid (0.50 g, 54% yield). MS <i>m</i>/<i>z</i> = 671.8 [M + H]<sup>+</sup>. Calcd for C<sub>37</sub>H<sub>59</sub>ClN<sub>3</sub>O<sub>4</sub>Si: 672.4.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(3-chloro-2-fluorophenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7f</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>5f</b> and <b>6</b> via a method analogous to the preparation of <b>7a</b>, giving a white solid (7.9 g, 72% yield). MS <i>m</i>/<i>z</i> = 690.1 [M + H]<sup>+</sup>. Calcd for C<sub>37</sub>H<sub>58</sub>ClFN<sub>3</sub>O<sub>4</sub>Si: 690.4.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-Bromophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9a</b>)</h3><div class="NLM_p last">A solution of (2<i>S</i>,3<i>R</i>)-1-(3-bromophenyl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7a</b>) (1.45 g, 2.00 mmol) in methanol (5 mL) was treated with hydrogen chloride (10 mL of a 4N solution in 1,4-dioxane, 40 mmol), and the resulting solution was stirred for 16 h. The reaction mixture was concentrated in vacuo, and the residue was taken up in dichloromethane (25 mL) and <i>N</i>,<i>N</i>-diisopropylethylamine (7.8 mL, 44 mmol) to give a clear solution. A solution of 1-(1<i>H</i>-imidazol-1-yl)-2-methoxyethanone (1.0 mL, 2.0 mmol) in dichloromethane (10 mL) was added, and the reaction mixture was to stirred at room temperature for 15 h. The reaction mixture was washed with a saturated aq sodium bicarbonate solution (50 mL), the layers were separated, and the aqueous layer was extracted with dichloromethane (2 × 25 mL). The organic layers were combined, and the combined solution was washed with water (50 mL), washed with brine (50 mL), dried over sodium sulfate, filtered, and concentrated. The crude product was purified by chromatography on silica gel (0–5% MeOH/DCM) to afford <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-bromophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9a</b>) (1.090 g, 94% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.79 (d, <i>J</i> = 1.76 Hz, 1 H), 7.70 (dd, <i>J</i> = 2.40, 1.03 Hz, 1 H), 7.40–7.45 (m, 1 H), 7.32–7.39 (m, 1 H), 7.17–7.24 (m, 2 H), 6.89 (d, <i>J</i> = 10.17 Hz, 1 H), 4.02–4.13 (m, 1 H), 3.90 (dd, <i>J</i> = 10.47, 5.48 Hz, 1 H), 3.53–3.79 (m, 4 H), 3.36–3.46 (m, 1 H), 3.25 (s, 2 H), 3.09 (dd, <i>J</i> = 14.04, 3.86 Hz, 1 H), 2.65–2.82 (m, 3 H), 2.43 (s, 4 H), 2.32–2.42 (m, 1 H), 2.17–2.24 (m, 1 H), 2.08–2.13 (m, 1 H), 1.87 (br s, 1 H), 1.71–1.79 (m, 1 H), 1.65 (ddd, <i>J</i> = 13.25, 10.51, 1.17 Hz, 1 H), 0.88 (s, 9 H). MS <i>m</i>/<i>z</i> = 574.2 [M + H]<sup>+</sup>. Calcd for C<sub>29</sub>H<sub>41</sub>BrN<sub>3</sub>O<sub>4</sub>: 574.2.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-Chloro-5-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9b</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>7b</b> via a method analogous to the preparation of <b>9a</b>, giving a white solid (0.64 g, 85% yield).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-Chloro-4-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9c</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>7c</b> via a method analogous to the preparation of <b>9a</b>, giving a white solid (0.87 g, 64% yield). MS <i>m</i>/<i>z</i> = 548.2 [M + H]<sup>+</sup>. Calcd for C<sub>29</sub>H<sub>40</sub>ClFN<sub>3</sub>O<sub>4</sub>: 548.3.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(5-Chloro-2-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9d</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>7d</b> via a method analogous to the preparation of <b>9a</b>, giving a yellow glass (1.2 g, 61% yield). MS <i>m</i>/<i>z</i> = 548.1 [M + H]<sup>+</sup>. Calcd for C<sub>29</sub>H<sub>40</sub>ClFN<sub>3</sub>O<sub>4</sub>: 548.3.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(4-Chlorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9e</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>7e</b> via a method analogous to the preparation of <b>9a</b>, giving a light-yellow solid. (0.81 g, 70% yield). MS <i>m</i>/<i>z</i> = 530.2 [M + H]<sup>+</sup>. Calcd for C<sub>29</sub>H<sub>41</sub>ClN<sub>3</sub>O<sub>4</sub>: 530.3.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(2-fluoro-3-(thiazol-2-yl)phenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>10g</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(3-chloro-2-fluorophenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7f</b>) (3.97 g, 5.75 mmol), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (1.64 g, 3.45 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (0.79 g, 0.86 mmol) in THF (15 mL) was degassed by sparging with N<sub>2</sub> (g) for 15 min. 2-(Tributylstannyl)thiazole (3.23 g, 8.63 mmol) was added, and the resulting mixture was heated to 135 °C for 40 min in a microwave reactor. The reaction mixture was cooled and filtered through a plug of silica gel with the aid of ethyl acetate. The filtrate was concentrated, and the residue was purified by chromatography on silica gel (10–60% EtOAc/hexane) to give <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(2-fluoro-3-(thiazol-2-yl)phenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>10g</b>) as a white solid (3.90 g, 92% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 8.04–8.17 (m, 1 H), 7.87–7.98 (m, 1 H), 7.80 (s, 1 H), 7.66 (s, 1 H), 7.63 (d, <i>J</i> = 3.33 Hz, 1 H), 7.36 (t, <i>J</i> = 8.17 Hz, 1 H), 7.22 (t, <i>J</i> = 7.68 Hz, 1 H), 5.51 (d, <i>J</i> = 8.61 Hz, 1 H), 4.01–4.25 (m, 1 H), 3.84–3.97 (m, 2 H), 3.07 (dd, <i>J</i> = 14.33, 4.65 Hz, 1 H), 2.94 (dd, <i>J</i> = 12.62, 3.91 Hz, 1 H), 2.69–2.82 (m, 2 H), 2.33–2.41 (m, 2 H), 2.21–2.33 (m, 1 H), 2.07–2.21 (m, 2 H), 1.84–1.93 (m, 1 H), 1.69–1.82 (m, 1 H), 1.60 (br s, 1 H), 1.22 (s, 9 H), 0.92 (s, 9 H), 0.85 (s, 9 H), 0.10 (s, 3 H), 0.09 (s, 3 H). MS <i>m</i>/<i>z</i> = 739.2 [M + H]<sup>+</sup>. Calcd for C<sub>40</sub>H<sub>60</sub>FN<sub>4</sub>O<sub>4</sub>SSi: 739.4.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(2-fluoro-3-((trimethylsilyl)ethynyl)phenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>10h</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(3-chloro-2-fluorophenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>7f</b>) (3.97 g, 5.75 mmol), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (1.64 g, 3.45 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (0.79 g, 0.86 mmol) in THF (15 mL) was degassed by sparging with N<sub>2</sub> (g) for 15 min. Trimethyl(2-(tributylstannyl)ethynyl)silane (3.34 g, 8.63 mmol) was added, and the resulting mixture was heated to 135 °C for 40 min in a microwave reactor. The reaction mixture was cooled and filtered through a plug of silica gel with the aid of ethyl acetate. The filtrate was concentrated, and the residue was purified by chromatography on silica gel (10–60% EtOAc/hexane) to give <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(2-fluoro-3-((trimethylsilyl)ethynyl)phenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate as a white solid (3.67 g, 85% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.81 (d, <i>J</i> = 2.15 Hz, 1 H), 7.65 (s, 1 H), 7.19–7.33 (m, 2 H), 7.06 (t, <i>J</i> = 7.63 Hz, 1 H), 5.42 (d, <i>J</i> = 9.39 Hz, 1 H), 3.96–4.09 (m, 1 H), 3.78–3.96 (m, 2 H), 2.86–3.06 (m, 2 H), 2.68–2.83 (m, 1 H), 2.63 (t, <i>J</i> = 13.01 Hz, 1 H), 2.32–2.42 (m, 2 H), 2.20–2.32 (m, 1 H), 2.04–2.20 (m, 2 H), 1.84–1.93 (m, 1 H), 1.69–1.82 (m, 2 H), 1.23–1.32 (m, 9 H), 0.90–0.98 (m, 9 H), 0.83–0.90 (m, 9 H), 0.20–0.30 (m, 9 H), 0.10 (s, 3 H), 0.09 (s, 3 H).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(4-((trimethylsilyl)ethynyl)phenyl)butan-2-ylcarbamate (<b>10i</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>7e</b> via a method analogous to the preparation of <b>10h</b>, giving a white solid (0.30 g, 93% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.81 (br s, 1 H), 7.54–7.68 (m, 1 H), 7.33 (d, <i>J</i> = 8.02 Hz, 2 H), 7.21 (d, <i>J</i> = 8.12 Hz, 2 H), 5.57 (d, <i>J</i> = 10.27 Hz, 1 H), 3.92–4.03 (m, 1 H), 3.79–3.92 (m, 2 H), 2.84–2.98 (m, 2 H), 2.67–2.75 (m, 1 H), 2.57–2.67 (m, 1 H), 2.31–2.40 (m, 3 H), 2.22–2.31 (m, 1 H), 2.14–2.23 (m, 3 H), 1.83–1.92 (m, 1 H), 1.77 (d, <i>J</i> = 2.54 Hz, 2 H), 1.30 (s, 9 H), 0.90 (s, 9 H), 0.88 (s, 9 H), 0.22 (s, 9 H), 0.04–0.09 (m, 6 H). <i>m</i>/<i>z</i> = 734.4 [M + H]<sup>+</sup>. Calcd for C<sub>42</sub>H<sub>68</sub>N<sub>3</sub>O<sub>4</sub>Si<sub>2</sub>: 734.5.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(pyridin-4-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>11</b>)</h3><div class="NLM_p last">A solution of <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-bromophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9a</b>) (0.30 g, 0.52 mmol), 4-(tributylstannyl)pyridine (0.21 g, 0.57 mmol), and tetrakis(tripheynlphosphine)palladium (0.12 g, 0.10 mmol) in 1,4-dioxane (5 mL) was heated to 140 °C for 30 min in a microwave reactor. The reaction mixture was cooled, stirred with 10% aq potassium fluoride solution (10 mL), and extracted with EtOAc (3 × 10 mL). The organic layers were combined, and the combined solution was washed with brine, dried over magnesium sulfate, filtered, and concentrated. The residue was purified by reverse-phase chromatography (10–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.l% TFA). Pure fractions containing product were combined in saturated aq sodium bicarbonate solution and extracted with DCM. The organic extract was dried over sodium sulfate, filtered, and evaporated to give <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(pyridin-4-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>11</b>) (0.105 g, 35% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 8.61 (d, <i>J</i> = 6.16 Hz, 2 H), 7.79 (d, <i>J</i> = 2.25 Hz, 1 H), 7.70 (dd, <i>J</i> = 2.40, 1.03 Hz, 1 H), 7.54–7.61 (m, 4 H), 7.41 (dt, <i>J</i> = 1.00, 7.62 Hz, 1 H), 7.33 (dt, <i>J</i> = 7.53, 1.00 Hz, 1 H), 6.93 (d, <i>J</i> = 9.39 Hz, 1 H), 4.11–4.25 (m, 1 H), 3.91 (dd, <i>J</i> = 10.51, 5.53 Hz, 1 H), 3.74 (dd, <i>J</i> = 15.16 Hz, 1 H), 3.60–3.65 (m, 1 H), 3.58 (dd, <i>J</i> = 15.20 Hz, 1 H), 3.14–3.23 (m, 3 H), 2.76–2.89 (m, 2 H), 2.67–2.75 (m, 1 H), 2.32–2.47 (m, 4 H), 2.06–2.26 (m, 6 H), 1.81–1.91 (m, 1 H), 1.61–1.78 (m, 2 H), 0.86 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 573.3427 [M + H]<sup>+</sup>. Calcd for C<sub>34</sub> H<sub>44</sub>N<sub>4</sub>O<sub>4</sub>: 573.3425.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(pyridin-2-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>12</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>9a</b> and 2-(tributylstannyl)pyridine via a method analogous to the preparation of <b>12</b>, giving a white solid (0.088 g, 32% yield). <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 8.69 (dt, <i>J</i> = 4.75, 1.35 Hz, 1 H), 7.82–7.99 (m, 3 H), 7.64–7.80 (m, 2 H), 7.56 (d, <i>J</i> = 1.61 Hz, 1 H), 7.42 (t, <i>J</i> = 7.60 Hz, 1 H), 7.18–7.35 (m, 2 H), 6.62 (d, <i>J</i> = 9.06 Hz, 1 H), 4.09–4.28 (m, <i>J</i> = 8.51, 8.20, 8.20, 4.46 Hz, 1 H), 3.89–3.99 (m, 1 H), 3.66–3.89 (m, 2 H), 3.47–3.62 (m, 1 H), 3.16–3.29 (m, 4 H), 2.94–3.07 (m, 1 H), 2.83 (dd, <i>J</i> = 12.35, 4.75 Hz, 1 H), 2.65 (dd, <i>J</i> = 12.42, 3.95 Hz, 1 H), 2.54 (t, <i>J</i> = 10.23 Hz, 1 H), 2.41 (s, 2 H), 2.33 (dd, <i>J</i> = 13.15, 5.55 Hz, 1 H), 2.12–2.28 (m, 1 H), 2.06 (ddd, <i>J</i> = 7.71, 4.24, 3.98 Hz, 1 H), 1.87–1.99 (m, 1 H), 1.60–1.86 (m, 3 H), 0.89 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 573.3439 [M + H]<sup>+</sup>. Calcd for C<sub>34</sub> H<sub>45</sub>N<sub>4</sub>O<sub>4</sub>: 573.3425.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(oxazol-2-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>13</b>)</h3><div class="NLM_p last">A solution of <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-bromophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9a</b>) (0.28 g, 0.50 mmol), 2-(tributylstannyl)oxazole (0.20 g, 0.55 mmol), and tetrakis(tripheynlphosphine)palladium (0.12 g, 0.10 mmol) in 1,4-dioxane (5 mL) was heated to 140 °C for 30 min in a microwave reactor. The reaction mixture was cooled, stirred with 10% aq potassium fluoride solution (10 mL), and extracted with EtOAc (3 × 10 mL). The organic layers were combined, and the combined solution was washed with brine, dried over magnesium sulfate, filtered, and concentrated. The residue was purified by reverse-phase chromatography (10–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.l% TFA). Pure fractions containing product were combined in saturated aq sodium bicarbonate solution and extracted with DCM. The organic extract was dried over sodium sulfate, filtered, and evaporated to give <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(oxazol-2-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>13</b>) (0.065 g, 23% yield) as a white solid. MS (ESI+) <i>m</i>/<i>z</i> = 563.3226 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>43</sub>N<sub>4</sub>O<sub>5</sub>: 563.3218.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-1-(3-(1-methyl-1<i>H</i>-imidazol-2-yl)phenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>14</b>)</h3><div class="NLM_p last">A solution of <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-bromophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9a</b>) (0.30 g, 0.52 mmol), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (0.075 g, 0.157 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.79 g, 0.86 mmol), and cesium fluoride (0.397 g, 2.61 mmol) in 1,4-dioxane (4 mL) was degassed by sparging with N<sub>2</sub> (g) for 15 min. 1-Methyl-2-(tributylstannyl)-1<i>H</i>-imidazole (0.484 g, 1.31 mmol) was added, and the mixture was heated to 160 °C for 1 h in a microwave reactor. The reaction mixture was cooled to room temperature and filtered through a silica gel plug with 10% MeOH/EtOAc. The filtrate was concentrated, and the residue was purified by reverse-phase chromatography (10–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.l% TFA). Pure fractions containing product were combined in saturated aq sodium bicarbonate solution and extracted with DCM. The organic extract was dried over sodium sulfate, filtered, and evaporated to give <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-1-(3-(1-methyl-1<i>H</i>-imidazol-2-yl)phenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide <b>(14)</b> (0.12 g, 40% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.81 (s, 1 H), 7.74 (s, 1 H), 7.36 (t, <i>J</i> = 7.34 Hz, 2 H), 7.25–7.32 (m, 2 H), 7.23 (d, <i>J</i> = 7.73 Hz, 2 H), 6.91 (d, <i>J</i> = 9.19 Hz, 1 H), 4.12–4.22 (m, 1 H), 3.96 (dd, <i>J</i> = 9.24, 5.04 Hz, 1 H), 3.74 (d, <i>J</i> = 15.26 Hz, 1 H), 3.64 (s, 1 H), 3.62 (d, <i>J</i> = 1.56 Hz, 1 H), 3.56–3.61 (m, 1 H), 3.20 (s, 3 H), 3.14–3.19 (m, 1 H), 2.70–2.86 (m, 5 H), 2.35–2.46 (m, 7 H), 2.20–2.25 (m, 2 H), 1.83–1.90 (m, 1 H), 1.63–1.76 (m, 2 H), 0.87 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 576.3555 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>H<sub>45</sub>N<sub>5</sub>O<sub>4</sub>: 576.3534.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>15</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>9a</b> and 2-(tributylstannyl)thiazole via a method analogous to the preparation of <b>14</b>, giving a white solid (0.066 g, 22% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.76 (d, <i>J</i> = 2.15 Hz, 1 H), 7.67 (d, <i>J</i> = 1.66 Hz, 1 H), 7.63 (d, <i>J</i> = 9.49 Hz, 1 H), 7.14–7.31 (m, 6 H), 4.92 (d, <i>J</i> = 5.77 Hz, 1 H), 4.10 (s, 1 H), 4.09 (dd, <i>J</i> = 13.89, 3.62 Hz, 1 H), 3.90–3.98 (m, 1 H), 3.72–3.80 (m, 1 H), 3.68 (dt, <i>J</i> = 7.90, 6.52 Hz, 1 H), 3.51–3.60 (m, 1 H), 3.30 (s, 1 H), 3.17 (d, <i>J</i> = 5.28 Hz, 1 H), 3.01 (dd, <i>J</i> = 13.89, 3.62 Hz, 1 H), 2.64–2.73 (m, 1 H), 2.53–2.64 (m, 1 H), 2.38 (s, 3 H), 2.28–2.36 (m, 1 H), 2.13–2.24 (m, 1 H) 2.04–2.13 (m, 1 H), 1.90–2.03 (m, 1 H), 1.83 (dd, <i>J</i> = 10.12, 7.09 Hz, 1 H), 1.58–1.77 (m, 4 H), 0.85 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 579.2992 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub>S: 579.2989.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-5-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>16</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>9a</b> and 5-thiazolyltributylstannane via a method analogous to the preparation of <b>14</b>, giving a white solid (0.16 g, 55% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.86 (t, <i>J</i> = 1.57 Hz, 1 H), 7.85 (d, <i>J</i> = 3.23 Hz, 1 H), 7.79–7.83 (m, 2 H), 7.73–7.75 (m, 1 H), 7.50 (d, <i>J</i> = 3.33 Hz, 1 H), 7.38 (t, <i>J</i> = 7.58 Hz, 1 H), 7.30–7.34 (m, 1 H), 6.96 (d, <i>J</i> = 9.68 Hz, 1 H), 4.10–4.20 (m, 1 H), 4.00–4.09 (m, 1 H), 3.74 (d, <i>J</i> = 15.26 Hz, 1 H), 3.64–3.71 (m, 1 H), 3.59 (d, <i>J</i> = 15.26 Hz, 1 H), 3.16–3.23 (m, 4 H), 2.78–2.88 (m, 2 H), 2.36–2.49 (m, 3 H), 2.07–2.26 (m, 5 H), 1.84 (s, 1 H), 1.67–1.79 (m, 2 H), 1.18 (s, 2 H), 0.87 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 579.3001 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub>S: 579.2989.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-4-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>17</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>9a</b> and 4-(tributylstannyl)thiazole via a method analogous to the preparation of <b>14</b>, giving a white solid (0.078 g, 44% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.87 (t, <i>J</i> = 1.52 Hz, 1 H), 7.77–7.82 (m, 3 H), 7.75 (d, <i>J</i> = 1.96 Hz, 1 H), 7.71 (dd, <i>J</i> = 2.35, 0.98 Hz, 1 H), 7.35 (t, <i>J</i> = 7.68 Hz, 1 H), 7.22 (ddd, <i>J</i> = 7.80, 1.34, 1.12 Hz, 1 H), 6.93 (d, <i>J</i> = 9.49 Hz, 1 H), 4.11–4.20 (m, 1 H), 3.93 (dd, <i>J</i> = 10.32, 5.43 Hz, 1 H), 3.72 (d, <i>J</i> = 15.16 Hz, 1 H), 3.61–3.65 (m, 1 H), 3.52 (d, <i>J</i> = 15.20 Hz, 1 H), 3.14–3.21 (m, 4 H), 2.78–2.85 (m, 2 H), 2.70–2.76 (m, 1 H), 2.35–2.46 (m, 4 H), 2.07–2.25 (m, 5 H), 1.80–1.91 (m, 1 H), 1.62–1.78 (m, 2 H), 0.87 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 579.2998 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub>S: 579.2989.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-1-(3-(4-methylthiazol-2-yl)phenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>18</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>9a</b> and 4-methyl-2-(tributylstannyl)thiazole via a method analogous to the preparation of <b>14</b>, giving a white solid (0.097 g, 38% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.80 (ddd, <i>J</i> = 3.45, 1.91, 1.79 Hz, 2 H), 7.75 (dt, <i>J</i> = 7.63, 1.52 Hz, 1 H), 7.71 (dd, <i>J</i> = 2.25, 0.78 Hz, 1 H), 7.36 (t, <i>J</i> = 7.63 Hz, 1 H), 7.28–7.32 (m, 1 H), 7.04 (d, <i>J</i> = 1.08 Hz, 1 H), 6.96 (d, <i>J</i> = 9.59 Hz, 1 H), 4.09–4.19 (m, 1 H), 3.95 (dd, <i>J</i> = 10.71, 5.72 Hz, 1 H), 3.74 (d, <i>J</i> = 15.25 Hz, 1 H), 3.61–3.66 (m, 1 H), 3.58 (d, <i>J</i> = 15.26 Hz, 1 H), 3.21 (s, 3 H), 3.20–3.23 (m, 1 H), 3.18 (dd, <i>J</i> = 14.04, 3.86 Hz, 1 H), 2.77–2.86 (m, 2 H), 2.70–2.77 (m, 1 H), 2.35–2.45 (m, 7 H), 2.09–2.26 (m, 4 H), 1.81–1.90 (m, 1 H), 1.63–1.79 (m, 2 H), 0.86 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 593.3163 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>H<sub>45</sub>N<sub>4</sub>O<sub>4</sub>S: 593.3146.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-Ethynylphenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>19</b>)</h3><div class="NLM_p last"><i>n</i>-Butyllithium (1.96 mL of a 2.5 M solution in hexane, 4.9 mmol) was added dropwise to a solution of ethynltrimethylsilane (0.68 mL, 4.9 mmol) in THF (1 mL) at −78 °C, and the resulting mixture was stirred for 15 min. A solution of zinc chloride (4.9 mL of a 1.0 M solution in THF, 4.9 mmol) wass added dropwise. The mixture was warmed to room temperature and stirred for 30 min. This mixture was added to a vessel containing Pd<sub>2</sub>(dba)<sub>3</sub> (0.032 mg, 0.035 mmol), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (0.10 g, 0.21 mmol), and <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-bromophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9a</b>). The vessel was sealed and heated to 120 °C for 2 h, cooled to room temperature, and diluted with a saturated aq Rochelle’s salt solution (20 mL). After stirring for 1 h, biphasic mixture was diluted with EtOAc (50 mL), washed with 2N aq NaOH (25 mL), washed with brine, dried over magnesium sulfate, filtered, and concentrated. The crude reside was dissolved in methanol (10 mL) and treated with cesium fluoride (1.1 g, 7.0 mmol). The mixture was heated to 50 °C for 1 h and then concentrated. The crude product was purified by chromatography on a silica gel (10–50% EtOAc/hexane) to give <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-ethynylphenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>19</b>) as a white solid (0.12 g, 33% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.82 (d, <i>J</i> = 1.96 Hz, 1 H), 7.74 (d, <i>J</i> = 1.47 Hz, 1 H), 7.25–7.37 (m, 4 H), 6.90 (d, <i>J</i> = 9.29 Hz, 1 H), 3.74 (d, <i>J</i> = 16.0 Hz, 1 H), 3.60–3.66 (m, 1 H), 3.59 (d, <i>J</i> = 15.9 Hz, 1 H), 3.27 (s, 1 H), 3.24 (s, 2 H), 3.11 (dd, <i>J</i> = 14.04, 3.86 Hz, 1 H), 2.78–2.83 (m, 3 H), 2.36–2.49 (m, 4 H), 2.08–2.27 (m, 8 H), 1.83–1.92 (m, 1 H), 1.66–1.79 (m, 2 H), 0.88 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 520.3167 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>42</sub>N<sub>3</sub>O<sub>4</sub>: 520.3160.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(prop-1-ynyl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>20</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>9a</b> and tributyl(prop-1-ynyl)stannane via a method analogous to the preparation of <b>14</b>, giving a white solid (0.058 g, 45% yield). MS <i>m</i>/<i>z</i> = 534.2 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>44</sub>N<sub>3</sub>O<sub>4</sub>: 534.3.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(4-(thiazol-2-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>21</b>)</h3><div class="NLM_p last">A solution of <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(4-chlorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9e</b>) (0.20 g, 0.38 mmol), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (0.36 g, 0.76 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (0.345 g, 0.377 mmol) in 1,4-dioxane (4.0 mL) was degassed by sparging with N<sub>2</sub> (g) for 15 min. 2-(Tributylstannyl)thiazole (0.494 g, 1.32 mmol) was added, and the mixture was heated to 160 °C for 1 h in a microwave reactor. The reaction mixture was cooled to room temperature and filtered through a silica gel plug with 10% MeOH/DCM. The filtrate was concentrated, and the residue was purified by reverse-phase chromatography (10–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.l% TFA). Fractions containing product were combined and evaporated to give the triflate salt of <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(4-(thiazol-2-yl)phenyl)butan-2-yl)-2-methoxyacetamide (<b>21</b>) as a light-yellow solid (0.10 g, 33% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.00–9.30 (s, 1 H), 7.70–8.02 (m, 6 H), 7.34 (d, <i>J</i> = 8.02 Hz, 2 H), 5.90 (s, 1 H), 4.77 (s, 1 H), 3.90–4.13 (m, 2 H), 3.74 (d, <i>J</i> = 15.10 Hz, 1 H), 3.63 (d, <i>J</i> = 15.15 Hz, 1 H), 2.99–3.26 (m, 5 H), 2.73–2.92 (m, 3 H), 2.60 (dd, <i>J</i> = 13.45, 6.90 Hz, 1 H), 2.36–2.47 (m, 3 H), 2.10–2.29 (m, 2 H), 2.02 (dd, <i>J</i> = 17.80, 6.94 Hz, 2 H), 1.79–1.91 (m, 1 H), 1.66–1.79 (m, 1 H), 0.87 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 579.3001 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub>S: 579.2990.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(4-Ethynylphenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>22</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(4-((trimethylsilyl)ethynyl)phenyl)butan-2-ylcarbamate (<b>10i</b>) (0.42 g, 0.63 mmol) in THF (6 mL) was treated with TBAF (0.63 mL of a 1 M solution in THF, 0.63 mmoL), and the resulting solution was stirred for 30 min. The volatiles were evaporated in vacuo, and the residue was dissolved in methanol (3 mL) and a solution of 4N hydrogen chloride in dioxane (0.63 mL, 2.5 mmol). The solution was heated to 50 °C for 1 h and then cooled to room temperature. The cooled mixture was diluted with ether, and the resulting solid was allowed to settle. The ether was decanted, and the remaining solid was taken up in 2N aq sodium hydroxide solution and extracted with EtOAc. The organic extract was washed with brine, dried over magnesium sulfate, filtered, and evaporated to afford intermediate (2<i>R</i>,3<i>S</i>)-3-amino-4-(4-ethynylphenyl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol. A portion of the intermediate amine (0.135 g, 0.300 mmol) was combined with <i>N</i>,<i>N</i>-diisopropylethylamine (0.08 mL, 0.45 mmol) in DCM (3 mL). Separately, a solution of carbonyl diimidazole (0.05 g, 0.30 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.05 mL, 0.40 mmol) in DCM (1 mL) was treated with 2-methoxyacetic acid. The resulting mixture was stirred for 1 h and then was added to the solution of amine. The combined mixture was stirred for 1 h at room temperature and then was concentrated. The residue was purified by chromatography on silica gel (0–5% MeOH/DCM) to give <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(4-ethynylphenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>22</b>) as a white solid (0.067 g, 43% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.80 (d, <i>J</i> = 2.05 Hz, 1 H), 7.69 (dd, <i>J</i> = 2.40, 1.03 Hz, 1 H), 7.36–7.43 (m, 2 H), 7.18–7.26 (m, 2 H), 6.82–6.91 (m, 1 H), 4.09–4.16 (m, 1 H), 3.90 (dd, <i>J</i> = 10.27, 5.38 Hz, 1 H), 3.73 (d, <i>J</i> = 15.26 Hz, 1 H), 3.58–3.64 (m, 2 H), 3.61 (d, <i>J</i> = 15.25 Hz, 1 H), 3.33 (s, 1 H), 3.11 (dd, <i>J</i> = 14.08, 4.01 Hz, 1 H), 2.65–2.85 (m, 4 H), 2.33–2.45 (m, 5 H), 2.18–2.28 (m, 1 H), 2.07–2.15 (m, 4 H), 1.81–1.91 (m, 1 H), 1.61–1.80 (m, 2 H), 0.88 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 520.3169 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>42</sub>N<sub>3</sub>O<sub>4</sub>: 520.3160.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(2-Fluoro-3-(thiazol-2-yl)phenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>23</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(2-fluoro-3-(thiazol-2-yl)phenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (<b>10i</b>) (3.90 g, 5.30 mmol) in methanol (10 mL) was treated with a solution of 4N hydrogen chloride in dioxane (26 mL, 106 mmol), and the resulting mixture was heated to 50 °C for 3 h. The reaction mixture was cooled, diluted with ether (300 mL), and aged for 12 h. The ether was decanted, and the remaining solid was dried under vacuum to give the 4.24 g of the hydrochloride salt of (2<i>R</i>,3<i>S</i>)-3-amino-4-(2-fluoro-3-(thiazol-2-yl)phenyl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol. A portion of this intermediate amine hydrchloride (1.41 g, 2.1 mmol) was combined with <i>N</i>,<i>N</i>-diisopropylethylamine (2.2 mL, 13 mmol) in DCM (8 mL). Separately, a solution of carbonyl diimidazole (0.34 g, 2.1 mmol) in DCM (8 mL) was treated with 2-methoxyacetic acid. The resulting mixture was stirred for 1 h and then was added to the solution of amine. The combined mixture was stirred for 1 h at room temperature and then was concentrated. The residue was purified by chromatography on silica gel (0–5% MeOH/DCM) to give <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(2-fluoro-3-(thiazol-2-yl)phenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>23</b>) (0.76 g, 60%). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 8.12 (td, <i>J</i> = 7.48, 1.76 Hz, 1 H), 7.93 (dd, <i>J</i> = 3.23, 2.54 Hz, 1 H), 7.79 (d, <i>J</i> = 1.76 Hz, 1 H), 7.71 (dd, <i>J</i> = 2.40, 1.03 Hz, 1 H), 7.64 (d, <i>J</i> = 3.33 Hz, 1 H), 7.35 (td, <i>J</i> = 7.38, 1.86 Hz, 1 H), 7.22 (t, <i>J</i> = 7.73 Hz, 1 H), 6.98 (d, <i>J</i> = 8.80 Hz, 1 H), 4.14–4.24 (m, 1 H), 3.92 (dd, <i>J</i> = 10.47, 5.58 Hz, 1 H), 3.71 (d, <i>J</i> = 15.18 Hz, 1 H), 3.63–3.68 (m, 1 H), 3.58 (d, <i>J</i> = 15.20 Hz, 1 H), 3.27 (d, <i>J</i> = 5.18 Hz, 2 H), 3.21–3.25 (m, 3 H), 2.89 (ddd, <i>J</i> = 1.37, 10.66, 13.98 Hz, 1 H), 2.83 (dd, <i>J</i> = 12.42, 5.86 Hz, 1 H), 2.73 (dd, <i>J</i> = 12.33, 4.31 Hz, 1 H), 2.35–2.48 (m, 4 H), 2.08–2.26 (m, 3 H), 1.82–1.91 (m, 1 H), 1.61–1.82 (m, 3 H), 0.87 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 597.2901 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>42</sub>FN<sub>4</sub>O<sub>4</sub>: 597.2896.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(4-Fluoro-3-(thiazol-2-yl)phenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>24</b>)</h3><div class="NLM_p last">The triflate salt of the title compound was prepared from <b>9c</b> and 2-(tributylstannyl)thiazole via a method analogous to the preparation of <b>21</b>, giving a light-yellow oil (0.109 g, 38% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.09 (dd, <i>J</i> = 7.38, 2.10 Hz, 1 H), 7.99 (dd, <i>J</i> = 3.28, 2.40 Hz, 1 H), 7.91 (d, <i>J</i> = 3.23 Hz, 1 H), 7.58–7.81 (m, 3 H), 7.22–7.38 (m, 2 H), 4.97 (d, <i>J</i> = 5.87 Hz, 1 H), 3.99–4.16 (m, 1 H), 3.86 (br s, 1 H), 3.52–3.75 (m, 3 H), 3.14 (s, 3 H), 3.10 (dd, <i>J</i> = 13.60, 3.62 Hz, 1 H), 2.74 (dd, <i>J</i> = 13.64, 10.42 Hz, 1 H), 2.56–2.69 (m, 2 H), 2.27–2.40 (m, 4 H), 2.14–2.23 (m, 1 H), 2.08 (t, <i>J</i> = 7.97 Hz, 3 H), 1.77–1.88 (m, 1 H), 1.60–1.77 (m, 2 H), 0.83 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 597.2899 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>41</sub>FN<sub>4</sub>O<sub>4</sub>S: 597.2896.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(4-Fluoro-3-(thiazol-2-yl)phenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>25</b>)</h3><div class="NLM_p last">The triflate salt of the title compound was prepared from <b>9b</b> and 2-(tributylstannyl)thiazole via a method analogous to the preparation of <b>21</b>, giving a light-yellow solid (0.31 g, 58% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.87 (d, <i>J</i> = 3.23 Hz, 1 H), 7.79 (d, <i>J</i> = 2.05 Hz, 1 H), 7.70 (dd, <i>J</i> = 2.35, 0.98 Hz, 1 H), 7.67 (t, <i>J</i> = 1.37 Hz, 1 H), 7.52–7.60 (m, 2 H), 7.09 (ddd, <i>J</i> = 9.73, 2.30, 1.47 Hz, 1 H), 6.96 (d, <i>J</i> = 9.68 Hz, 1 H), 4.11–4.23 (m, <i>J</i> = 9.92, 9.92, 6.33, 3.86 Hz, 1 H), 3.91 (dd, <i>J</i> = 10.32, 5.33 Hz, 1 H), 3.53–3.79 (m, 4 H), 3.22 (s, 3 H), 3.13–3.21 (m, 1 H), 2.65–2.91 (m, 3 H), 2.34–2.47 (m, 4 H), 2.16–2.28 (m, 2 H), 2.05–2.17 (m, 2 H), 1.79–1.91 (m, 1 H), 1.57–1.79 (m, 2 H), 0.87 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 597.2904 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>41</sub>FN<sub>4</sub>O<sub>4</sub>S: 597.2896.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(2-Fluoro-5-(thiazol-2-yl)phenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>26</b>)</h3><div class="NLM_p last">The triflate salt of the title compound was prepared from <b>9d</b> and 2-(tributylstannyl)thiazole via a method analogous to the preparation of <b>21</b>, giving a light-yellow solid (0.16 g, 40% yield). <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 8.04 (s, 2 H), 7.74–7.95 (m, 3 H), 7.61 (d, <i>J</i> = 3.36 Hz, 1 H), 7.20 (t, <i>J</i> = 9.06 Hz, 1 H), 4.06–4.25 (m, 2 H), 3.54–3.94 (m, 2 H), 3.33–3.46 (m, 2 H), 3.24 (s, 3 H), 3.09 (dd, <i>J</i> = 12.13, 8.62 Hz, 1 H), 2.84–3.01 (m, 1 H), 2.79 (dd, <i>J</i> = 13.15, 6.14 Hz, 1 H), 2.49–2.67 (m, 3 H), 2.10–2.42 (m, 4 H), 1.96–2.08 (m, 1 H), 1.74–1.96 (m, 1 H), 1.38 (dd, <i>J</i> = 6.50, 3.00 Hz, 1 H), 0.95 (s, 9 H). MS <i>m</i>/<i>z</i> = 597.0 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>41</sub>FN<sub>4</sub>O<sub>4</sub>S: 597.2</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-Ethynyl-2-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>27</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>10h</b> via a method analogous to the preparation of <b>22</b>, giving a white solid (0.49 g, 51% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.79 (d, <i>J</i> = 1.76 Hz, 1 H), 7.71 (dd, <i>J</i> = 2.45, 1.08 Hz, 1 H), 7.36 (td, <i>J</i> = 7.19, 1.76 Hz, 1 H), 7.29 (td, <i>J</i> = 7.43, 1.66 Hz, 1 H), 7.07 (t, <i>J</i> = 7.73 Hz, 1 H), 6.92 (d, <i>J</i> = 9.29 Hz, 1 H), 4.07–4.21 (m, 1 H), 3.91 (dd, <i>J</i> = 10.47, 5.48 Hz, 1 H), 3.72 (d, <i>J</i> = 15.22 Hz, 1 H), 3.62–3.67 (m, 2 H), 3.61 (s, 1 H), 3.56 (d, <i>J</i> = 15.24 Hz, 1 H), 3.21–3.29 (m, 2 H), 3.16 (dd, <i>J</i> = 14.48, 4.21 Hz, 1 H), 2.67–2.85 (m, 3 H), 2.33–2.48 (m, 4 H), 2.06–2.26 (m, 5 H), 1.82–1.91 (m, 1 H), 1.70–1.80 (m, 1 H), 1.61–1.70 (m, 1 H), 0.88 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 538.3078 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>41</sub>FN<sub>3</sub>O<sub>4</sub>: 538.3066.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-Ethynyl-4-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>28</b>)</h3><div class="NLM_p last">A mixture of <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-chloro-4-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9c</b>) (100 mg, 0.18 mmol), cesium carbonate (178 mg, 0.55 mmol), PdCl<sub>2</sub>(CH<sub>3</sub>CN)<sub>2</sub> (3.5 mg, 0.009 mmol), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (13 mg, 0.02 mmol), and ethynyltrimethylsilane (63 mg, 0.64 mmol) in acetonitrile (2 mL) was heated to 125 °C for 30 min in a microwave reactor. The mixture was stirred at room temperature for 16 h (until only <i>des</i>-TMS alkyne product could be detected by LCMS) before being filtered through Celite with the aid of methanol. The filtrate was concentrated, and the residue was purified by reverse-phase chromatography (10–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.l% TFA). Fractions containing product were combined and evaporated to give the triflate salt of <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-ethynyl-4-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>28</b>) (35 mg, 25% yield). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 7.98 (d, <i>J</i> = 1.57 Hz, 1 H), 7.87 (d, <i>J</i> = 1.60 Hz, 1 H), 7.18 (s, 1 H), 6.98–7.11 (m, 2 H), 4.78–4.85 (m, 1 H), 4.07 (ddd, <i>J</i> = 10.91, 7.63, 3.47 Hz, 1 H), 3.96–4.03 (m, 1 H), 3.85 (d, <i>J</i> = 15.26 Hz, 1 H), 3.67 (d, <i>J</i> = 15.36 Hz, 1 H), 3.58 (s, 1 H), 3.17–3.33 (m, 3 H), 3.04 (dd, <i>J</i> = 12.57, 9.24 Hz, 1 H), 2.68–2.82 (m, 2 H), 2.47–2.63 (m, 3 H), 2.25–2.36 (m, 1 H), 2.05–2.25 (m, 3 H), 1.79–2.04 (m, 3 H), 0.87 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 538.3078 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>41</sub>FN<sub>3</sub>O<sub>4</sub>: 538.3066.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-Ethynyl-5-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>29</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>9b</b> and ethynyltrimethylsilane via a method analogous to the preparation of <b>19</b>, giving a cream-colored solid (0.73 g, 83% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.90 (d, <i>J</i> = 1.86 Hz, 1 H), 7.66 (br s, 1 H), 7.13 (s, 1 H), 7.05 (ddd, <i>J</i> = 8.93, 2.32, 1.17 Hz, 1 H), 6.95 (dt, <i>J</i> = 9.32, 1.80 Hz, 1 H), 6.63 (d, <i>J</i> = 9.10 Hz, 1 H), 4.19 (br s, 1 H), 3.99–4.13 (m, 1 H), 3.57–3.93 (m, 4 H), 3.32–3.34 (m, 3 H), 3.02–3.20 (m, 2 H), 2.84 (dd, <i>J</i> = 14.28, 9.10 Hz, 1 H), 2.78 (d, <i>J</i> = 4.60 Hz, 2 H), 2.51–2.65 (m, 1 H), 2.36–2.51 (m, 4 H), 2.16–2.35 (m, 2 H), 2.03–2.15 (m, 1 H), 1.91–2.03 (m, 1 H), 1.86 (t, <i>J</i> = 12.03 Hz, 1 H), 1.74 (dt, <i>J</i> = 11.25, 8.71 Hz, 1 H), 0.90 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 538.3077 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>41</sub>FN<sub>3</sub>O<sub>4</sub>: 538.3066.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(5-Ethynyl-2-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>30</b>)</h3><div class="NLM_p last">A solution of <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(5-chloro-2-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>9d</b>) (0.30 g, 0.55 mmol), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (0.14 g, 0.29 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (0.18 g, 0.19 mmol) in THF (4 mL) was degassed by sparging with N<sub>2</sub> (g) for 15 min. 1-Trimethyl(2-(tributylstannyl)ethynyl)silane (0.58 g, 1.59 mmol) was added, and the mixture was heated to 160 °C for 1 h in a microwave reactor. The reaction mixture was cooled to room temperature and filtered through a silica gel plug with 10% MeOH/EtOAc. The filtrate was evaporated, and the residue was purified by chromatography on silica gel (0–10% MeOH/DCM) to give 300 mg of the intermediate <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(2-fluoro-5-((trimethylsilyl)ethynyl)phenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide. This material was combined with TBAF (1.0 mL of a 1 M solution in THF, 1.0 mmol) and THF (15 mL), and the resulting mixture was stirred for 15 h. The mixture was diluted with water (20 mL) and brine (20 mL) and extracted with EtOAc (50 mL). The organic extrac was dried over sodium sulfate, filtered, and evaporated. The residue was purified by reverse-phase chromatography (10–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.l% TFA). Pure fractions containing product were combined in saturated aq sodium bicarbonate solution and extracted with DCM. The organic extract was dried over sodium sulfate, filtered, and evaporated to give <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(5-ethynyl-2-fluorophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>30</b>) as a white solid (51 mg, 19% yield). <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 7.80 (dd, <i>J</i> = 16.30, 1.68 Hz, 2 H), 7.42 (dd, <i>J</i> = 7.16, 2.19 Hz, 1 H), 7.34 (ddd, <i>J</i> = 8.44, 4.93, 2.12 Hz, 1 H), 7.03 (dd, <i>J</i> = 9.87, 8.55 Hz, 1 H), 4.26 (ddd, <i>J</i> = 10.63, 6.61, 3.80 Hz, 1 H), 4.03 (dd, <i>J</i> = 10.45, 5.33 Hz, 1 H), 3.60–3.86 (m, 3 H), 3.22 (dd, <i>J</i> = 13.96, 3.58 Hz, 1 H), 2.69–2.89 (m, 4 H), 2.39–2.57 (m, 5 H), 2.10–2.35 (m, 4 H), 1.87–2.04 (m, 1 H), 1.70–1.87 (m, 2 H), 0.92 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 538.3072 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>41</sub>FN<sub>3</sub>O<sub>4</sub>: 538.3066.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-4 hydroxy-1-(3-(thiazol-2-yl)phenyl)butan-2-ylcarbamate (<b>31</b>)</h3><div class="NLM_p last">A dry 1 L round-bottom flask was charged with <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-1-(3-bromophenyl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4 hydroxybutan-2-ylcarbamate (<b>5a</b>) (51.2 g, 108 mmol) and 1,4-dioxane (110 mL). The mixture was stirred for 10 min, by which time most of the solid had dissolved. The solution was then covered with a blanket of Ar(g). Zinc chloride (29.4 g, 216 mmol) and bis(tri-<i>t</i>-butylphosphine)palladium(0) (5.51 g, 10.8 mmol) were added in sequence. The mixture was sonicated for 1 min, and then 2-thiazolyl-zinc bromide (259 mL of a 0.5 M solution in THF, 129 mmol) was added in one portion. The resulting mixture was stirred for 16 h and then poured into a 1N aq citric acid solution (350 mL) with the aid of ethyl acetate (150 mL). The mixture was shaken vigorously, and then the layers were separated. The aqueous layer was extracted with ethyl acetate (150 mL). The organic layers were combined and washed with saturated aq sodium bicarbonate solution (200 mL) The layers were then separated, and the aqueous layer was extracted with EtOAc (150 mL). The combined organic extracts were then washed with water (150 mL) and brine (150 mL). The water and brine layers were combined and extracted with ethyl acetate (100 mL). The organic layers were again combined and dried over sodium sulfate, filtered, and concentrate. The crude product was purified by chromatography on silica gel to give <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxy-1-(3-(thiazol-2-yl)phenyl)butan-2-ylcarbamate (<b>31</b>) (42.4 g, 92% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.82 (d, <i>J</i> = 3.33 Hz, 2 H), 7.74 (s, 1 H), 7.68 (d, <i>J</i> = 3.13 Hz, 2 H), 7.66 (s, 1 H), 7.30 (t, <i>J</i> = 7.63 Hz, 1 H), 7.19–7.26 (m, 1 H), 4.52 (t, <i>J</i> = 5.04 Hz, 1 H), 3.56–3.69 (m, 2 H), 3.38–3.46 (m, 1 H), 3.23–3.33 (m, 1 H), 2.87 (d, <i>J</i> = 13.50 Hz, 1 H), 2.48–2.57 (m, 1 H), 1.14 (s, 9 H), 0.81 (s, 9 H), 0.00 (s, 6 H). MS <i>m</i>/<i>z</i> = 479.2 [M + H]<sup>+</sup>. Calcd for C<sub>24 h39</sub>N<sub>2</sub>O<sub>4</sub>SSi: 479.2.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>tert</i>-Butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-ylcarbamate (<b>32</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4 hydroxy-1-(3-(thiazol-2-yl)phenyl)butan-2-ylcarbamate (7.925 g, 16.62 mmol) (<b>31</b>) and (<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridin]-4′-amine (<b>6</b>) (4.502 g, 17.29 mmol) in DCM (100 mL) was treated with trimethyl orthoformate (14.7 mL, 133 mmol). The resulting solution was stirred for 1 h, and then sodium triacetoxyborohydride (8.456 g, 39.90 mmol) was added. The mixture was stirred for 4 h and then diluted with DCM (100 mL) and saturated aq Rochelle’s salt solution (500 mL). The resulting biphasic mixture was stirred vigorously for 1 h, and then the layers were separated. The aq layer was extracted with DCM (250 mL), and the organic layers were combined. The combined solution was washed with brine (200 mL), dried over sodium sulfate, filtered, and concentrated. The crude product was purified by chromatography on silica gel (0–50% EtOAc/hexane) to afford <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-ylcarbamate (<b>32</b>) (9.960 g, 83.09% yield) as a white solid. MS <i>m</i>/<i>z</i> = 721.4 [M + H]<sup>+</sup>. Calcd for C<sub>40</sub>H<sub>61</sub>N<sub>4</sub>O<sub>4</sub>SSi: 721.4.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (2<i>R</i>,3<i>S</i>)-3-Amino-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-4-(3-(thiazol-2-yl)phenyl)butan-2-ol hydrochloride (<b>33</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-ylcarbamate (<b>32</b>) (500 mg, 0.824 mmol) in methanol (4 mL) was cooled to 0 °C in an ice-bath. Hydrogen chloride (10.3 mL of a 4N solution in 1,4-dioxane, 41.2 mmol) was added, the ice-bath was removed, and the mixture was strred for 2 h at room temperature. The volatiles were removed in vacuo to afford the hydrochloride salt of (2<i>R</i>,3<i>S</i>)-3-amino-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-4-(3-(thiazol-2-yl)phenyl)butan-2-ol hydrochloride (<b>33</b>) (551 mg) as an off-white foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.45 (br s, 1 H), 9.69 (br s, 1 H), 8.18–8.54 (m, 4 H), 7.98 (s, 2 H), 7.94 (d, <i>J</i> = 3.23 Hz, 1 H), 7.86 (dt, <i>J</i> = 7.41, 1.38 Hz, 1 H), 7.81 (d, 1 H), 7.41–7.73 (m, 2 H), 4.78 (br s, 1 H), 4.47 (d, <i>J</i> = 10.17 Hz, 1 H), 3.28–3.44 (m, 1 H), 2.91–3.19 (m, 3 H), 2.68 (dd, <i>J</i> = 13.16, 5.62 Hz, 1 H), 2.43 (d, <i>J</i> = 3.91 Hz, 2 H), 2.13–2.25 (m, 2 H), 1.97–2.11 (m, 2 H), 1.84 (br s, 1 H), 1.60–1.79 (m, 1 H), 0.87 (s, 9 H). MS <i>m</i>/<i>z</i> = 507.2 [M + H]<sup>+</sup>. Calcd for C<sub>29</sub>H<sub>39</sub>N<sub>4</sub>O<sub>2</sub>Si: 507.3.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)acetamide (<b>34</b>)</h3><div class="NLM_p last">The title compound was prepared from <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3-bromophenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)acetamide (prepared as <b>9a</b>) and 2-(tributylstannyl)thiazole via a method analogous to the preparation of <b>14</b>, giving a white solid (0.079 g, 48% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.86 (t, <i>J</i> = 1.52 Hz, 1 H), 7.85 (d, <i>J</i> = 3.23 Hz, 1 H), 7.82 (dt, <i>J</i> = 1.52, 7.40 Hz, 1 H), 7.78 (d, <i>J</i> = 1.76 Hz, 1 H), 7.70 (dd, <i>J</i> = 2.40, 1.03 Hz, 1 H), 7.50 (d, <i>J</i> = 3.33 Hz, 1 H), 7.35–7.40 (m, 1 H), 7.30–7.34 (m, 1 H), 6.48 (d, <i>J</i> = 8.90 Hz, 1 H), 4.01–4.10 (m, 1 H), 3.91 (dd, <i>J</i> = 10.56, 5.48 Hz, 1 H), 3.53 (td, <i>J</i> = 6.31, 4.50 Hz, 1 H), 3.16 (dd, <i>J</i> = 13.94, 3.77 Hz, 1 H), 2.65–2.82 (m, 2 H), 2.34–2.46 (m, 3 H), 2.08–2.24 (m, 8 H), 1.81–1.91 (m, 1 H), 1.69–1.77 (m, 3 H), 1.64 (ddd, <i>J</i> = 13.28, 10.64, 1.22 Hz, 1 H), 0.86 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 549.2895 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>41</sub>N<sub>4</sub>O<sub>3</sub>S: 549.2885.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)propionamide (<b>35</b>)</h3><div class="NLM_p last">A mixture of (2<i>R</i>,3<i>S</i>)-3-amino-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-4-(3-(thiazol-2-yl)phenyl)butan-2-ol hydrochloride (<b>33</b>) (0.136 g, 0.221 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.192 mL, 1.10 mmol) in DMF (3 mL) was treated with propionic acid (16.5 μL, 0.221 mmol) and 1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate (84 mg, 0.22 mmol) in sequence. The resulting mixture was stirred for 2 h and then was purified directly by reverse-phase chromatography (10–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.l% TFA). Pure fractions containing product were combined and evaporated to give the triflate salt of <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)propionamide (<b>35</b>) as a white solid (93 mg, 53% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.03 (d, <i>J</i> = 4.30 Hz, 2 H), 7.94 (d, <i>J</i> = 3.52 Hz, 1 H), 7.88 (s, 1 H), 7.73 (d, <i>J</i> = 8.02 Hz, 1 H), 7.51 (d, <i>J</i> = 3.52 Hz, 1 H), 7.43 (t, <i>J</i> = 7.73 Hz, 1 H), 7.34 (d, <i>J</i> = 7.63 Hz, 1 H), 6.72 (d, <i>J</i> = 8.02 Hz, 1 H), 4.78 (dd, <i>J</i> = 11.15, 6.06 Hz, 1 H), 4.06–4.21 (m, 1 H), 3.93–4.04 (m, 1 H), 3.09–3.32 (m, 2 H), 2.78–3.05 (m, 2 H), 2.54–2.70 (m, 2 H), 2.45 (s, 2 H), 2.19–2.34 (m, 2 H), 2.06–2.19 (m, 4 H), 1.91–2.06 (m, 1 H), 1.68–1.83 (m, 1 H), 0.98 (t, <i>J</i> = 7.53 Hz, 3 H), 0.88 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 563.3048 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>43</sub>N<sub>4</sub>O<sub>3</sub>S: 563.3041.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 2-Ethoxy-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)acetamide (<b>36</b>)</h3><div class="NLM_p last">To a solution of 2-ethoxyacetic acid (0.439 g, 4.22 mmol) in DCM (10 mL) was added carbonyl diimidazole (0.584 g, 4.22 mmol), and the resulting mixture was stirred for 30 min. This solution was then added via cannula to a preformed solution of (2<i>R</i>,3<i>S</i>)-3-amino-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-4-(3-(thiazol-2-yl)phenyl)butan-2-ol hydrochloride (<b>33</b>) (2.60 g, 4.22 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (3.68 mL, 21.1 mmol) in DCM (50 mL). The mixture was stirred for 2 h at room temperature and then was diluted with DCM (30 mL), washed with saturated aq sodium bicarbonate solution (50 mL), washed with water (50 mL), washed with brine, dried over sodium sulfate, filtered, and evaporated. The crude product was purified by chromatography on silica gel (0–5% MeOH/DCM) to give 2-ethoxy-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)acetamide (<b>36</b>) as a white solid (1.76 g, 70%). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 7.82–7.87 (m, 2 H), 7.72–7.81 (m, 3 H), 7.59 (d, <i>J</i> = 3.33 Hz, 1 H), 7.28–7.42 (m, 2 H), 4.28 (ddd, <i>J</i> = 10.37, 6.46, 4.30 Hz, 1 H), 4.00 (dd, <i>J</i> = 10.56, 5.48 Hz, 1 H), 3.61–3.87 (m, 3 H), 3.32–3.40 (m, 2 H), 3.22 (dd, <i>J</i> = 13.99, 4.21 Hz, 1 H), 2.72–2.92 (m, 3 H), 2.40–2.54 (m, 4 H), 2.10–2.32 (m, 3 H), 1.86–1.99 (m, 1 H), 1.70–1.84 (m, 2 H), 1.08 (t, <i>J</i> = 7.04 Hz, 3 H), 0.89 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 593.3157 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>H<sub>45</sub>N<sub>4</sub>O<sub>4</sub>S: 593.3146.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (<i>R</i>)-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)-2-methoxypropanamide (<b>37</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33</b> and (<i>R</i>)-2-methoxypropanoic acid via a method analogous to the preparation of <b>36</b>, giving a white solid (0.74 g, 79% yield). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 7.80–7.87 (m, 3 H), 7.72–7.80 (m, 2 H), 7.59 (d, <i>J</i> = 3.33 Hz, 1 H), 7.31–7.44 (m, 2 H), 4.25 (ddd, <i>J</i> = 10.91, 7.09, 3.91 Hz, 1 H), 4.02 (dd, <i>J</i> = 10.56, 5.28 Hz, 1 H), 3.74 (td, <i>J</i> = 7.04, 3.91 Hz, 1 H), 3.49 (q, <i>J</i> = 6.72 Hz, 1 H), 3.06 (s, 3 H), 2.66–2.90 (m, 3 H), 2.41–2.53 (m, 4 H), 2.09–2.31 (m, 3 H), 1.87–2.01 (m, 1 H), 1.66–1.84 (m, 2 H), 1.25–1.37 (m, 1 H), 1.14 (d, <i>J</i> = 6.85 Hz, 3 H), 0.83–0.95 (m, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 593.3151 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>H<sub>45</sub>N<sub>4</sub>O<sub>4</sub>S: 593.3146.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)-2-methoxypropanamide (<b>38</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33</b> and (<i>S</i>)-2-methoxypropanoic acid via a method analogous to the preparation of <b>36</b>, giving a white solid (0.08 g, 73% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.86 (s, 1 H), 7.85 (d, <i>J</i> = 3.91 Hz, 1 H), 7.76–7.83 (m, 3 H), 7.50 (d, <i>J</i> = 3.23 Hz, 1 H), 7.38 (t, <i>J</i> = 7.53 Hz, 1 H), 7.31–7.35 (m, 1 H), 6.58 (d, <i>J</i> = 7.24 Hz, 1 H), 4.02–4.10 (m, 1 H), 3.89–3.98 (m, 1 H), 3.50–3.57 (m, 1 H), 3.32–3.46 (m, 2 H), 3.27 (d, <i>J</i> = 5.38 Hz, 2 H), 3.21 (dd, <i>J</i> = 14.13, 3.57 Hz, 1 H), 3.14 (s, 3 H), 2.80–2.88 (m, 1 H), 2.73 (dd, <i>J</i> = 14.18, 10.47 Hz, 2 H), 2.35–2.49 (m, 3 H), 2.18–2.26 (m, 3 H), 2.08–2.13 (m, 3 H), 1.81–1.91 (m, 1 H), 1.69–1.79 (m, 1 H), 1.59–1.67 (m, 1 H), 0.87 (s, 9 H). MS <i>m</i>/<i>z</i> = 593.2 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>H<sub>45</sub>N<sub>4</sub>O<sub>4</sub>S: 593.3.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (<i>R</i>)-2-Ethoxy-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)propanamide (<b>39</b>)</h3><div class="NLM_p last">The title compound was prepared as a diastereomeric mixture from <b>33</b> and 2-ethoxypropanoic acid via a method analogous to the preparation of <b>35</b>. Following workup, chromatographic separation of the diastereomers afforded (<i>S</i>)-2-ethoxy-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)propanamide (107 mg, 14% yield) and (<i>R</i>)-2-ethoxy-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)propanamide (<b>39</b>) (119 mg, 15% yield). Data for the title compound: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.84–7.92 (m, 3 H), 7.82 (d, <i>J</i> = 7.63 Hz, 1 H), 7.69 (br s, 1 H), 7.38 (t, <i>J</i> = 7.63 Hz, 1 H), 7.28–7.36 (m, 2 H), 6.60 (d, <i>J</i> = 8.80 Hz, 1 H), 4.12–4.26 (m, <i>J</i> = 8.85, 8.63, 8.63, 4.01 Hz, 1 H), 4.08 (br s, 1 H), 3.54–3.75 (m, 2 H), 3.22–3.37 (m, 2 H), 3.10 (dq, <i>J</i> = 9.17, 6.99 Hz, 1 H), 2.93 (dd, <i>J</i> = 14.48, 9.39 Hz, 1 H), 2.80–2.88 (m, 1 H), 2.68–2.80 (m, 1 H), 2.50–2.65 (m, 1 H), 2.43 (s, 3 H), 2.24–2.38 (m, 1 H), 2.20 (dddd, <i>J</i> = 12.25, 8.29, 4.11, 3.91 Hz, 1 H), 2.07 (dddd, <i>J</i> = 12.08, 8.27, 4.11, 3.72 Hz, 1 H), 1.89–2.02 (m, 1 H), 1.65–1.85 (m, 2 H), 1.30 (d, <i>J</i> = 6.85 Hz, 3 H), 0.98 (t, <i>J</i> = 6.94 Hz, 3 H), 0.90 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 607.3312 [M + H]<sup>+</sup>. Calcd for C<sub>34 h47</sub>N<sub>4</sub>O<sub>4</sub>S: 607.3302.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)-2,2-dimethoxyacetamide (<b>40</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33</b> and 2,2-dimethoxyacetic acid via a method analogous to the preparation of <b>36</b>, giving a white solid (0.41 g, 49% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.83–7.92 (m, 3 H), 7.80 (d, <i>J</i> = 7.53 Hz, 1 H), 7.58 (s, 1 H), 7.28–7.43 (m, 3 H), 6.68 (d, <i>J</i> = 9.03 Hz, 1 H), 4.58 (s, 1 H), 4.08–4.23 (m, 1 H), 3.94 (d, <i>J</i> = 4.52 Hz, 1 H), 3.54–3.63 (m, 1 H), 3.31 (s, 3 H), 3.21–3.29 (m, 1 H), 3.03 (s, 3 H), 2.79–2.95 (m, 2 H), 2.71 (dd, <i>J</i> = 12.05, 3.51 Hz, 1 H), 2.47–2.62 (m, 1 H), 2.42 (s, 2 H), 2.24–2.39 (m, 2 H), 2.20 (ddd, <i>J</i> = 11.80, 4.52, 4.27 Hz, 1 H), 2.05 (ddd, <i>J</i> = 11.92, 8.41, 4.27 Hz, 1 H), 1.88–2.01 (m, 1 H), 1.62–1.85 (m, 2 H), 0.90 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 609.3104 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>H<sub>45</sub>N<sub>4</sub>O<sub>5</sub>S: 609.3095.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (<i>R</i>)-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)tetrahydrofuran-2-carboxamide (<b>41</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33</b> and (<i>R</i>)-tetrahydrofuran-2-carboxylic acid via a method analogous to the preparation of <b>36</b>, giving a white solid (0.15 g, 82% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.73–7.87 (m, 5 H), 7.50 (d, <i>J</i> = 3.81 Hz, 1 H), 7.38 (t, <i>J</i> = 7.58 Hz, 1 H), 7.28–7.33 (m, 1 H), 7.07 (d, <i>J</i> = 8.51 Hz, 1 H), 3.98–4.10 (m, 2 H), 3.89–3.97 (m, 1 H), 3.75–3.84 (m, 1 H), 3.67–3.74 (m, 1 H), 3.57–3.65 (m, 1 H), 3.27 (d, <i>J</i> = 5.09 Hz, 1 H), 3.20 (dd, <i>J</i> = 14.23, 3.77 Hz, 1 H), 2.76–2.88 (m, 2 H), 2.67–2.74 (m, 1 H), 2.36–2.47 (m, 4 H), 2.24 (s, 7 H), 1.60–1.84 (m, 4 H), 0.87 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 605.3160 [M + H]<sup>+</sup>. Calcd for C<sub>34 h45</sub>N<sub>4</sub>O<sub>4</sub>S: 605.3146.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-Hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)tetrahydrofuran-2-carboxamide (<b>42</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33</b> and (<i>S</i>)-tetrahydrofuran-2-carboxylic acid via a method analogous to the preparation of <b>36</b>, giving a white solid (1.50 g, 47% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 7.84 (d, <i>J</i> = 3.23 Hz, 2 H), 7.71–7.82 (m, 3 H), 7.50 (d, <i>J</i> = 3.23 Hz, 1 H), 7.38 (t, <i>J</i> = 7.63 Hz, 1 H), 7.29–7.34 (m, 1 H), 6.96 (d, <i>J</i> = 11.15 Hz, 1 H), 4.10 (dd, <i>J</i> = 8.17, 5.53 Hz, 2 H), 3.94 (dd, <i>J</i> = 11.74, 5.18 Hz, 1 H), 3.68–3.75 (m, 1 H), 3.65 (t, <i>J</i> = 7.38 Hz, 1 H), 3.53–3.61 (m, 1 H), 3.27 (d, <i>J</i> = 5.28 Hz, 2 H), 3.21–3.26 (m, 1 H), 2.67–2.86 (m, 3 H), 2.35–2.49 (m, 4 H), 2.08–2.25 (m, 5 H), 1.82–1.92 (m, 1 H), 1.50–1.79 (m, 2 H), 1.16–1.42 (m, 2 H), 0.88 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 605.3158 [M + H]<sup>+</sup>. Calcd for C<sub>34 h45</sub>N<sub>4</sub>O<sub>4</sub>S: 605.3146.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (<i>R</i>)-2-Hydroxy-<i>N</i>-((2<i>S</i>,3<i>R</i>)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)-1-(3-(thiazol-2-yl)phenyl)butan-2-yl)propanamide (<b>43</b>)</h3><div class="NLM_p last">The triflate salt of the title compound was prepared from <b>33</b> and (<i>R</i>)-2-hydroxypropanoic acid via method analogous to the preparation of <b>35</b>, giving a white solid (0.102 g, 55% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 8.17 (s, 1 H), 8.07 (s, 1 H), 7.97 (d, <i>J</i> = 3.52 Hz, 1 H), 7.87 (s, 1 H), 7.66 (d, <i>J</i> = 7.63 Hz, 1 H), 7.60 (d, <i>J</i> = 3.52 Hz, 1 H), 7.33–7.51 (m, 3 H), 4.78 (dd, <i>J</i> = 11.05, 5.77 Hz, 1 H), 4.03–4.20 (m, 2 H), 3.94 (t, <i>J</i> = 7.92 Hz, 1 H), 3.37 (d, <i>J</i> = 11.54 Hz, 1 H), 3.01–3.19 (m, 2 H), 2.94 (dd, <i>J</i> = 11.84, 7.92 Hz, 1 H), 2.56–2.71 (m, 2 H), 2.40–2.52 (m, 2 H), 2.20–2.37 (m, 2 H), 2.08–2.21 (m, 2 H), 2.01 (d, <i>J</i> = 11.35 Hz, 1 H), 1.78 (dt, <i>J</i> = 11.40, 8.78 Hz, 1 H), 1.31 (d, <i>J</i> = 6.85 Hz, 3 H), 0.88 (s, 9 H). HRMS (ESI+) <i>m</i>/<i>z</i> = 579.2993 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>43</sub>N<sub>4</sub>O<sub>4</sub>S: 579.2990.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90"><a href="/doi/suppl/10.1021/jm300118s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">General information, experimentals and characterization, X-ray crystal structure information.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300118s/suppl_file/jm300118s_si_001.pdf">jm300118s_si_001.pdf (121.92 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300118s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas A. Dineen</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3541515c5b50505b75545852505b1b565a58"><span class="__cf_email__" data-cfemail="d1a5b5b8bfb4b4bf91b0bcb6b4bfffb2bebc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew M. Weiss</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toni Williamson</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Acton</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Safura Babu-Khan</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Bartberger</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Brown</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kui Chen</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuan Cheng</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Citron</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Croghan</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert T. Dunn</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel Esmay</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Russell F. Graceffa</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott S. Harried</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean Hickman</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen A. Hitchcock</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel B. Horne</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongbing Huang</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronke Imbeah-Ampiah</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ted Judd</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew R. Kaller</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles R. Kreiman</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel S. La</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vivian Li</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia Lopez</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Louie</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Holger Monenschein</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas T. Nguyen</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lewis D. Pennington</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tisha San Miguel</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">E. Allen Sickmier</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hugo M. Vargas</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert C. Wahl</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul H. Wen</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas A. Whittington</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Wood</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiufen Xue</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryant H. Yang</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod F. Patel</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenge Zhong</span> - <span class="hlFld-Affiliation affiliation">†Chemical
Research and Discovery, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span>; 
    <span class="hlFld-Affiliation affiliation">‡Department
of Neuroscience, §Department of HTS and Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, #Comparative Biology and Safety Sciences, Amgen Inc., One
Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s Disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid peptide</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">β-amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-site β-amyloid precursor protein cleaving enzyme</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">CV</td><td class="NLM_def"><p class="first last">cardiovascular</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">HEA</td><td class="NLM_def"><p class="first last">hydroxyethylamine</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">p-glycoprotein</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Small, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span> </span><span class="NLM_article-title">Alois Alzheimer and Alzeimer’s Disease: A Centennial Perspective</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1111%2Fj.1471-4159.2006.04212.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=17076655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=708-710&author=D.+H.+Smallauthor=R.+Cappai&title=Alois+Alzheimer+and+Alzeimer%E2%80%99s+Disease%3A+A+Centennial+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Alois Alzheimer and Alzheimer's disease: a centennial perspective</span></div><div class="casAuthors">Small, David H.; Cappai, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-710</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The year 2006 is the centenary of the famous presentation of Alois Alzheimer which first described the neuropathol. of Alzheimer's disease (AD).  Since this presentation, enormous progress has been made in understanding the biol. of AD.  The central role of the β-amyloid protein (Aβ) in the pathogenesis of AD and the relationship between plaque and tangle pathol. is now much better understood.  In this article, we review the current status of the amyloid hypothesis of AD and its role in the development of future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHVyze5z1W7Vg90H21EOLACvtfcHk0ljYzQAVAi2Rcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE&md5=27564c272b2bc577bbf4d568ffb7a079</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04212.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04212.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DCappai%26aufirst%3DR.%26atitle%3DAlois%2520Alzheimer%2520and%2520Alzeimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Centennial%2520Perspective%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D708%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A Century of Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+Century+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520Century%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Van Marum, R. J.</span><span> </span><span class="NLM_article-title">Current and Future Therapy in Alzheimer’s Disease</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1111%2Fj.1472-8206.2008.00578.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=18485144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=265-274&author=R.+J.+Van+Marum&title=Current+and+Future+Therapy+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Current and future therapy in Alzheimer's disease</span></div><div class="casAuthors">van Marum, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-274</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized as one of the most important medical problems in the elderly.  As most pharmacol. research within the field of dementia is focused on Alzheimer's dementia (AD), this review will focus on pharmacol. interventions in AD.  Most disease-modifying therapies are based on the amyloid hypothesis.  In this hypothesis, the pathol. accumulation of Aβ in the brain leads to oxidative stress, neuronal destruction and finally the clin. syndrome of AD.  Following this hypothesis, secondary prevention of AD can be made by: decreasing the prodn. of Aβ, stimulation of clearance of Aβ formed or prevention of aggregation of Aβ into amyloid plaques.  First a short overview on current approved therapies for AD is given.  The main part of the review will focus on potential disease-modifying therapies for AD that are currently being studied in phase I to phase III trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYSu96SxTqLVg90H21EOLACvtfcHk0ljYzQAVAi2Rcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D&md5=0813e575e9440a3e1ffc0e0ee79c5e7a</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2008.00578.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2008.00578.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMarum%26aufirst%3DR.%2BJ.%26atitle%3DCurrent%2520and%2520Future%2520Therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D22%26spage%3D265%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">100 Years and Counting: Prospects for Defeating Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=781-784&author=E.+D.+Robersonauthor=L.+Mucke&title=100+Years+and+Counting%3A+Prospects+for+Defeating+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3D100%2520Years%2520and%2520Counting%253A%2520Prospects%2520for%2520Defeating%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D781%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Catalano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henze, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafft, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span> </span><span class="NLM_article-title">The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimer’s Disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.2174%2F156802606776743066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=16712494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVOmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=597-608&author=S.+Catalanoauthor=E.+C.+Dodsonauthor=D.+A.+Henzeauthor=J.+G.+Joyceauthor=G.+A.+Krafftauthor=G.+G.+Kinney&title=The+Role+of+Amyloid-Beta+Derived+Diffusible+Ligands+%28ADDLs%29+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease</span></div><div class="casAuthors">Catalano, Susan M.; Dodson, Elizabeth C.; Henze, Darrell A.; Joyce, Joseph G.; Krafft, Grant A.; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid-β (Aβ) cascade hypothesis of Alzheimer's disease (AD) has dominated research and subsequent therapeutic drug development for over two decades.  Central to this hypothesis is the observation that Aβ is elevated in AD patients and that the disease is ultimately characterized by the central deposition of insol. senile plaques.  More recent evidence, however, suggests that the presence or absence of plaque is insufficient to fully account for the deleterious role of elevated Aβ in AD.  Such studies support the basis for an alternate interpretation of the Aβ cascade hypothesis.  Namely, that sol. oligomers of Aβ (i.e., ADDLs) accumulate and cause functional deficits prior to overt neuronal cell death or plaque deposition.  Accordingly, the following review focuses on research describing the prepn. and functional activity of ADDLs in vitro and in vivo.  These studies provide the basis for an alternate, ADDL-based, view of the Aβ cascade hypothesis and accounts for the disconnect between plaque burden and cognitive deficits.  Possible therapeutic approaches aimed at lowering ADDLs in AD patients are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXQlT7tzCPc7Vg90H21EOLACvtfcHk0lhw1dTRX1AcGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVOmsbY%253D&md5=fc371b4b30370dce13f04afebe292872</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156802606776743066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743066%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DS.%26aulast%3DDodson%26aufirst%3DE.%2BC.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJoyce%26aufirst%3DJ.%2BG.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DThe%2520Role%2520of%2520Amyloid-Beta%2520Derived%2520Diffusible%2520Ligands%2520%2528ADDLs%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pimplikar, S. W.</span><span> </span><span class="NLM_article-title">Reassessing the Amyloid Cascade Hypothesis of Alzheimer’s Disease</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1016%2Fj.biocel.2008.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=19124085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1261-1268&author=S.+W.+Pimplikar&title=Reassessing+the+Amyloid+Cascade+Hypothesis+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessing the amyloid cascade hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Pimplikar, Sanjay W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-1268</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since its inception, the amyloid cascade hypothesis has dominated the field of Alzheimer's disease (AD) research and has provided the intellectual framework for therapeutic intervention.  Although the details of the hypothesis continue to evolve, its core principle has remained essentially unaltered.  It posits that the amyloid-β peptides, derived from amyloid precursor protein (APP), are the root cause of AD.  Substantial genetic and biochem. data support this view, and yet a no. of findings also run contrary to its tenets.  The presence of familial AD mutations in APP and presenilins, demonstration of Aβ toxicity, and studies in mouse models of AD all support the hypothesis, whereas the presence of Aβ plaques in normal individuals, the uncertain nature of the pathogenic Aβ species, and repeated disappointments with Aβ-centered therapeutic trials are inconsistent with the hypothesis.  The current state of knowledge does not prove nor disprove the amyloid hypothesis, but rather points to the need for its reassessment.  A view that Aβ is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZoitUBRzaLVg90H21EOLACvtfcHk0lhw1dTRX1AcGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D&md5=e33973b5f125c34d95cb3f1b477d3ced</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPimplikar%26aufirst%3DS.%2BW.%26atitle%3DReassessing%2520the%2520Amyloid%2520Cascade%2520Hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D1261%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nature Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNature%2520Rev.%2520Drug.%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B. D.</span> <span class="citation_source-journal">Nature Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Karran%2C+E.%3B+Mercken%2C+M.%3B+De+Strooper%2C+B.+D.Nature+Rev.+Drug.+Discovery+2011%2C+10%2C+698%E2%80%93712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%2BD.%26jtitle%3DNature%2520Rev.%2520Drug.%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Beta-Secretase Cleavage of Alzheimer’s Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=Beta-Secretase+Cleavage+of+Alzheimer%E2%80%99s+Amyloid+Precursor+Protein+by+the+Transmembrane+Aspartic+Protease+BACE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DBeta-Secretase%2520Cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520Amyloid%2520Precursor%2520Protein%2520by%2520the%2520Transmembrane%2520Aspartic%2520Protease%2520BACE1%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a Novel Aspartic Protease (Asp 2) as Beta-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+Novel+Aspartic+Protease+%28Asp+2%29+as+Beta-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0ljAJTWy0b01Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Aspartic%2520Protease%2520%2528Asp%25202%2529%2520as%2520Beta-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashier, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membraned-Anchored Aspartyl Protease with Alzheimer’s Disease Beta-Secretase Activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashierauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membraned-Anchored+Aspartyl+Protease+with+Alzheimer%E2%80%99s+Disease+Beta-Secretase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashier%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembraned-Anchored%2520Aspartyl%2520Protease%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Beta-Secretase%2520Activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sinha%2C+S.%3B+Anderson%2C+J.+P.%3B+Barbour%2C+R.%3B+Basi%2C+G.+S.%3B+Caccavello%2C+R.%3B+Davis%2C+D.%3B+Doan%2C+M.%3B+Dovey%2C+H.+F.%3B+Frigon%2C+N.%3B+Hong%2C+J.%3B+Jacobson-Croak%2C+K.%3B+Jewett%2C+N.%3B+Keim%2C+P.%3B+Knops%2C+J.%3B+Lieberburg%2C+I.%3B+Power%2C+M.%3B+Tan%2C+H.%3B+Tatsuno%2C+G.%3B+Tung%2C+J.%3B+Schenk%2C+D.%3B+Seubert%2C+P.%3B+Suomensaari%2C+S.+M.%3B+Wang%2C+S.%3B+Walker%2C+D.%3B+Zhao%2C+J.%3B+McConlogue%2C+L.%3B+John%2C+V.Nature+1999%2C+402%2C+537%E2%80%93540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Durham, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, T. A.</span><span> </span><span class="NLM_article-title">Progress toward the discovery and development of efficacious BACE inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=776-791&author=T.+B.+Durhamauthor=T.+A.+Shepherd&title=Progress+toward+the+discovery+and+development+of+efficacious+BACE+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DShepherd%26aufirst%3DT.%2BA.%26atitle%3DProgress%2520toward%2520the%2520discovery%2520and%2520development%2520of%2520efficacious%2520BACE%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D776%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061197u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1124-1132&author=M.+Congreveauthor=D.+Aharonyauthor=J.+Albertauthor=O.+Callaghanauthor=J.+Campbellauthor=R.+A.+E.+Carrauthor=G.+Chessariauthor=S.+Cowanauthor=P.+D.+Edwardsauthor=M.+Fredericksonauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+the+discovery+of+aminopyridines+as+inhibitors+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm061197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061197u%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DJ.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520the%2520discovery%2520of%2520aminopyridines%2520as%2520inhibitors%2520of%2520beta-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1124%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Barrow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1002%2Fcmdc.200700038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=17458843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVyktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=995-999&author=J.+Barrowauthor=K.+Rittleauthor=P.+Ngoauthor=H.+Selnickauthor=S.+Grahamauthor=S.+Pitzenbergerauthor=G.+McGaugheyauthor=D.+Colussiauthor=M.-T.+Laiauthor=Q.+Huangauthor=K.+Tugushevaauthor=A.+Espesethauthor=A.+Simonauthor=S.+Munshiauthor=J.+Vacca&title=Design+and+synthesis+of+2%2C3%2C5-substituted+imidazolidin-4-one+inhibitors+of+BACE-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1</span></div><div class="casAuthors">Barrow, James C.; Rittle, Kenneth E.; Ngo, Phung L.; Selnick, Harold G.; Graham, Samuel L.; Pitzenberger, Steven M.; McGaughey, Georgia B.; Colussi, Dennis; Lai, Ming-Tain; Huang, Qian; Tugusheva, Katherine; Espeseth, Amy S.; Simon, Adam J.; Munshi, Sanjeev K.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">995-999</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2,3,5-Substituted imidazolidin-4-ones (e.g. I (R1 = Me, H; R2 = Bn)) were prepd. and tested as BACE-1 inhibitors.  The illustrated I are the most potent inhibitors.  The crystal and mol. structures of I (R1 = Me; R2 = Me) in the active site of BACE-1 were detd. by x-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgoCprsegvBLVg90H21EOLACvtfcHk0ljaGLPmMH4UKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVyktLc%253D&md5=e04a29f0ada03e808cbe5a10e8e57d0e</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700038%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%26aulast%3DRittle%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DP.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DPitzenberger%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202%252C3%252C5-substituted%2520imidazolidin-4-one%2520inhibitors%2520of%2520BACE-1%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D995%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Potent pyrrolidine- and piperidine-based BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1016%2Fj.bmcl.2007.10.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=18023580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1Wgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=414-417&author=U.+Iserlohauthor=Y.+Wuauthor=J.+N.+Cummingauthor=J.+Panauthor=L.+Y.+Wangauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=X.+Chenauthor=E.+M.+Parkerauthor=C.+Stricklandauthor=J.+Voigt&title=Potent+pyrrolidine-+and+piperidine-based+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Potent pyrrolidine- and piperidine-based BACE-1 inhibitors</span></div><div class="casAuthors">Iserloh, U.; Wu, Y.; Cumming, J. N.; Pan, J.; Wang, L. Y.; Stamford, A. W.; Kennedy, M. E.; Kuvelkar, R.; Chen, X.; Parker, E. M.; Strickland, C.; Voigt, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">414-417</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Based on lead compd. 1 identified from the patent literature, the authors developed novel patentable BACE-1 inhibitors by introducing a cyclic amine scaffold.  Extensive SAR studies on both pyrrolidines and piperidines ultimately led to inhibitor (I), one of the most potent inhibitors synthesized to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAchFs1p0DSrVg90H21EOLACvtfcHk0lhFxf1qiDO4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1Wgtg%253D%253D&md5=39db058f22f5ff8f12735456a6f7b70e</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.116%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DPotent%2520pyrrolidine-%2520and%2520piperidine-based%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D414%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mchugh, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Discovery of an orally efficacious 4-phenoxypyrrolidine-based BACE-1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=418-422&author=U.+Iserlohauthor=J.+Panauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=Q.+Zhangauthor=L.+Zhangauthor=E.+M.+Parkerauthor=N.+A.+Mchughauthor=L.+Favreauauthor=C.+Stricklandauthor=J.+Voigt&title=Discovery+of+an+orally+efficacious+4-phenoxypyrrolidine-based+BACE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DMchugh%26aufirst%3DN.%2BA.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520efficacious%25204-phenoxypyrrolidine-based%2520BACE-1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D418%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacPherson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanway, S.</span><span> </span><span class="NLM_article-title">BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1017-1022&author=B.+Clarkeauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=A.+Fallerauthor=J.+Hawkinsauthor=I.+Hussainauthor=D.+MacPhersonauthor=G.+Maileauthor=R.+Maticoauthor=P.+Milnerauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=D.+Riddellauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Stanway&title=BACE-1+inhibitors+part+2%3A+identification+of+hydroxy+ethylamines+%28HEAs%29+with+reduced+peptidic+character"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMacPherson%26aufirst%3DD.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMilner%26aufirst%3DP.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DStanway%26aufirst%3DS.%26atitle%3DBACE-1%2520inhibitors%2520part%25202%253A%2520identification%2520of%2520hydroxy%2520ethylamines%2520%2528HEAs%2529%2520with%2520reduced%2520peptidic%2520character%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1017%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3664</span><span class="NLM_x">–</span> <span class="NLM_lpage">3668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3664-3668&author=N.+Charrierauthor=B.+Clarkeauthor=L.+Cutlerauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=C.+Howesauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors.+Part+1%3A+The+need+for+improved+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors.%2520Part%25201%253A%2520The%2520need%2520for%2520improved%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3664%26epage%3D3668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors part 2: optimization of the non-prime side substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3669</span><span class="NLM_x">–</span> <span class="NLM_lpage">3673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3669-3673&author=N.+Charrierauthor=B.+Clarkeauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors+part+2%3A+optimization+of+the+non-prime+side+substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors%2520part%25202%253A%2520optimization%2520of%2520the%2520non-prime%2520side%2520substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3669%26epage%3D3673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors part 3: towards non-hydroxyethylamine transition state mimetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3674</span><span class="NLM_x">–</span> <span class="NLM_lpage">3678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3674-3678&author=N.+Charrierauthor=B.+Clarkeauthor=L.+Cutlerauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=C.+Howesauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors+part+3%3A+towards+non-hydroxyethylamine+transition+state+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors%2520part%25203%253A%2520towards%2520non-hydroxyethylamine%2520transition%2520state%2520mimetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3674%26epage%3D3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Stachel, S. J.</span><span> </span><span class="NLM_article-title">Progess Toward the Development of a Viable BACE1 Inhibitor</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=101-110&author=S.+J.+Stachel&title=Progess+Toward+the+Development+of+a+Viable+BACE1+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26atitle%3DProgess%2520Toward%2520the%2520Development%2520of%2520a%2520Viable%2520BACE1%2520Inhibitor%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references therein.</p></div><div class="NLM_citation" id="cit6k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichau, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and elective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichau&title=Aminoimidazoles+as+potent+and+elective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichau%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520elective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Al-Tel, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Qawasmeh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Aboudi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabri, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voelter, W.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of potent dibenzazepine motifs as β-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6484</span><span class="NLM_x">–</span> <span class="NLM_lpage">6488</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9008482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6484-6488&author=T.+H.+Al-Telauthor=R.+A.+Al-Qawasmehauthor=M.+F.+Schmidtauthor=A.+Al-Aboudiauthor=S.+N.+Raoauthor=S.+S.+Sabriauthor=W.+Voelter&title=Rational+design+and+synthesis+of+potent+dibenzazepine+motifs+as+%CE%B2-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=10.1021%2Fjm9008482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9008482%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Tel%26aufirst%3DT.%2BH.%26aulast%3DAl-Qawasmeh%26aufirst%3DR.%2BA.%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DAl-Aboudi%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DSabri%26aufirst%3DS.%2BS.%26aulast%3DVoelter%26aufirst%3DW.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520potent%2520dibenzazepine%2520motifs%2520as%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6484%26epage%3D6488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Cumming, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgur, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saionz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2837</span><span class="NLM_x">–</span> <span class="NLM_lpage">2842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2837-2842&author=J.+Cummingauthor=S.+Babuauthor=Y.+Huangauthor=C.+Carrolauthor=X.+Chenauthor=L.+Favreauauthor=W.+Greenleeauthor=T.+Guoauthor=M.+Kennedyauthor=R.+Kuvelkarauthor=T.+Leauthor=G.+Liauthor=N.+McHughauthor=P.+Orthauthor=L.+Ozgurauthor=E.+Parkerauthor=K.+Saionzauthor=A.+Stamfordauthor=C.+Stricklandauthor=D.+Tadesseauthor=J.+Voigtauthor=L.+Zhangauthor=Q.+Zhang&title=Piperazine+sulfonamide+BACE1+inhibitors%3A+design%2C+synthesis%2C+and+in+vivo+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCarrol%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLe%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMcHugh%26aufirst%3DN.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DOzgur%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DSaionz%26aufirst%3DK.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DPiperazine%2520sulfonamide%2520BACE1%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2837%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichau, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichau&title=Design+and+synthesis+of+5%2C5-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichau%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J.</span><span> </span><span class="NLM_article-title">Discovery of cyclic acylguanidines as highly potent and selective β-site amyloid cleaving enzyme (BACE) inhibitors: Part I. Inhibitor design and validation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901408p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=951-965&author=Z.+Zhuauthor=Z.+Sunauthor=Y.+Yeauthor=J.+Voigtauthor=C.+Stricklandauthor=E.+Smithauthor=J.+Cummingauthor=L.+Wangauthor=J.+Wongauthor=Y.+Wangauthor=D.+Wyssauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+Kennedyauthor=L.+Favreauauthor=E.+Parkerauthor=B.+McKittrickauthor=A.+Stamfordauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=J.+Hunter&title=Discovery+of+cyclic+acylguanidines+as+highly+potent+and+selective+%CE%B2-site+amyloid+cleaving+enzyme+%28BACE%29+inhibitors%3A+Part+I.+Inhibitor+design+and+validation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6o&amp;dbid=16384&amp;doi=10.1021%2Fjm901408p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901408p%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DCumming%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWyss%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DHunter%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520cyclic%2520acylguanidines%2520as%2520highly%2520potent%2520and%2520selective%2520%25CE%25B2-site%2520amyloid%2520cleaving%2520enzyme%2520%2528BACE%2529%2520inhibitors%253A%2520Part%2520I.%2520Inhibitor%2520design%2520and%2520validation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D951%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Al-Tel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semreen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Qawasmeh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Awadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaarour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Agnaf, O.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Qualitative Structure–Activity Evaluations of Novel β-Secretase Inhibitors as Potential Alzheimer’s Drug Leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8873</span><span class="NLM_x">–</span> <span class="NLM_lpage">8385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8873-8385&author=T.+Al-Telauthor=M.+H.+Semreenauthor=R.+A.+Al-Qawasmehauthor=M.+F.+Schmidtauthor=R.+El-Awadiauthor=M.+Ardahauthor=R.+Zaarourauthor=S.+N.+Raoauthor=O.+El-Agnaf&title=Design%2C+Synthesis%2C+and+Qualitative+Structure%E2%80%93Activity+Evaluations+of+Novel+%CE%B2-Secretase+Inhibitors+as+Potential+Alzheimer%E2%80%99s+Drug+Leads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Tel%26aufirst%3DT.%26aulast%3DSemreen%26aufirst%3DM.%2BH.%26aulast%3DAl-Qawasmeh%26aufirst%3DR.%2BA.%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DEl-Awadi%26aufirst%3DR.%26aulast%3DArdah%26aufirst%3DM.%26aulast%3DZaarour%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DEl-Agnaf%26aufirst%3DO.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Qualitative%2520Structure%25E2%2580%2593Activity%2520Evaluations%2520of%2520Novel%2520%25CE%25B2-Secretase%2520Inhibitors%2520as%2520Potential%2520Alzheimer%25E2%2580%2599s%2520Drug%2520Leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8873%26epage%3D8385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roberds, S. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branstetter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappenman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shopp, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintrup, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijsman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span> </span><span class="NLM_article-title">BACE1 Knockout Mice Are Healthy Despite Lacking the Primary Beta-Secretase Activity in Brain: Implications for Alzheimer’s Disease Therapeutics</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1093%2Fhmg%2F10.12.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11406613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1317-1324&author=S.+L+Roberdsauthor=J.+Andersonauthor=G.+Basiauthor=M.+J.+Bienkowskiauthor=D.+G.+Branstetterauthor=K.+S.+Chenauthor=S.+Freedmanauthor=N.+L.+Frigonauthor=D.+Gamesauthor=K.+Huauthor=K.+Johnson-Woodauthor=K.+E.+Kappenmanauthor=T.+T.+Kawabeauthor=I.+Kolaauthor=R.+Kuehnauthor=M.+Leeauthor=W.+Liuauthor=R.+Motterauthor=N.+F.+Nicholsauthor=M.+Powerauthor=D.+W.+Robertsonauthor=D.+Schenkauthor=M.+Schoorauthor=G.+M.+Shoppauthor=M.+E.+Shuckauthor=S.+Sinhaauthor=K.+A.+Svenssonauthor=G.+Tatsunoauthor=H.+Tintrupauthor=J.+Wijsmanauthor=S.+Wrightauthor=L.+McConlogue&title=BACE1+Knockout+Mice+Are+Healthy+Despite+Lacking+the+Primary+Beta-Secretase+Activity+in+Brain%3A+Implications+for+Alzheimer%E2%80%99s+Disease+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics</span></div><div class="casAuthors">Roberds, Steven L.; Anderson, John; Basi, Guriqbal; Bienkowski, Michael J.; Branstetter, Daniel G.; Chen, Karen S.; Freedman, Stephen B.; Frigon, Normand L.; Games, Dora; Hu, Kang; Johnson-Wood, Kelly; Kappenman, Karl E.; Kawabe, Thomas T.; Kola, Ismail; Kuehn, Ralf; Lee, Michael; Liu, Weiqun; Motter, Ruth; Nichols, Nanette F.; Power, Michael; Robertson, David W.; Schenk, Dale; Schoor, Michael; Shopp, George M.; Shuck, Mary E.; Sinha, Sukanto; Svensson, Kjell A.; Tatsuno, Gwen; Tintrup, Hartmut; Wijsman, John; Wright, Sarah; McConlogue, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1317-1324</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain.  The major components of plaque, β-amyloid peptides (Aβs), are produced from amyloid precursor protein (APP) by the activity of β- and γ-secretases.  β-Secretase activity cleaves APP to define the N-terminus of the Aβ1-x peptides and, therefore, has been a long-sought therapeutic target for treatment of AD.  The gene encoding a β-secretase for beta-site APP cleaving enzyme (BACE) was identified recently.  However, it was not known whether BACE was the primary β-secretase in mammalian brain nor whether inhibition of β-secretase might have effects in mammals that would preclude its utility as a therapeutic target.  In the work described herein, the authors generated two lines of BACE knockout mice and characterized them for pathol., β-secretase activity and Aβ prodn.  These mice appeared to develop normally and showed no consistent phenotypic differences from their wild-type littermates, including overall normal tissue morphol. and brain histochem., normal blood and urine chemistries, normal blood-cell compn., and no overt behavioral and neuromuscular effects.  Brain and primary cortical cultures from BACE knockout mice showed no detectable β-secretase activity, and primary cortical cultures from BACE knockout mice produced much less Aβ from APP.  The findings that BACE is the primary β-secretase activity in brain and that loss of β-secretase activity produces no profound phenotypic defects with a concomitant redn. in β-amyloid peptide clearly indicate that BACE is an excellent therapeutic target for treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ78rSt6xEe7Vg90H21EOLACvtfcHk0ljKaqpBY-0IUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D&md5=c18a9ff9f800eebd994476badc6ec1bc</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.12.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.12.1317%26sid%3Dliteratum%253Aachs%26aulast%3DRoberds%26aufirst%3DS.%2BL%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBasi%26aufirst%3DG.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DBranstetter%26aufirst%3DD.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%26aulast%3DFrigon%26aufirst%3DN.%2BL.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DKappenman%26aufirst%3DK.%2BE.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DKola%26aufirst%3DI.%26aulast%3DKuehn%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DNichols%26aufirst%3DN.%2BF.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DD.%2BW.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSchoor%26aufirst%3DM.%26aulast%3DShopp%26aufirst%3DG.%2BM.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTintrup%26aufirst%3DH.%26aulast%3DWijsman%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DMcConlogue%26aufirst%3DL.%26atitle%3DBACE1%2520Knockout%2520Mice%2520Are%2520Healthy%2520Despite%2520Lacking%2520the%2520Primary%2520Beta-Secretase%2520Activity%2520in%2520Brain%253A%2520Implications%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapeutics%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1317%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Mice Deficient in BACE1, the Alzheimer’s Beta-Secretase, Have Normal Phenotype and Abolished β-Amyloid Generation</span> <span class="citation_source-journal">Nature Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1038%2F85059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11224535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=231-232&author=Y.+Luoauthor=B.+Bolonauthor=S.+Kahnauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=P.+Denisauthor=W.+Fanauthor=H.+Khaauthor=J.+Zhangauthor=Y.+Gongauthor=L.+Martinauthor=J.-C.+Louisauthor=Q.+Yanauthor=W.+Richardsauthor=M.+Citronauthor=R.+Vassar&title=Mice+Deficient+in+BACE1%2C+the+Alzheimer%E2%80%99s+Beta-Secretase%2C+Have+Normal+Phenotype+and+Abolished+%CE%B2-Amyloid+Generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Kahn, Steve; Bennett, Brian D.; Babu-Khan, Safura; Denis, Paul; Fan, Wei; Kha, Hue; Zhang, Jianhua; Gong, Yunhua; Martin, Laura; Louis, Jean-Claude; Yan, Qiao; Richards, William G.; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Mice deficient in beta-site APP-cleaving enzyme 1 (BACE1) lack Aβ- and β-secretase-cleaved APP C-terminal fragments (CTFs) in the brain.  Moreover, BACE1-/- mice are normal in appearance and behavior and are healthy and fertile.  These results provide validation of BACE1 as the major β-secretase in vivo and indicated that BACE2 is not significant in β-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9Z5X-KkqkbVg90H21EOLACvtfcHk0lix5bsr459hnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D&md5=f733e8c48464c6521ce302be48c76b12</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2F85059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85059%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DKha%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DRichards%26aufirst%3DW.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DMice%2520Deficient%2520in%2520BACE1%252C%2520the%2520Alzheimer%25E2%2580%2599s%2520Beta-Secretase%252C%2520Have%2520Normal%2520Phenotype%2520and%2520Abolished%2520%25CE%25B2-Amyloid%2520Generation%26jtitle%3DNature%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">BACE1 is the Major Beta-secretase for Generation of Aβ Peptides by Neurons</span> <span class="citation_source-journal">Nature Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1038%2F85064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11224536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=233-234&author=H.+Caiauthor=Y.+Wangauthor=D.+McCarthyauthor=H.+Wenauthor=D.+R.+Borcheltauthor=D.+L.+Priceauthor=P.+C.+Wong&title=BACE1+is+the+Major+Beta-secretase+for+Generation+of+A%CE%B2+Peptides+by+Neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 is the major β-secretase for generation of Aβ peptides by neurons</span></div><div class="casAuthors">Cai, Huaibin; Wang, Yanshu; McCarthy, Diane; Wen, Hongjin; Borchelt, David R.; Price, Donald L.; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-234</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Secretion of Alzheimer's disease (AD) Aβ peptides (Aβ1-40/42 and Aβ11-40) is abolished in cultures of BACE1-deficient cortical neurons; BACE1-deficient is one of the two β-secretases involved in generating AD Aβ peptides.  This study also establishes that BACE1-deficient is the principal neuronal protease required to cleave amyloid precursor protein (APP) at the +1 and +11 sites that generate N-termini of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvJeMWCAU69rVg90H21EOLACvtfcHk0lix5bsr459hnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbc%253D&md5=fd3d6b77770735ed2b12687281fc511e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1038%2F85064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85064%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMcCarthy%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DH.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DBACE1%2520is%2520the%2520Major%2520Beta-secretase%2520for%2520Generation%2520of%2520A%25CE%25B2%2520Peptides%2520by%2520Neurons%26jtitle%3DNature%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D233%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span> </span><span class="NLM_article-title">Inhibition of BACE1 for Therapeutic Use in Alzheimer’s Disease</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=20661410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFagtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=618-628&author=X.+Luoauthor=R.+Yan&title=Inhibition+of+BACE1+for+Therapeutic+Use+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BACE1 for therapeutic use in Alzheimer's disease</span></div><div class="casAuthors">Luo, Xiaoyang; Yan, Riqiang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-628</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Since BACE1 was reported as the β-secretase in Alzheimer's disease (AD) over ten years ago, encouraging progress has been made toward understanding the cellular functions of BACE1.  Genetic studies have further confirmed that BACE1 is essential for processing amyloid precursor protein (APP) at the β-secretase site.  Only after this cleavage can the membrane-bound APP C-terminal fragment be subsequently cleaved by γ-secretase to release so-called AD-causing Aβ peptides.  Hence, in the past decade, a wide variety of BACE1 inhibitors have been developed for AD therapy.  This review will summarize the major historical events during the evolution of BACE1 inhibitors designed through different strategies of drug discovery.  Although BACE1 inhibitors are expected to be safe in general, careful titrn. of drug dosage to avoid undesirable side effects in BACE1-directed AD therapy is also emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUFz1x-AF9XbVg90H21EOLACvtfcHk0lix5bsr459hnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFagtbo%253D&md5=0cf2745b97b31229b1de6b7db04911e2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520BACE1%2520for%2520Therapeutic%2520Use%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2010%26volume%3D3%26spage%3D618%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kaller, M. R.; Harried, S. S.; Albrecht, B.; Amarante, P.; Babu-Khan, S.; Bartberger, M. D.; Brown, J.; Brown, R.; Chen, K.; Cheng, Y.; Citron, M.; Croghan, M. D.; Dunn, R.; Graceffa, R.; Hickman, D.; Judd, T.; Kreiman, C.; La, D.; Lopez, P.; Luo, Y.; Masse, C.; Monenschein, H.; Nguyen, T.; Pennington, L. D.; San Miguel, T.; Wahl, R. C.; Weiss, M. M.; Wen, P. H.; Williamson, T.; Wood, S.; Xue, M.; Yang, B.; Zhang, J.; Patel, V.; Zhong, W.; Hitchcock, S.</span><span> </span><span class="NLM_article-title">A Potent and Orally Efficacious, Hydroxyethylamine Based Inhibitor of Beta-Secretase</span>.  <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>doi <span class="refDoi"> DOI: 10.1021/ml3000148</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/ml3000148" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+R.+Kaller&author=S.+S.+Harried&author=B.+Albrecht&author=P.+Amarante&author=S.+Babu-Khan&author=M.+D.+Bartberger&author=J.+Brown&author=R.+Brown&author=K.+Chen&author=Y.+Cheng&author=M.+Citron&author=M.+D.+Croghan&author=R.+Dunn&author=R.+Graceffa&author=D.+Hickman&author=T.+Judd&author=C.+Kreiman&author=D.+La&author=P.+Lopez&author=Y.+Luo&author=C.+Masse&author=H.+Monenschein&author=T.+Nguyen&author=L.+D.+Pennington&author=T.+San+Miguel&author=R.+C.+Wahl&author=M.+M.+Weiss&author=P.+H.+Wen&author=T.+Williamson&author=S.+Wood&author=M.+Xue&author=B.+Yang&author=J.+Zhang&author=V.+Patel&author=W.+Zhong&author=S.+Hitchcock&title=A+Potent+and+Orally+Efficacious%2C+Hydroxyethylamine+Based+Inhibitor+of+Beta-Secretase&doi=10.1021%2Fml3000148"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fml3000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000148%26sid%3Dliteratum%253Aachs%26aulast%3DKaller%26aufirst%3DM.%2BR.%26atitle%3DA%2520Potent%2520and%2520Orally%2520Efficacious%252C%2520Hydroxyethylamine%2520Based%2520Inhibitor%2520of%2520Beta-Secretase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26doi%3D10.1021%2Fml3000148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Weiss, M. M.; Williamson, T.; Babu-Khan, S.; Bartberger, M. D.; Brown, J.; Chen, K.; Cheng, Y.; Citron, M.; Croghan, M. D.; Dineen, T. A.; Esmay, J.; Graceffa, R. F.; Harried, S. S.; Hickman, D.; Hitchcock, S. A.; Horne, D. B.; Huang, H.; Imbeah-Ampiah, R.; Judd, T.; Kaller, M. R.; Kreiman, C. R.; La, D. S.; Li, V.; Lopez, P.; Louie, S.; Monenschein, H.; Nguyen, T. T.; Pennington, L. D.; Rattan, C.; San Miguel, T.; Sickmier, E. A.; Wahl, R. C.; Wen, P. H.; Wood, S.; Xue, Q.; Yang, B. H.; Patel, V. F.; Zhong, W.</span><span> </span><span class="NLM_article-title">Design and Preparation of a Potent Series of Hydroxy Ethylamine Containing β-secretase Inhibitors that Demonstrate Robust Reduction of Central β-amyloid</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>doi <span class="refDoi"> DOI: 10.1021/jm300119p</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm300119p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+M.+Weiss&author=T.+Williamson&author=S.+Babu-Khan&author=M.+D.+Bartberger&author=J.+Brown&author=K.+Chen&author=Y.+Cheng&author=M.+Citron&author=M.+D.+Croghan&author=T.+A.+Dineen&author=J.+Esmay&author=R.+F.+Graceffa&author=S.+S.+Harried&author=D.+Hickman&author=S.+A.+Hitchcock&author=D.+B.+Horne&author=H.+Huang&author=R.+Imbeah-Ampiah&author=T.+Judd&author=M.+R.+Kaller&author=C.+R.+Kreiman&author=D.+S.+La&author=V.+Li&author=P.+Lopez&author=S.+Louie&author=H.+Monenschein&author=T.+T.+Nguyen&author=L.+D.+Pennington&author=C.+Rattan&author=T.+San+Miguel&author=E.+A.+Sickmier&author=R.+C.+Wahl&author=P.+H.+Wen&author=S.+Wood&author=Q.+Xue&author=B.+H.+Yang&author=V.+F.+Patel&author=W.+Zhong&title=Design+and+Preparation+of+a+Potent+Series+of+Hydroxy+Ethylamine+Containing+%CE%B2-secretase+Inhibitors+that+Demonstrate+Robust+Reduction+of+Central+%CE%B2-amyloid&doi=10.1021%2Fjm300119p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DDesign%2520and%2520Preparation%2520of%2520a%2520Potent%2520Series%2520of%2520Hydroxy%2520Ethylamine%2520Containing%2520%25CE%25B2-secretase%2520Inhibitors%2520that%2520Demonstrate%2520Robust%2520Reduction%2520of%2520Central%2520%25CE%25B2-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26doi%3D10.1021%2Fjm300119p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hollenberg, P. F.</span><span> </span><span class="NLM_article-title">Characteristic and Common Properties of Inhibitors, Inducers, and Activators of CYP Enzymes</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1081%2FDMR-120001387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11996009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1KgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=17-35&author=P.+F.+Hollenberg&title=Characteristic+and+Common+Properties+of+Inhibitors%2C+Inducers%2C+and+Activators+of+CYP+Enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics and common properties of inhibitors, inducers, and activators of CYP [cytochrome P 450] enzymes</span></div><div class="casAuthors">Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">17-35</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1tGuvyvnmSLVg90H21EOLACvtfcHk0lheVIhPxJrnaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1KgsL0%253D&md5=b20e7498802e30d66ffb15f807f77262</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1081%2FDMR-120001387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120001387%26sid%3Dliteratum%253Aachs%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DCharacteristic%2520and%2520Common%2520Properties%2520of%2520Inhibitors%252C%2520Inducers%252C%2520and%2520Activators%2520of%2520CYP%2520Enzymes%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2002%26volume%3D34%26spage%3D17%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lewis, D. F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickins, M.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationship For Human Cytochrome P450 Substrates and Inhibitors</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1081%2FDMR-120001391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11996013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1KgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=69-82&author=D.+F.+V.+Lewisauthor=S.+Modiauthor=M.+Dickins&title=Structure%E2%80%93Activity+Relationship+For+Human+Cytochrome+P450+Substrates+and+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship for human cytochrome P450 substrates and inhibitors</span></div><div class="casAuthors">Lewis, David F. V.; Modi, Sandeep; Dickins, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">69-82</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  Criteria governing the avidity of substrate binding to human hepatic cytochromes P 450 (CYP) assocd. with Phase 1 metab. of drugs are described.  The results of extensive quant. structure-activity relationship (QSAR) analyses are reported for substrates of human P450s: CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4, representing the enzymes exhibiting major involvement in the metab. of drug substrates in Homo sapiens.  In particular, it is shown that hydrogen bond properties in each class of enzyme-substrate complex are esp. important factors in detg. substrate binding affinity towards those human P450s which are involved in drug metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolHlRucex0d7Vg90H21EOLACvtfcHk0lheVIhPxJrnaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1KgsLk%253D&md5=b8783a098d7b48259d940b1d58e50415</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1081%2FDMR-120001391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120001391%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BF.%2BV.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DDickins%26aufirst%3DM.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationship%2520For%2520Human%2520Cytochrome%2520P450%2520Substrates%2520and%2520Inhibitors%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2002%26volume%3D34%26spage%3D69%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhou, S.-F.</span><span> </span><span class="NLM_article-title">Drugs Behave as Substrates, Inhibitors, and Inducers of Human Cytochrome P450 3A4</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.2174%2F138920008784220664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=18473749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1aitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=310-322&author=S.-F.+Zhou&title=Drugs+Behave+as+Substrates%2C+Inhibitors%2C+and+Inducers+of+Human+Cytochrome+P450+3A4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4</span></div><div class="casAuthors">Zhou, Shu-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">310-322</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human cytochrome P 450 (CYP) 3A4 is the most abundant hepatic and intestinal phase I enzyme that metabolizes approx. 50% marketed drugs.  The crystal structure of bound and unbound CYP3A4 has been recently constructed, and a small active site and a peripheral binding site are identified.  A recent study indicates that CYP3A4 undergoes dramatic conformational changes upon binding to ketoconazole or erythromycin with a differential but substantial (>80%) increase in the active site vol., providing a structural basis for ligand promiscuity of CYP3A4.  A no. of important drugs have been identified as substrates, inducers and/or inhibitors of CYP3A4.  The ability of drugs to act as inducers, inhibitors, or substrates for CYP3A is predictive of whether concurrent administration of these compds. with a known CYP3A substrate might lead to altered drug disposition, efficacy or toxicity.  The substrates of CYP3A4 considerably overlap with those of P-glycoprotein (P-gp).  To date, the identified clin. important CYP3A4 inhibitors mainly include macrolide antibiotics (e.g., clarithromycin, and erythromycin), anti-HIV agents (e.g., ritonavir and delavirdine), antidepressants (E.g. fluoxetine and fluvoxamine), calcium channel blockers (e.g. verapamil and diltiazem), steroids and their modulators (e.g., gestodene and mifepristone), and several herbal and dietary components.  Many of these drugs are also mechanism-based inhibitors of CYP3A4, which involves formation of reactive metabolites, binding to CYP3A4 and irreversible enzyme inactivation.  A small no. of drugs such as rifampin, phenytoin and ritonavir are identified as inducers of CYP3A4.  The orphan nuclear receptor, pregnane X receptor (PXR), have been found to play a crit. role in the induction of CYP3A4.  The inhibition or induction of CYP3A4 by drugs often causes unfavorable and long-lasting drug-drug interactions and probably fatal toxicity, depending on many factors assocd. with the enzyme, drugs and the patients.  The study of interactions of newly synthesized compds. with CYP3A4 has been incorporated into drug development and detection of possible CYP3A4 inhibitors and inducers during the early stages of drug development is crit. in preventing potential drug-drug interactions and side effects.  Clinicians are encouraged to have a sound knowledge on drugs that behave as substrates, inhibitors or inducers of CYP3A4, and take proper cautions and close monitoring for potential drug interactions when using drugs that are CYP3A4 inhibitors or inducers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv7PWdiHlenbVg90H21EOLACvtfcHk0lgtDNgYZuJPlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1aitLY%253D&md5=df7e7825fd46cd35b8937245771cb972</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.2174%2F138920008784220664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008784220664%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.-F.%26atitle%3DDrugs%2520Behave%2520as%2520Substrates%252C%2520Inhibitors%252C%2520and%2520Inducers%2520of%2520Human%2520Cytochrome%2520P450%25203A4%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D310%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span> </span><span class="NLM_article-title">Stereoselective Synthesis <i>anti</i>-<i>N</i>-Protected 3-Amino-1,2-epoxides by Nucleophilic Addition to <i>N</i>-<i>tert</i>-Butanesulfinyl Imine of a Glyceraldehyde Synthon</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">5975</span><span class="NLM_x">–</span> <span class="NLM_lpage">5982</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo900643b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=5975-5982&author=S.+S.+Harriedauthor=M.+D.+Croghanauthor=M.+R.+Kallerauthor=P.+Lopezauthor=W.+Zhongauthor=R.+Hungateauthor=P.+J.+Reider&title=Stereoselective+Synthesis+anti-N-Protected+3-Amino-1%2C2-epoxides+by+Nucleophilic+Addition+to+N-tert-Butanesulfinyl+Imine+of+a+Glyceraldehyde+Synthon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjo900643b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900643b%26sid%3Dliteratum%253Aachs%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26atitle%3DStereoselective%2520Synthesis%2520anti-N-Protected%25203-Amino-1%252C2-epoxides%2520by%2520Nucleophilic%2520Addition%2520to%2520N-tert-Butanesulfinyl%2520Imine%2520of%2520a%2520Glyceraldehyde%2520Synthon%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D5975%26epage%3D5982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Dess, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">Readily Accessible 12-I-5 Oxidant for the Conversion of Primary and Secondary Alcohols to Aldehydes and Ketones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4155</span><span class="NLM_x">–</span> <span class="NLM_lpage">4156</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00170a070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaL3sXlslCqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=4155-4156&author=D.+B.+Dessauthor=J.+C.+Martin&title=Readily+Accessible+12-I-5+Oxidant+for+the+Conversion+of+Primary+and+Secondary+Alcohols+to+Aldehydes+and+Ketones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones</span></div><div class="casAuthors">Dess, D. B.; Martin, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4155-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Oxidn. of 2-IC6H4CO2H with KBrO3 in aq. H2SO4, followed by treatment of the oxidn. product with Ac2O gave 87% periodinane I, a 10-I-5 species (i.e., 10 valence electrons are formally involved in binding 5 ligands to the central iodine atom).  I reacted rapidly with primary or secondary alcs. at room temp. to give the corresponding aldehydes or ketones in high yield.  Excess I does not further oxidize the aldehyde or ketone under the reaction conditions.  The reaction is strongly catalyzed by excess alc. or strong acid, but is unaffected by pyridine.  I oxidizes benzylic alcs. selectively in the presence of satd. alcs.  Procedures for sepg. the carbonyl product from the reaction mixt. are mild and simple.  Cryst. I is stable at room temp. in the absence of moisture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAtQbosBW467Vg90H21EOLACvtfcHk0lgtDNgYZuJPlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslCqsro%253D&md5=31b4835cd94c04773221d921e76231d1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjo00170a070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00170a070%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DReadily%2520Accessible%252012-I-5%2520Oxidant%2520for%2520the%2520Conversion%2520of%2520Primary%2520and%2520Secondary%2520Alcohols%2520to%2520Aldehydes%2520and%2520Ketones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26spage%3D4155%26epage%3D4156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okukado, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negishi, E.-I.</span><span> </span><span class="NLM_article-title">Highly General Stereo-, Regio-, and Chemo-selective Synthesis of Terminal and Internal Conjugated Enynes by the Pd-catalysed Reaction of Alkynylzinc Reagents with Alkenyl Halides</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1039%2Fc39770000683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaE1cXht1SmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1977&pages=683-684&author=A.+O.+Kingauthor=N.+Okukadoauthor=E.-I.+Negishi&title=Highly+General+Stereo-%2C+Regio-%2C+and+Chemo-selective+Synthesis+of+Terminal+and+Internal+Conjugated+Enynes+by+the+Pd-catalysed+Reaction+of+Alkynylzinc+Reagents+with+Alkenyl+Halides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Highly general stereo-, regio-, and chemo-selective synthesis of terminal and internal conjugated enynes by the palladium-catalyzed reaction of alkynylzinc reagents with alkenyl halides</span></div><div class="casAuthors">King, Anthony O.; Okukado, Nobuhisa; Negishi, Eiichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Chemical Communications</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">683-4</span>CODEN:
                <span class="NLM_cas:coden">JCCCAT</span>;
        ISSN:<span class="NLM_cas:issn">0022-4936</span>.
    </div><div class="casAbstract">RC≡CZnCl [R = H, Bu, (CH2)4Me], prepd. by reaction of RC≡CLi with ZnCl2, underwent palladium phosphine complex-catalyzed condensation with R1CR2:CHR3 (R1 = H, R2 = Bu, R3 = I; R1 = Bu, R2 = H, Et, R3 = I; R1 = CO2Me, R1 = Me, R3 = Br) to give ≥65% R1CR2:CHC≡CR, the stereospecificity of the reaction being ≥97%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp24Kxv9jQNqbVg90H21EOLACvtfcHk0ljt3I-QmEf_3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXht1SmsLc%253D&md5=b235d8eaaede6ef4d5d4fded38433b2c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fc39770000683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39770000683%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DOkukado%26aufirst%3DN.%26aulast%3DNegishi%26aufirst%3DE.-I.%26atitle%3DHighly%2520General%2520Stereo-%252C%2520Regio-%252C%2520and%2520Chemo-selective%2520Synthesis%2520of%2520Terminal%2520and%2520Internal%2520Conjugated%2520Enynes%2520by%2520the%2520Pd-catalysed%2520Reaction%2520of%2520Alkynylzinc%2520Reagents%2520with%2520Alkenyl%2520Halides%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1977%26spage%3D683%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a Surrogate for Assessing CNS Exposure: An Industrial Perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+Surrogate+for+Assessing+CNS+Exposure%3A+An+Industrial+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0ljt3I-QmEf_3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520Surrogate%2520for%2520Assessing%2520CNS%2520Exposure%253A%2520An%2520Industrial%2520Perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+Drug+Concentration+in+Brain+Homogenate+and+Cerebral+Spinal+Fluid+at+Steady+State+as+a+Surrogate+for+Unbound+Concentration+in+Brain+Interstitial+Fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0lgrXGfKaBiOJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520Drug%2520Concentration%2520in%2520Brain%2520Homogenate%2520and%2520Cerebral%2520Spinal%2520Fluid%2520at%2520Steady%2520State%2520as%2520a%2520Surrogate%2520for%2520Unbound%2520Concentration%2520in%2520Brain%2520Interstitial%2520Fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Coordinates for the complex of BACE1 with inhibitor <b>37</b> have been deposited in the Protein Data Bank under PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DI2">4DI2</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mahar Doan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Passive Permeability and P-glycoprotein Mediated Efflux Differentiate CNS and Non-CNS Marketed Drugs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=K.+M.+Mahar+Doanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkinsonauthor=J.+W.+Polli&title=Passive+Permeability+and+P-glycoprotein+Mediated+Efflux+Differentiate+CNS+and+Non-CNS+Marketed+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Mahar Doan Kelly M; Humphreys Joan E; Webster Lindsey O; Wring Stephen A; Shampine Larry J; Serabjit-Singh Cosette J; Adkison Kimberly K; Polli Joseph W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-37</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to determine whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochemical properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compounds for drug development.  Apparent permeability (P(app)) and Pgp substrate profiles for 93 CNS (n = 48) and non-CNS (n = 45) drugs were determined by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were positive in the calcein-AM assay when tested at 100 microM.  The CNS drug set (n = 7 of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (n = 19 of 45, 42.2%).  Analysis of 18 physicochemical properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer positive charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group (p < 0.05), properties that enhance membrane permeability.  This study on a large, diverse set of marketed compounds clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochemical properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B --> A/A --> B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_HiV1Xqt18Vf1XRtfYM0dfW6udTcc2eYgcUDs2ALlkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D&md5=b841902aa8502de47c1e1603c80e09fb</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DMahar%2BDoan%26aufirst%3DK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520Permeability%2520and%2520P-glycoprotein%2520Mediated%2520Efflux%2520Differentiate%2520CNS%2520and%2520Non-CNS%2520Marketed%2520Drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–Brain Exposure Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93Brain+Exposure+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593Brain%2520Exposure%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Turner, R. T.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanheira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Subsite specificity of memapsin (β-secretase): implications for inhibitor design</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10001</span><span class="NLM_x">–</span> <span class="NLM_lpage">10006</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi015546s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10001-10006&author=R.+T.+Turnerauthor=G.+Koelschauthor=L.+Hongauthor=P.+Castanheiraauthor=A.+Ghoshauthor=J.+Tang&title=Subsite+specificity+of+memapsin+%28%CE%B2-secretase%29%3A+implications+for+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi015546s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi015546s%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BT.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DCastanheira%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DSubsite%2520specificity%2520of%2520memapsin%2520%2528%25CE%25B2-secretase%2529%253A%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10001%26epage%3D10006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Haniu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span> </span><span class="NLM_article-title">Characterization of Alzheimer’s beta-secretase protein BACE1. A pepsin family member with unusual properties</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">21099</span><span class="NLM_x">–</span> <span class="NLM_lpage">21106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=21099-21106&author=M.+Haniuauthor=P.+Denisauthor=Y.+Youngauthor=E.+A.+Mendiazauthor=J.+Fullerauthor=J.+O.+Huiauthor=B.+D.+Bennettauthor=S.+Kahnauthor=S.+Rossauthor=T.+Burgess&title=Characterization+of+Alzheimer%E2%80%99s+beta-secretase+protein+BACE1.+A+pepsin+family+member+with+unusual+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaniu%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DY.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DHui%26aufirst%3DJ.%2BO.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520Alzheimer%25E2%2580%2599s%2520beta-secretase%2520protein%2520BACE1.%2520A%2520pepsin%2520family%2520member%2520with%2520unusual%2520properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D21099%26epage%3D21106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Schinkel, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deemter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span> </span><span class="NLM_article-title">Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">–</span> <span class="NLM_lpage">1705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1995&pages=1698-1705&author=A.+H.+Schinkelauthor=E.+Wagenaarauthor=L.+van+Deemterauthor=C.+A.+A.+M.+Molauthor=P.+Borst&title=Absence+of+the+mdr1a+P-glycoprotein+in+mice+affects+tissue+distribution+and+pharmacokinetics+of+dexamethasone%2C+digoxin%2C+and+cyclosporin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3Dvan%2BDeemter%26aufirst%3DL.%26aulast%3DMol%26aufirst%3DC.%2BA.%2BA.%2BM.%26aulast%3DBorst%26aufirst%3DP.%26atitle%3DAbsence%2520of%2520the%2520mdr1a%2520P-glycoprotein%2520in%2520mice%2520affects%2520tissue%2520distribution%2520and%2520pharmacokinetics%2520of%2520dexamethasone%252C%2520digoxin%252C%2520and%2520cyclosporin%2520A%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1995%26volume%3D96%26spage%3D1698%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Booth-Genthe, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlini, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leake, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhandler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rushmore, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, M.</span><span> </span><span class="NLM_article-title">Development and characterization of LLC-PK1 cells containing Sprague–Dawley rat <i>Abcb</i>1a (<i>Mdr</i>1a): Comparison of rat P-glycoprotein transport to human and mouse</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1016%2Fj.vascn.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=16545584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFSkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=78-89&author=C.+L.+Booth-Gentheauthor=S.+W.+Louieauthor=E.+J.+Carliniauthor=B.+Liauthor=B.+F.+Leakeauthor=R.+Eisenhandlerauthor=J.+H.+Hochmanauthor=Q.+Meiauthor=R.+B.+Kimauthor=T.+H.+Rushmoreauthor=M.+Yamazaki&title=Development+and+characterization+of+LLC-PK1+cells+containing+Sprague%E2%80%93Dawley+rat+Abcb1a+%28Mdr1a%29%3A+Comparison+of+rat+P-glycoprotein+transport+to+human+and+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): Comparison of rat P-glycoprotein transport to human and mouse</span></div><div class="casAuthors">Booth-Genthe, Catherine L.; Louie, Steven W.; Carlini, Edward J.; Li, Bing; Leake, Brenda F.; Eisenhandler, Roy; Hochman, Jerome H.; Mei, Qin; Kim, Richard B.; Rushmore, Thomas H.; Yamazaki, Masayo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-89</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">P-glycoprotein is localized in numerous tissues throughout the body and plays an important role in the disposition of many xenobiotics.  The contribution of P-glycoprotein-mediated drug transport is being evaluated in early drug discovery stages, particularly for compds. targeted to the central nervous system, using in vitro tools including cell lines expressing P-glycoprotein.  Previous work in our lab. suggests there are species differences in P-glycoprotein transport activity between humans and animals.  The rat Abcb1a form of P-glycoprotein (formerly known as Mdr1a), the predominate isoform in the brain, has not been described in a functional cell system.  Here, we describe the development and characterization of LLC-PK1 cells expressing rat Abcb1.  We cloned rat Abcb1a and generated a stable LLC-PK1 cell line.  Expression and function of the cells were evaluated by immunoblot anal., cytotoxicity anal., cellular accumulation assays, and transcellular transport of probe substrates.  The transport ratios of structurally diverse compds. obtained from parental cells or cells stably transfected with human ABCB1, mouse Abcb1a or rat Abcb1a were compared.  Two forms of rat Abcb1a were cloned from Sprague-Dawley cDNA that differ by six amino acids and a base pair deletion.  The intact form was stably transfected in LLC-PK1 cells.  Immunoblot anal. demonstrated expression of the protein.  The cells demonstrated P-glycoprotein-mediated function by directional transport of dexamethasone, ritonavir, and vinblastine in a transwell assay that was inhibited in the presence of cyclosporin A, verapamil, or quinidine.  Likewise, the cells showed reduced cellular accumulation of Rh123 by FACS anal. that was reversed in the presence of cyclosporin A.  These cells showed ≥ 350-fold resistance to colchicine, doxorubicin, vinblastine, and taxol and were sensitized in the presence of verapamil or cyclosporin A.  Of 179 chem. diverse compds. evaluated, ∼20% of the compds. evaluated were predicted to be substrates in one species but not in other species.  Taken together, these data suggest these cells will be useful for evaluation of rat Abcb1a-mediated transport and for evaluation of species-specific P-glycoprotein-mediated transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTnY-e_sTc7LVg90H21EOLACvtfcHk0lj_9c5N4PWWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFSkuro%253D&md5=3390b072631084f62434e147269b6c13</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBooth-Genthe%26aufirst%3DC.%2BL.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DCarlini%26aufirst%3DE.%2BJ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLeake%26aufirst%3DB.%2BF.%26aulast%3DEisenhandler%26aufirst%3DR.%26aulast%3DHochman%26aufirst%3DJ.%2BH.%26aulast%3DMei%26aufirst%3DQ.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DRushmore%26aufirst%3DT.%2BH.%26aulast%3DYamazaki%26aufirst%3DM.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520LLC-PK1%2520cells%2520containing%2520Sprague%25E2%2580%2593Dawley%2520rat%2520Abcb1a%2520%2528Mdr1a%2529%253A%2520Comparison%2520of%2520rat%2520P-glycoprotein%2520transport%2520to%2520human%2520and%2520mouse%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D78%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE1 (β-secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE1+%28%CE%B2-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE1%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lj_9c5N4PWWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljYamkTE5k2_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ljYamkTE5k2_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title"><i>Coot</i>: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">D60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljYamkTE5k2_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3DD60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g','cit6h','cit6i','cit6j','cit6k','cit6l','cit6m','cit6n','cit6o','cit6p'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':[],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Liping H. Pettus, Matthew P. Bourbeau, Jodi Bradley, Michael D. Bartberger, Kui Chen, Dean Hickman, Michael Johnson, Qingyian Liu, James R. Manning, Adrian Nanez, Aaron C. Siegmund, Paul H. Wen, Douglas A. Whittington, Jennifer R. Allen, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Wood</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2263-2281. <a href="https://doi.org/10.1021/acs.jmedchem.9b01034" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAM-6494%25253A%252BA%252BPotent%252Band%252BOrally%252BEfficacious%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitor%252Bwith%252Bin%252BVivo%252BSelectivity%252Bover%252BBACE2%26aulast%3DPettus%26aufirst%3DLiping%2BH.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D29062019%26date%3D18102019%26date%3D07102019%26volume%3D63%26issue%3D5%26spage%3D2263%26epage%3D2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Steven M.    Mennen </span><span class="hlFld-ContribAuthor "> John    Stellwagen </span><span class="hlFld-ContribAuthor "> Ryan D.    White </span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Identification and Development of AM-6138: An Inhibitor of BACE1 for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 29-52. <a href="https://doi.org/10.1021/bk-2018-1307.ch002" title="DOI URL">https://doi.org/10.1021/bk-2018-1307.ch002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2018-1307.ch002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2018-1307.ch002%26sid%3Dliteratum%253Aachs%26atitle%3DPreclinical%252BIdentification%252Band%252BDevelopment%252Bof%252BAM-6138%25253A%252BAn%252BInhibitor%252Bof%252BBACE1%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMennen%26aufirst%3DSteven%2BM.%26date%3D2018%26date%3D2018%26spage%3D29%26epage%3D52%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2018%26date%3D2018%26volume%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mihirbaran  Mandal</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Misiaszek</span>, <span class="hlFld-ContribAuthor ">Guoqing  Li</span>, <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>, <span class="hlFld-ContribAuthor ">John P.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Xiaoxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Robert D.  Mazzola</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>, <span class="hlFld-ContribAuthor ">Johannes  Voigt</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Michael  Grzelak</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Prescott T.  Leach</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Maria S.  Michener</span>, <span class="hlFld-ContribAuthor ">Brad  Smith</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Diane  Grotz</span>, <span class="hlFld-ContribAuthor ">Leonard  Favreau</span>, <span class="hlFld-ContribAuthor ">Kaushik  Mitra</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Brian A.  McKittrick</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3231-3248. <a href="https://doi.org/10.1021/acs.jmedchem.5b01995" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ban%252BIminoheterocyclic%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE%252529%252BInhibitor%252Bthat%252BLowers%252BCentral%252BA%2525CE%2525B2%252Bin%252BNonhuman%252BPrimates%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D23122015%26date%3D22032016%26date%3D14042016%26date%3D03032016%26volume%3D59%26issue%3D7%26spage%3D3231%26epage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric P.  Gillis</span>, <span class="hlFld-ContribAuthor ">Kyle J.  Eastman</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hill</span>, <span class="hlFld-ContribAuthor ">David J.  Donnelly</span>, and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Fluorine in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8315-8359. <a href="https://doi.org/10.1021/acs.jmedchem.5b00258" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplications%252Bof%252BFluorine%252Bin%252BMedicinal%252BChemistry%26aulast%3DGillis%26aufirst%3DEric%2BP.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D22072015%26date%3D12112015%26volume%3D58%26issue%3D21%26spage%3D8315%26epage%3D8359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Katayoun  Derakhchan</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Zihao  Hua</span>, <span class="hlFld-ContribAuthor ">Jason B.  Human</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Xiao Mei  Zheng</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, and <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>  . </span><span class="cited-content_cbyCitation_article-title">Lead Optimization and Modulation of hERG Activity in a Series of Aminooxazoline Xanthene β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9796-9810. <a href="https://doi.org/10.1021/jm501266w" title="DOI URL">https://doi.org/10.1021/jm501266w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501266w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252Band%252BModulation%252Bof%252BhERG%252BActivity%252Bin%252Ba%252BSeries%252Bof%252BAminooxazoline%252BXanthene%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%252BInhibitors%26aulast%3DEpstein%26aufirst%3DOleg%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D12112014%26date%3D11122014%26volume%3D57%26issue%3D23%26spage%3D9796%26epage%3D9810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Katayoun  Derakhchan</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Joel  Esmay</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Chuck E.  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, and <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9811-9831. <a href="https://doi.org/10.1021/jm5012676" title="DOI URL">https://doi.org/10.1021/jm5012676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5012676%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%25253A%252BIdentification%252Bof%252B%252528S%252529-7-%2525282-Fluoropyridin-3-yl%252529-3-%252528%2525283-methyloxetan-3-yl%252529ethynyl%252529-5%2525E2%252580%2525B2H-spiro%25255Bchromeno%25255B2%25252C3-b%25255Dpyridine-5%25252C4%2525E2%252580%2525B2-oxazol%25255D-2%2525E2%252580%2525B2-amine%252B%252528AMG-8718%252529%26aulast%3DDineen%26aufirst%3DThomas%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D14112014%26date%3D11122014%26date%3D01112014%26volume%3D57%26issue%3D23%26spage%3D9811%26epage%3D9831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erick M.  Carreira</span> and <span class="hlFld-ContribAuthor ">Thomas C.  Fessard</span>  . </span><span class="cited-content_cbyCitation_article-title">Four-Membered Ring-Containing Spirocycles: Synthetic Strategies and Opportunities. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (16)
                                     , 8257-8322. <a href="https://doi.org/10.1021/cr500127b" title="DOI URL">https://doi.org/10.1021/cr500127b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500127b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500127b%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DFour-Membered%252BRing-Containing%252BSpirocycles%25253A%252BSynthetic%252BStrategies%252Band%252BOpportunities%26aulast%3DCarreira%26aufirst%3DErick%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03032014%26date%3D08072014%26date%3D27082014%26volume%3D114%26issue%3D16%26spage%3D8257%26epage%3D8322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fiona I.  McGonagle</span>, <span class="hlFld-ContribAuthor ">Helen F.  Sneddon</span>, <span class="hlFld-ContribAuthor ">Craig  Jamieson</span>, and <span class="hlFld-ContribAuthor ">Allan J. B.  Watson</span>  . </span><span class="cited-content_cbyCitation_article-title">Molar Efficiency: A Useful Metric To Gauge Relative Reaction Efficiency in Discovery Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2014,</strong> <em>2 </em>
                                    (3)
                                     , 523-532. <a href="https://doi.org/10.1021/sc4004532" title="DOI URL">https://doi.org/10.1021/sc4004532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/sc4004532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fsc4004532%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DMolar%252BEfficiency%25253A%252BA%252BUseful%252BMetric%252BTo%252BGauge%252BRelative%252BReaction%252BEfficiency%252Bin%252BDiscovery%252BMedicinal%252BChemistry%26aulast%3DMcGonagle%26aufirst%3DFiona%2BI.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06112013%26date%3D28112013%26date%3D06122013%26date%3D03032014%26date%3D02122013%26volume%3D2%26issue%3D3%26spage%3D523%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Yuan</span>, <span class="hlFld-ContribAuthor ">Shankar  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Brian M.  McKeever</span>, <span class="hlFld-ContribAuthor ">Lawrence W.  Dillard</span>, and <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4156-4180. <a href="https://doi.org/10.1021/jm301659n" title="DOI URL">https://doi.org/10.1021/jm301659n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301659n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252B%2525CE%2525B2-Site%252BAPP%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DYuan%26aufirst%3DJing%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D09112012%26date%3D05042013%26date%3D13062013%26date%3D19032013%26volume%3D56%26issue%3D11%26spage%3D4156%26epage%3D4180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Toni  Williamson</span>, <span class="hlFld-ContribAuthor ">Safura  Babu-Khan</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Martin  Citron</span>, <span class="hlFld-ContribAuthor ">Michael D.  Croghan</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Joel  Esmay</span>, <span class="hlFld-ContribAuthor ">Russell F.  Graceffa</span>, <span class="hlFld-ContribAuthor ">Scott S.  Harried</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Daniel B.  Horne</span>, <span class="hlFld-ContribAuthor ">Hongbing  Huang</span>, <span class="hlFld-ContribAuthor ">Ronke  Imbeah-Ampiah</span>, <span class="hlFld-ContribAuthor ">Ted  Judd</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Kaller</span>, <span class="hlFld-ContribAuthor ">Charles R.  Kreiman</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Vivian  Li</span>, <span class="hlFld-ContribAuthor ">Patricia  Lopez</span>, <span class="hlFld-ContribAuthor ">Steven  Louie</span>, <span class="hlFld-ContribAuthor ">Holger  Monenschein</span>, <span class="hlFld-ContribAuthor ">Thomas T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Claire  Rattan</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">E.Allen   Sickmier</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Qiufen  Xue</span>, <span class="hlFld-ContribAuthor ">Bryant H.  Yang</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, and <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (21)
                                     , 9009-9024. <a href="https://doi.org/10.1021/jm300119p" title="DOI URL">https://doi.org/10.1021/jm300119p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300119p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BPreparation%252Bof%252Ba%252BPotent%252BSeries%252Bof%252BHydroxyethylamine%252BContaining%252B%2525CE%2525B2-Secretase%252BInhibitors%252BThat%252BDemonstrate%252BRobust%252BReduction%252Bof%252BCentral%252B%2525CE%2525B2-Amyloid%26aulast%3DWeiss%26aufirst%3DMatthew%2BM.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D27012012%26date%3D18042012%26date%3D08112012%26date%3D02042012%26volume%3D55%26issue%3D21%26spage%3D9009%26epage%3D9024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongbing  Huang</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Russell  Graceffa</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Y.-H.  Kiang</span>, <span class="hlFld-ContribAuthor ">Steven  Louie</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, and <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure- and Property-Based Design of Aminooxazoline Xanthenes as Selective, Orally Efficacious, and CNS Penetrable BACE Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (21)
                                     , 9156-9169. <a href="https://doi.org/10.1021/jm300598e" title="DOI URL">https://doi.org/10.1021/jm300598e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300598e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-%252Band%252BProperty-Based%252BDesign%252Bof%252BAminooxazoline%252BXanthenes%252Bas%252BSelective%25252C%252BOrally%252BEfficacious%25252C%252Band%252BCNS%252BPenetrable%252BBACE%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHuang%26aufirst%3DHongbing%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D30042012%26date%3D11092012%26date%3D08112012%26date%3D28082012%26volume%3D55%26issue%3D21%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Archana S.  Gurjar</span>, <span class="hlFld-ContribAuthor ">Vivek S.  Solanki</span>, <span class="hlFld-ContribAuthor ">Ankita R.  Meshram</span>, <span class="hlFld-ContribAuthor ">Suchita S.  Vishwakarma</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring beta amyloid cleavage enzyme‐1 inhibition and neuroprotective role of benzimidazole analogues as anti‐alzheimer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Chinese Chemical Society</span><span> <strong>2020,</strong> <em>67 </em>
                                    (5)
                                     , 864-873. <a href="https://doi.org/10.1002/jccs.201900200" title="DOI URL">https://doi.org/10.1002/jccs.201900200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jccs.201900200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjccs.201900200%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Chinese%2520Chemical%2520Society%26atitle%3DExploring%252Bbeta%252Bamyloid%252Bcleavage%252Benzyme%2525E2%252580%2525901%252Binhibition%252Band%252Bneuroprotective%252Brole%252Bof%252Bbenzimidazole%252Banalogues%252Bas%252Banti%2525E2%252580%252590alzheimer%252Bagents%26aulast%3DGurjar%26aufirst%3DArchana%2BS.%26date%3D2020%26date%3D2019%26volume%3D67%26issue%3D5%26spage%3D864%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudip  Dhakal</span>, <span class="hlFld-ContribAuthor ">Naufal  Kushairi</span>, <span class="hlFld-ContribAuthor ">Chia Wei  Phan</span>, <span class="hlFld-ContribAuthor ">Benu  Adhikari</span>, <span class="hlFld-ContribAuthor ">Vikineswary  Sabaratnam</span>, <span class="hlFld-ContribAuthor ">Ian  Macreadie</span>. </span><span class="cited-content_cbyCitation_article-title">Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (20)
                                     , 5090. <a href="https://doi.org/10.3390/ijms20205090" title="DOI URL">https://doi.org/10.3390/ijms20205090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20205090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20205090%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDietary%252BPolyphenols%25253A%252BA%252BMultifactorial%252BStrategy%252Bto%252BTarget%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DDhakal%26aufirst%3DSudip%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D20%26spage%3D5090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyi  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Jia</span>, <span class="hlFld-ContribAuthor ">Zaihui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of amide isosteres in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2535-2550. <a href="https://doi.org/10.1016/j.bmcl.2019.07.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplications%252Bof%252Bamide%252Bisosteres%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2535%26epage%3D2550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa A.  Herbage</span>, <span class="hlFld-ContribAuthor ">Jolaine  Savoie</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Sieber</span>, <span class="hlFld-ContribAuthor ">Jean-Nicolas  Desrosiers</span>, <span class="hlFld-ContribAuthor ">Yongda  Zhang</span>, <span class="hlFld-ContribAuthor ">Maurice A.  Marsini</span>, <span class="hlFld-ContribAuthor ">Keith R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Daniel  Rivalti</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Addition of Non-Stabilized Carbon-Based Nucleophilic Reagents to Chiral
              N
              -Sulfinyl Imines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-422. <a href="https://doi.org/10.1002/0471264180.or099.01" title="DOI URL">https://doi.org/10.1002/0471264180.or099.01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or099.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or099.01%26sid%3Dliteratum%253Aachs%26atitle%3DAddition%252Bof%252BNon-Stabilized%252BCarbon-Based%252BNucleophilic%252BReagents%252Bto%252BChiral%252BN%252B-Sulfinyl%252BImines%26aulast%3DHerbage%26aufirst%3DMelissa%2BA.%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D422%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankit  Ganeshpurkar</span>, <span class="hlFld-ContribAuthor ">Rayala  Swetha</span>, <span class="hlFld-ContribAuthor ">Devendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Gore P.  Gangaram</span>, <span class="hlFld-ContribAuthor ">Ravi  Singh</span>, <span class="hlFld-ContribAuthor ">Gopichand  Gutti</span>, <span class="hlFld-ContribAuthor ">Srabanti  Jana</span>, <span class="hlFld-ContribAuthor ">Dileep  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashok  Kumar</span>, <span class="hlFld-ContribAuthor ">Sushil K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 501-533. <a href="https://doi.org/10.2174/1568026619666190304153353" title="DOI URL">https://doi.org/10.2174/1568026619666190304153353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190304153353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190304153353%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DProtein-Protein%252BInteractions%252Band%252BAggregation%252BInhibitors%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGaneshpurkar%26aufirst%3DAnkit%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D501%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piyoosh  Sharma</span>, <span class="hlFld-ContribAuthor ">Pavan  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ankit  Seth</span>, <span class="hlFld-ContribAuthor ">Prabhash Nath  Tripathi</span>, <span class="hlFld-ContribAuthor ">Anupam G.  Banerjee</span>, <span class="hlFld-ContribAuthor ">Sushant K.  Shrivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2019,</strong> <em>174 </em>, 53-89. <a href="https://doi.org/10.1016/j.pneurobio.2018.12.006" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2018.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2018.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DComprehensive%252Breview%252Bof%252Bmechanisms%252Bof%252Bpathogenesis%252Binvolved%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bpotential%252Btherapeutic%252Bstrategies%26aulast%3DSharma%26aufirst%3DPiyoosh%26date%3D2019%26volume%3D174%26spage%3D53%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Shen</span>, <span class="hlFld-ContribAuthor ">Haibo  Wang</span>, <span class="hlFld-ContribAuthor ">Qiying  Sun</span>, <span class="hlFld-ContribAuthor ">Hailan  Yao</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Keegan</span>, <span class="hlFld-ContribAuthor ">Mike  Mullan</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Wilson</span>, <span class="hlFld-ContribAuthor ">Simone  Lista</span>, <span class="hlFld-ContribAuthor ">Thomas  Leyhe</span>, <span class="hlFld-ContribAuthor ">Christoph  Laske</span>, <span class="hlFld-ContribAuthor ">Dan  Rujescu</span>, <span class="hlFld-ContribAuthor ">Allan  Levey</span>, <span class="hlFld-ContribAuthor ">Anders  Wallin</span>, <span class="hlFld-ContribAuthor ">Kaj  Blennow</span>, <span class="hlFld-ContribAuthor ">Rena  Li</span>, <span class="hlFld-ContribAuthor ">Harald  Hampel</span>. </span><span class="cited-content_cbyCitation_article-title">Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment. </span><span class="cited-content_cbyCitation_journal-name">Biological Psychiatry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (5)
                                     , 447-455. <a href="https://doi.org/10.1016/j.biopsych.2017.02.007" title="DOI URL">https://doi.org/10.1016/j.biopsych.2017.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopsych.2017.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopsych.2017.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Psychiatry%26atitle%3DIncreased%252BPlasma%252BBeta-Secretase%252B1%252BMay%252BPredict%252BConversion%252Bto%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BDementia%252Bin%252BIndividuals%252BWith%252BMild%252BCognitive%252BImpairment%26aulast%3DShen%26aufirst%3DYong%26date%3D2018%26volume%3D83%26issue%3D5%26spage%3D447%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anantha Krishnan  Dhanabalan</span>, <span class="hlFld-ContribAuthor ">Manish  Kesherwani</span>, <span class="hlFld-ContribAuthor ">Devadasan  Velmurugan</span>, <span class="hlFld-ContribAuthor ">Krishnasamy  Gunasekaran</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of new BACE1 inhibitors using Pharmacophore and Molecular dynamics simulations approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2017,</strong> <em>76 </em>, 56-69. <a href="https://doi.org/10.1016/j.jmgm.2017.06.001" title="DOI URL">https://doi.org/10.1016/j.jmgm.2017.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2017.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2017.06.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DIdentification%252Bof%252Bnew%252BBACE1%252Binhibitors%252Busing%252BPharmacophore%252Band%252BMolecular%252Bdynamics%252Bsimulations%252Bapproach%26aulast%3DDhanabalan%26aufirst%3DAnantha%2BKrishnan%26date%3D2017%26volume%3D76%26spage%3D56%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravichand  Palakurti</span>, <span class="hlFld-ContribAuthor ">Ramakrishna  Vadrevu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2017,</strong> <em>68 </em>, 107-117. <a href="https://doi.org/10.1016/j.compbiolchem.2017.03.001" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2017.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2017.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2017.03.001%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DPharmacophore%252Bbased%252B3D-QSAR%252Bmodeling%25252C%252Bvirtual%252Bscreening%252Band%252Bdocking%252Bfor%252Bidentification%252Bof%252Bpotential%252Binhibitors%252Bof%252B%2525CE%2525B2-secretase%26aulast%3DPalakurti%26aufirst%3DRavichand%26date%3D2017%26volume%3D68%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravichand  Palakurti</span>, <span class="hlFld-ContribAuthor ">Ramakrishna  Vadrevu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of abelson tyrosine kinase inhibitors as potential therapeutics for Alzheimer’s disease using multiple e-pharmacophore modeling and molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2017,</strong> <em>35 </em>
                                    (4)
                                     , 883-896. <a href="https://doi.org/10.1080/07391102.2016.1166454" title="DOI URL">https://doi.org/10.1080/07391102.2016.1166454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2016.1166454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2016.1166454%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentification%252Bof%252Babelson%252Btyrosine%252Bkinase%252Binhibitors%252Bas%252Bpotential%252Btherapeutics%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Busing%252Bmultiple%252Be-pharmacophore%252Bmodeling%252Band%252Bmolecular%252Bdynamics%26aulast%3DPalakurti%26aufirst%3DRavichand%26date%3D2017%26date%3D2016%26volume%3D35%26issue%3D4%26spage%3D883%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Wyss</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, <span class="hlFld-ContribAuthor ">Corey O.  Strickland</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>. </span><span class="cited-content_cbyCitation_article-title">BACE Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 327-354. <a href="https://doi.org/10.1002/9783527683604.ch14" title="DOI URL">https://doi.org/10.1002/9783527683604.ch14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch14%26sid%3Dliteratum%253Aachs%26atitle%3DBACE%252BInhibitors%26aulast%3DWyss%26aufirst%3DDaniel%2BF.%26date%3D2016%26date%3D2016%26spage%3D327%26epage%3D354%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">Chester  Yuan</span>, <span class="hlFld-ContribAuthor ">Vijay  Gore</span>, <span class="hlFld-ContribAuthor ">Patricia  Lopez</span>, <span class="hlFld-ContribAuthor ">Vu  Ma</span>, <span class="hlFld-ContribAuthor ">Albert  Amegadzie</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Ted C.  Judd</span>, <span class="hlFld-ContribAuthor ">Ana E.  Minatti</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">May  Xue</span>, <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Jason  Human</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac  Marx</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Timothy S.  Powers</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Werner</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Nancy E.  Everds</span>, <span class="hlFld-ContribAuthor ">Steven L.  Vonderfecht</span>, <span class="hlFld-ContribAuthor ">Robert T.  Dunn</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 767-774. <a href="https://doi.org/10.1016/j.bmcl.2014.12.092" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.092%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252B2-aminooxazoline%252B3-azaxanthenes%252Bas%252Borally%252Befficacious%252B%2525CE%2525B2-secretase%252Binhibitors%252Bfor%252Bthe%252Bpotential%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DChen%26aufirst%3DJian%2BJeffrey%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D767%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">The use of spirocyclic scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3673-3682. <a href="https://doi.org/10.1016/j.bmcl.2014.06.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Buse%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliette  Janson</span>, <span class="hlFld-ContribAuthor ">Susanna  Eketjäll</span>, <span class="hlFld-ContribAuthor ">Karin  Tunblad</span>, <span class="hlFld-ContribAuthor ">Fredrik  Jeppsson</span>, <span class="hlFld-ContribAuthor ">Stefan  Von Berg</span>, <span class="hlFld-ContribAuthor ">Camilla  Niva</span>, <span class="hlFld-ContribAuthor ">Ann-Cathrin  Radesäter</span>, <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>, <span class="hlFld-ContribAuthor ">Sandra A. G.  Visser</span>. </span><span class="cited-content_cbyCitation_article-title">Population PKPD Modeling of BACE1 Inhibitor-Induced Reduction in Aβ Levels In Vivo and Correlation to In Vitro Potency in Primary Cortical Neurons from Mouse and Guinea Pig. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2014,</strong> <em>31 </em>
                                    (3)
                                     , 670-683. <a href="https://doi.org/10.1007/s11095-013-1189-y" title="DOI URL">https://doi.org/10.1007/s11095-013-1189-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-013-1189-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-013-1189-y%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DPopulation%252BPKPD%252BModeling%252Bof%252BBACE1%252BInhibitor-Induced%252BReduction%252Bin%252BA%2525CE%2525B2%252BLevels%252BIn%252BVivo%252Band%252BCorrelation%252Bto%252BIn%252BVitro%252BPotency%252Bin%252BPrimary%252BCortical%252BNeurons%252Bfrom%252BMouse%252Band%252BGuinea%252BPig%26aulast%3DJanson%26aufirst%3DJuliette%26date%3D2014%26date%3D2013%26volume%3D31%26issue%3D3%26spage%3D670%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Heather L.  Osswald</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Chem. Soc. Rev.</span><span> <strong>2014,</strong> <em>43 </em>
                                    (19)
                                     , 6765-6813. <a href="https://doi.org/10.1039/C3CS60460H" title="DOI URL">https://doi.org/10.1039/C3CS60460H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3CS60460H%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Soc.%2520Rev.%26atitle%3DBACE1%252B%252528%2525CE%2525B2-secretase%252529%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2014%26date%3D2014%26volume%3D43%26issue%3D19%26spage%3D6765%26epage%3D6813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshio  Hamada</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Kiso</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the identification of β-secretase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 709-731. <a href="https://doi.org/10.1517/17460441.2013.784267" title="DOI URL">https://doi.org/10.1517/17460441.2013.784267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.784267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.784267%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAdvances%252Bin%252Bthe%252Bidentification%252Bof%252B%2525CE%2525B2-secretase%252Binhibitors%26aulast%3DHamada%26aufirst%3DYoshio%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D709%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Steven R.  Jordan</span>, <span class="hlFld-ContribAuthor ">Holger  Monenschein</span>, <span class="hlFld-ContribAuthor ">Thomas T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Bryant H.  Yang</span>, <span class="hlFld-ContribAuthor ">Qiufen M.  Xue</span>, <span class="hlFld-ContribAuthor ">Filisaty  Vounatsos</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Martin  Citron</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxyethylamine-based inhibitors of BACE1: P1–P3 macrocyclization can improve potency, selectivity, and cell activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (15)
                                     , 4459-4464. <a href="https://doi.org/10.1016/j.bmcl.2013.05.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHydroxyethylamine-based%252Binhibitors%252Bof%252BBACE1%25253A%252BP1%2525E2%252580%252593P3%252Bmacrocyclization%252Bcan%252Bimprove%252Bpotency%25252C%252Bselectivity%25252C%252Band%252Bcell%252Bactivity%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4459%26epage%3D4464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Harvey  Wong</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>, <span class="hlFld-ContribAuthor ">Melis  Coraggio</span>, <span class="hlFld-ContribAuthor ">Young G.  Shin</span>, <span class="hlFld-ContribAuthor ">Kun  Peng</span>, <span class="hlFld-ContribAuthor ">Kristin R.  Wildsmith</span>, <span class="hlFld-ContribAuthor ">Jasvinder K.  Atwal</span>, <span class="hlFld-ContribAuthor ">Jason  Mango</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Schauer</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Joseph  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Cornelis E. C. A.  Hop</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic Pharmacokinetic-Pharmacodynamic Modeling of BACE1 Inhibition in Monkeys: Development of a Predictive Model for Amyloid Precursor Protein Processing. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2013,</strong> <em>41 </em>
                                    (7)
                                     , 1319-1328. <a href="https://doi.org/10.1124/dmd.112.050864" title="DOI URL">https://doi.org/10.1124/dmd.112.050864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.112.050864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.112.050864%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMechanistic%252BPharmacokinetic-Pharmacodynamic%252BModeling%252Bof%252BBACE1%252BInhibition%252Bin%252BMonkeys%25253A%252BDevelopment%252Bof%252Ba%252BPredictive%252BModel%252Bfor%252BAmyloid%252BPrecursor%252BProtein%252BProcessing%26aulast%3DLiu%26aufirst%3DXingrong%26date%3D2013%26date%3D2013%26volume%3D41%26issue%3D7%26spage%3D1319%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Stamford</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2013,</strong> <em>17 </em>
                                    (3)
                                     , 320-328. <a href="https://doi.org/10.1016/j.cbpa.2013.04.016" title="DOI URL">https://doi.org/10.1016/j.cbpa.2013.04.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2013.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2013.04.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DInhibitors%252Bof%252BBACE%252Bfor%252Btreating%252BAlzheimer%252527s%252Bdisease%25253A%252Ba%252Bfragment-based%252Bdrug%252Bdiscovery%252Bstory%26aulast%3DStamford%26aufirst%3DAndrew%26date%3D2013%26volume%3D17%26issue%3D3%26spage%3D320%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-zi  Xu</span>, <span class="hlFld-ContribAuthor ">Shendong  Yuan</span>, <span class="hlFld-ContribAuthor ">Simeon  Bowers</span>, <span class="hlFld-ContribAuthor ">Roy K.  Hom</span>, <span class="hlFld-ContribAuthor ">Wayman  Chan</span>, <span class="hlFld-ContribAuthor ">Hing L.  Sham</span>, <span class="hlFld-ContribAuthor ">Yong L.  Zhu</span>, <span class="hlFld-ContribAuthor ">Paul  Beroza</span>, <span class="hlFld-ContribAuthor ">Hu  Pan</span>, <span class="hlFld-ContribAuthor ">Eric  Brecht</span>, <span class="hlFld-ContribAuthor ">Nanhua  Yao</span>, <span class="hlFld-ContribAuthor ">Julie  Lougheed</span>, <span class="hlFld-ContribAuthor ">Jiangli  Yan</span>, <span class="hlFld-ContribAuthor ">Danny  Tam</span>, <span class="hlFld-ContribAuthor ">Zhao  Ren</span>, <span class="hlFld-ContribAuthor ">Lany  Ruslim</span>, <span class="hlFld-ContribAuthor ">Michael P.  Bova</span>, <span class="hlFld-ContribAuthor ">Dean R.  Artis</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 3075-3080. <a href="https://doi.org/10.1016/j.bmcl.2013.03.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bthiophene%252Bdihydroisoquinolines%252Bas%252Bnovel%252BBACE1%252Binhibitors%26aulast%3DXu%26aufirst%3DYing-zi%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D3075%26epage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 283-381. <a href="https://doi.org/10.1007/7355_2013_29" title="DOI URL">https://doi.org/10.1007/7355_2013_29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_29%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInfluence%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%25253A%252BTactical%252BApplications%252Bto%252BAddress%252BDevelopability%252BProblems%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2014%26spage%3D283%26epage%3D381%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Jianhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Safura  Babu-Khan</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Roger  Pham</span>, <span class="hlFld-ContribAuthor ">Joel  Esmay</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Kaller</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Martin  Citron</span>, <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Toni  Williamson</span>. </span><span class="cited-content_cbyCitation_article-title">Establishing the Relationship between In Vitro Potency, Pharmacokinetic, and Pharmacodynamic Parameters in a Series of Orally Available, Hydroxyethylamine-Derived β-Secretase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2012,</strong> <em>343 </em>
                                    (2)
                                     , 460-467. <a href="https://doi.org/10.1124/jpet.112.197954" title="DOI URL">https://doi.org/10.1124/jpet.112.197954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.112.197954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.112.197954%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DEstablishing%252Bthe%252BRelationship%252Bbetween%252BIn%252BVitro%252BPotency%25252C%252BPharmacokinetic%25252C%252Band%252BPharmacodynamic%252BParameters%252Bin%252Ba%252BSeries%252Bof%252BOrally%252BAvailable%25252C%252BHydroxyethylamine-Derived%252B%2525CE%2525B2-Secretase%252BInhibitors%26aulast%3DWood%26aufirst%3DStephen%26date%3D2012%26date%3D2012%26volume%3D343%26issue%3D2%26spage%3D460%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Properties of BACE1 inhibitor <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of P1-Biaryl BACE1 Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) R-MgBr, THF, −70 °C; (b) HCl, 1,4-dioxane-EtOH, −20 °C, Et<sub>3</sub>N, Boc<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, −20 to 23 °C; (c) (i) Dess–Martin periodinane, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 23 °C (ii) <b>6,</b> (EtO)<sub>3</sub>CH, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C; (d) (i) HCl, 1,4-dioxane-CH<sub>3</sub>OH, 40 °C, (ii) <b>8</b>, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C; (e) Ar-SnBu<sub>3</sub> or R-CC-SnBu<sub>3</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, CsF, 1,4-dioxane, 160 °C, μ-wave; (f) Ar-SnBu<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 140 °C, μ-wave; (g) R-CC-ZnCl, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, THF, 120 °C, sealed vessel.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Acetamide Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Pd(P<i>t</i>-Bu<sub>3</sub>)<sub>2</sub> (5 mol %), ZnCl<sub>2</sub> (2 equiv), 2-thiazolyl zinc bromide (1.2 equiv), dioxane, 23 °C; (b) (i) Dess–Martin periodinane, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 23 °C, (ii) <b>6,</b> (EtO)<sub>3</sub>CH, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C; (c) HCl, dioxane-CH<sub>3</sub>OH, 40 °C; (d) carboxylic acid, carbonyl diimidazole, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/medium/jm-2012-00118s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structure of BACE1 complexed with <b>37</b>. (a) Interactions of <b>37</b> with the BACE1 enzyme and extension of the <i>meta</i>-thiazole unit into S3. (b) Interactions of the methoxyacetamide group with BACE1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300118s/production/images/large/jm-2012-00118s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300118s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12182" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12182" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Small, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span> </span><span class="NLM_article-title">Alois Alzheimer and Alzeimer’s Disease: A Centennial Perspective</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1111%2Fj.1471-4159.2006.04212.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=17076655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=708-710&author=D.+H.+Smallauthor=R.+Cappai&title=Alois+Alzheimer+and+Alzeimer%E2%80%99s+Disease%3A+A+Centennial+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Alois Alzheimer and Alzheimer's disease: a centennial perspective</span></div><div class="casAuthors">Small, David H.; Cappai, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-710</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The year 2006 is the centenary of the famous presentation of Alois Alzheimer which first described the neuropathol. of Alzheimer's disease (AD).  Since this presentation, enormous progress has been made in understanding the biol. of AD.  The central role of the β-amyloid protein (Aβ) in the pathogenesis of AD and the relationship between plaque and tangle pathol. is now much better understood.  In this article, we review the current status of the amyloid hypothesis of AD and its role in the development of future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHVyze5z1W7Vg90H21EOLACvtfcHk0lgSHi26EvQ1kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE&md5=27564c272b2bc577bbf4d568ffb7a079</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04212.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04212.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DCappai%26aufirst%3DR.%26atitle%3DAlois%2520Alzheimer%2520and%2520Alzeimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Centennial%2520Perspective%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D708%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A Century of Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+Century+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520Century%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Van Marum, R. J.</span><span> </span><span class="NLM_article-title">Current and Future Therapy in Alzheimer’s Disease</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1111%2Fj.1472-8206.2008.00578.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=18485144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=265-274&author=R.+J.+Van+Marum&title=Current+and+Future+Therapy+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Current and future therapy in Alzheimer's disease</span></div><div class="casAuthors">van Marum, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-274</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized as one of the most important medical problems in the elderly.  As most pharmacol. research within the field of dementia is focused on Alzheimer's dementia (AD), this review will focus on pharmacol. interventions in AD.  Most disease-modifying therapies are based on the amyloid hypothesis.  In this hypothesis, the pathol. accumulation of Aβ in the brain leads to oxidative stress, neuronal destruction and finally the clin. syndrome of AD.  Following this hypothesis, secondary prevention of AD can be made by: decreasing the prodn. of Aβ, stimulation of clearance of Aβ formed or prevention of aggregation of Aβ into amyloid plaques.  First a short overview on current approved therapies for AD is given.  The main part of the review will focus on potential disease-modifying therapies for AD that are currently being studied in phase I to phase III trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYSu96SxTqLVg90H21EOLACvtfcHk0ljOkmD-dPRWrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D&md5=0813e575e9440a3e1ffc0e0ee79c5e7a</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2008.00578.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2008.00578.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMarum%26aufirst%3DR.%2BJ.%26atitle%3DCurrent%2520and%2520Future%2520Therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D22%26spage%3D265%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">100 Years and Counting: Prospects for Defeating Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=781-784&author=E.+D.+Robersonauthor=L.+Mucke&title=100+Years+and+Counting%3A+Prospects+for+Defeating+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3D100%2520Years%2520and%2520Counting%253A%2520Prospects%2520for%2520Defeating%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D781%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Catalano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henze, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafft, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span> </span><span class="NLM_article-title">The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimer’s Disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.2174%2F156802606776743066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=16712494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVOmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=597-608&author=S.+Catalanoauthor=E.+C.+Dodsonauthor=D.+A.+Henzeauthor=J.+G.+Joyceauthor=G.+A.+Krafftauthor=G.+G.+Kinney&title=The+Role+of+Amyloid-Beta+Derived+Diffusible+Ligands+%28ADDLs%29+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease</span></div><div class="casAuthors">Catalano, Susan M.; Dodson, Elizabeth C.; Henze, Darrell A.; Joyce, Joseph G.; Krafft, Grant A.; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid-β (Aβ) cascade hypothesis of Alzheimer's disease (AD) has dominated research and subsequent therapeutic drug development for over two decades.  Central to this hypothesis is the observation that Aβ is elevated in AD patients and that the disease is ultimately characterized by the central deposition of insol. senile plaques.  More recent evidence, however, suggests that the presence or absence of plaque is insufficient to fully account for the deleterious role of elevated Aβ in AD.  Such studies support the basis for an alternate interpretation of the Aβ cascade hypothesis.  Namely, that sol. oligomers of Aβ (i.e., ADDLs) accumulate and cause functional deficits prior to overt neuronal cell death or plaque deposition.  Accordingly, the following review focuses on research describing the prepn. and functional activity of ADDLs in vitro and in vivo.  These studies provide the basis for an alternate, ADDL-based, view of the Aβ cascade hypothesis and accounts for the disconnect between plaque burden and cognitive deficits.  Possible therapeutic approaches aimed at lowering ADDLs in AD patients are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXQlT7tzCPc7Vg90H21EOLACvtfcHk0liEz9ihX4f3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVOmsbY%253D&md5=fc371b4b30370dce13f04afebe292872</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156802606776743066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743066%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DS.%26aulast%3DDodson%26aufirst%3DE.%2BC.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJoyce%26aufirst%3DJ.%2BG.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DThe%2520Role%2520of%2520Amyloid-Beta%2520Derived%2520Diffusible%2520Ligands%2520%2528ADDLs%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pimplikar, S. W.</span><span> </span><span class="NLM_article-title">Reassessing the Amyloid Cascade Hypothesis of Alzheimer’s Disease</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1016%2Fj.biocel.2008.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=19124085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1261-1268&author=S.+W.+Pimplikar&title=Reassessing+the+Amyloid+Cascade+Hypothesis+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessing the amyloid cascade hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Pimplikar, Sanjay W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-1268</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since its inception, the amyloid cascade hypothesis has dominated the field of Alzheimer's disease (AD) research and has provided the intellectual framework for therapeutic intervention.  Although the details of the hypothesis continue to evolve, its core principle has remained essentially unaltered.  It posits that the amyloid-β peptides, derived from amyloid precursor protein (APP), are the root cause of AD.  Substantial genetic and biochem. data support this view, and yet a no. of findings also run contrary to its tenets.  The presence of familial AD mutations in APP and presenilins, demonstration of Aβ toxicity, and studies in mouse models of AD all support the hypothesis, whereas the presence of Aβ plaques in normal individuals, the uncertain nature of the pathogenic Aβ species, and repeated disappointments with Aβ-centered therapeutic trials are inconsistent with the hypothesis.  The current state of knowledge does not prove nor disprove the amyloid hypothesis, but rather points to the need for its reassessment.  A view that Aβ is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZoitUBRzaLVg90H21EOLACvtfcHk0liEz9ihX4f3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D&md5=e33973b5f125c34d95cb3f1b477d3ced</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPimplikar%26aufirst%3DS.%2BW.%26atitle%3DReassessing%2520the%2520Amyloid%2520Cascade%2520Hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D1261%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nature Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNature%2520Rev.%2520Drug.%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B. D.</span> <span class="citation_source-journal">Nature Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Karran%2C+E.%3B+Mercken%2C+M.%3B+De+Strooper%2C+B.+D.Nature+Rev.+Drug.+Discovery+2011%2C+10%2C+698%E2%80%93712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%2BD.%26jtitle%3DNature%2520Rev.%2520Drug.%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Beta-Secretase Cleavage of Alzheimer’s Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=Beta-Secretase+Cleavage+of+Alzheimer%E2%80%99s+Amyloid+Precursor+Protein+by+the+Transmembrane+Aspartic+Protease+BACE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DBeta-Secretase%2520Cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520Amyloid%2520Precursor%2520Protein%2520by%2520the%2520Transmembrane%2520Aspartic%2520Protease%2520BACE1%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a Novel Aspartic Protease (Asp 2) as Beta-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+Novel+Aspartic+Protease+%28Asp+2%29+as+Beta-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0ljFVDpQlozHkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520Novel%2520Aspartic%2520Protease%2520%2528Asp%25202%2529%2520as%2520Beta-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashier, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membraned-Anchored Aspartyl Protease with Alzheimer’s Disease Beta-Secretase Activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashierauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membraned-Anchored+Aspartyl+Protease+with+Alzheimer%E2%80%99s+Disease+Beta-Secretase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashier%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembraned-Anchored%2520Aspartyl%2520Protease%2520with%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Beta-Secretase%2520Activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sinha%2C+S.%3B+Anderson%2C+J.+P.%3B+Barbour%2C+R.%3B+Basi%2C+G.+S.%3B+Caccavello%2C+R.%3B+Davis%2C+D.%3B+Doan%2C+M.%3B+Dovey%2C+H.+F.%3B+Frigon%2C+N.%3B+Hong%2C+J.%3B+Jacobson-Croak%2C+K.%3B+Jewett%2C+N.%3B+Keim%2C+P.%3B+Knops%2C+J.%3B+Lieberburg%2C+I.%3B+Power%2C+M.%3B+Tan%2C+H.%3B+Tatsuno%2C+G.%3B+Tung%2C+J.%3B+Schenk%2C+D.%3B+Seubert%2C+P.%3B+Suomensaari%2C+S.+M.%3B+Wang%2C+S.%3B+Walker%2C+D.%3B+Zhao%2C+J.%3B+McConlogue%2C+L.%3B+John%2C+V.Nature+1999%2C+402%2C+537%E2%80%93540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Durham, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, T. A.</span><span> </span><span class="NLM_article-title">Progress toward the discovery and development of efficacious BACE inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=776-791&author=T.+B.+Durhamauthor=T.+A.+Shepherd&title=Progress+toward+the+discovery+and+development+of+efficacious+BACE+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DShepherd%26aufirst%3DT.%2BA.%26atitle%3DProgress%2520toward%2520the%2520discovery%2520and%2520development%2520of%2520efficacious%2520BACE%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D776%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061197u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1124-1132&author=M.+Congreveauthor=D.+Aharonyauthor=J.+Albertauthor=O.+Callaghanauthor=J.+Campbellauthor=R.+A.+E.+Carrauthor=G.+Chessariauthor=S.+Cowanauthor=P.+D.+Edwardsauthor=M.+Fredericksonauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+the+discovery+of+aminopyridines+as+inhibitors+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm061197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061197u%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DJ.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520the%2520discovery%2520of%2520aminopyridines%2520as%2520inhibitors%2520of%2520beta-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1124%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Barrow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1002%2Fcmdc.200700038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=17458843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVyktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=995-999&author=J.+Barrowauthor=K.+Rittleauthor=P.+Ngoauthor=H.+Selnickauthor=S.+Grahamauthor=S.+Pitzenbergerauthor=G.+McGaugheyauthor=D.+Colussiauthor=M.-T.+Laiauthor=Q.+Huangauthor=K.+Tugushevaauthor=A.+Espesethauthor=A.+Simonauthor=S.+Munshiauthor=J.+Vacca&title=Design+and+synthesis+of+2%2C3%2C5-substituted+imidazolidin-4-one+inhibitors+of+BACE-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1</span></div><div class="casAuthors">Barrow, James C.; Rittle, Kenneth E.; Ngo, Phung L.; Selnick, Harold G.; Graham, Samuel L.; Pitzenberger, Steven M.; McGaughey, Georgia B.; Colussi, Dennis; Lai, Ming-Tain; Huang, Qian; Tugusheva, Katherine; Espeseth, Amy S.; Simon, Adam J.; Munshi, Sanjeev K.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">995-999</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2,3,5-Substituted imidazolidin-4-ones (e.g. I (R1 = Me, H; R2 = Bn)) were prepd. and tested as BACE-1 inhibitors.  The illustrated I are the most potent inhibitors.  The crystal and mol. structures of I (R1 = Me; R2 = Me) in the active site of BACE-1 were detd. by x-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgoCprsegvBLVg90H21EOLACvtfcHk0lgRUOTftSjl6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVyktLc%253D&md5=e04a29f0ada03e808cbe5a10e8e57d0e</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700038%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%26aulast%3DRittle%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DP.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DPitzenberger%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202%252C3%252C5-substituted%2520imidazolidin-4-one%2520inhibitors%2520of%2520BACE-1%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D995%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Potent pyrrolidine- and piperidine-based BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1016%2Fj.bmcl.2007.10.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=18023580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1Wgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=414-417&author=U.+Iserlohauthor=Y.+Wuauthor=J.+N.+Cummingauthor=J.+Panauthor=L.+Y.+Wangauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=X.+Chenauthor=E.+M.+Parkerauthor=C.+Stricklandauthor=J.+Voigt&title=Potent+pyrrolidine-+and+piperidine-based+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Potent pyrrolidine- and piperidine-based BACE-1 inhibitors</span></div><div class="casAuthors">Iserloh, U.; Wu, Y.; Cumming, J. N.; Pan, J.; Wang, L. Y.; Stamford, A. W.; Kennedy, M. E.; Kuvelkar, R.; Chen, X.; Parker, E. M.; Strickland, C.; Voigt, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">414-417</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Based on lead compd. 1 identified from the patent literature, the authors developed novel patentable BACE-1 inhibitors by introducing a cyclic amine scaffold.  Extensive SAR studies on both pyrrolidines and piperidines ultimately led to inhibitor (I), one of the most potent inhibitors synthesized to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAchFs1p0DSrVg90H21EOLACvtfcHk0lgRUOTftSjl6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1Wgtg%253D%253D&md5=39db058f22f5ff8f12735456a6f7b70e</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.116%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DPotent%2520pyrrolidine-%2520and%2520piperidine-based%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D414%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mchugh, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Discovery of an orally efficacious 4-phenoxypyrrolidine-based BACE-1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=418-422&author=U.+Iserlohauthor=J.+Panauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=Q.+Zhangauthor=L.+Zhangauthor=E.+M.+Parkerauthor=N.+A.+Mchughauthor=L.+Favreauauthor=C.+Stricklandauthor=J.+Voigt&title=Discovery+of+an+orally+efficacious+4-phenoxypyrrolidine-based+BACE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DMchugh%26aufirst%3DN.%2BA.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520efficacious%25204-phenoxypyrrolidine-based%2520BACE-1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D418%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacPherson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanway, S.</span><span> </span><span class="NLM_article-title">BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1017-1022&author=B.+Clarkeauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=A.+Fallerauthor=J.+Hawkinsauthor=I.+Hussainauthor=D.+MacPhersonauthor=G.+Maileauthor=R.+Maticoauthor=P.+Milnerauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=D.+Riddellauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Stanway&title=BACE-1+inhibitors+part+2%3A+identification+of+hydroxy+ethylamines+%28HEAs%29+with+reduced+peptidic+character"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMacPherson%26aufirst%3DD.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMilner%26aufirst%3DP.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DStanway%26aufirst%3DS.%26atitle%3DBACE-1%2520inhibitors%2520part%25202%253A%2520identification%2520of%2520hydroxy%2520ethylamines%2520%2528HEAs%2529%2520with%2520reduced%2520peptidic%2520character%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1017%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3664</span><span class="NLM_x">–</span> <span class="NLM_lpage">3668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3664-3668&author=N.+Charrierauthor=B.+Clarkeauthor=L.+Cutlerauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=C.+Howesauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors.+Part+1%3A+The+need+for+improved+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors.%2520Part%25201%253A%2520The%2520need%2520for%2520improved%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3664%26epage%3D3668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors part 2: optimization of the non-prime side substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3669</span><span class="NLM_x">–</span> <span class="NLM_lpage">3673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3669-3673&author=N.+Charrierauthor=B.+Clarkeauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors+part+2%3A+optimization+of+the+non-prime+side+substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors%2520part%25202%253A%2520optimization%2520of%2520the%2520non-prime%2520side%2520substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3669%26epage%3D3673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors part 3: towards non-hydroxyethylamine transition state mimetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3674</span><span class="NLM_x">–</span> <span class="NLM_lpage">3678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3674-3678&author=N.+Charrierauthor=B.+Clarkeauthor=L.+Cutlerauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=C.+Howesauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors+part+3%3A+towards+non-hydroxyethylamine+transition+state+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors%2520part%25203%253A%2520towards%2520non-hydroxyethylamine%2520transition%2520state%2520mimetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3674%26epage%3D3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Stachel, S. J.</span><span> </span><span class="NLM_article-title">Progess Toward the Development of a Viable BACE1 Inhibitor</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=101-110&author=S.+J.+Stachel&title=Progess+Toward+the+Development+of+a+Viable+BACE1+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26atitle%3DProgess%2520Toward%2520the%2520Development%2520of%2520a%2520Viable%2520BACE1%2520Inhibitor%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references therein.</p></div><div class="NLM_citation" id="rightTab-cit6k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichau, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and elective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichau&title=Aminoimidazoles+as+potent+and+elective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichau%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520elective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Al-Tel, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Qawasmeh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Aboudi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabri, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voelter, W.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of potent dibenzazepine motifs as β-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6484</span><span class="NLM_x">–</span> <span class="NLM_lpage">6488</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9008482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6484-6488&author=T.+H.+Al-Telauthor=R.+A.+Al-Qawasmehauthor=M.+F.+Schmidtauthor=A.+Al-Aboudiauthor=S.+N.+Raoauthor=S.+S.+Sabriauthor=W.+Voelter&title=Rational+design+and+synthesis+of+potent+dibenzazepine+motifs+as+%CE%B2-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=10.1021%2Fjm9008482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9008482%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Tel%26aufirst%3DT.%2BH.%26aulast%3DAl-Qawasmeh%26aufirst%3DR.%2BA.%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DAl-Aboudi%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DSabri%26aufirst%3DS.%2BS.%26aulast%3DVoelter%26aufirst%3DW.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520potent%2520dibenzazepine%2520motifs%2520as%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6484%26epage%3D6488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Cumming, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgur, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saionz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2837</span><span class="NLM_x">–</span> <span class="NLM_lpage">2842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2837-2842&author=J.+Cummingauthor=S.+Babuauthor=Y.+Huangauthor=C.+Carrolauthor=X.+Chenauthor=L.+Favreauauthor=W.+Greenleeauthor=T.+Guoauthor=M.+Kennedyauthor=R.+Kuvelkarauthor=T.+Leauthor=G.+Liauthor=N.+McHughauthor=P.+Orthauthor=L.+Ozgurauthor=E.+Parkerauthor=K.+Saionzauthor=A.+Stamfordauthor=C.+Stricklandauthor=D.+Tadesseauthor=J.+Voigtauthor=L.+Zhangauthor=Q.+Zhang&title=Piperazine+sulfonamide+BACE1+inhibitors%3A+design%2C+synthesis%2C+and+in+vivo+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCarrol%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLe%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMcHugh%26aufirst%3DN.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DOzgur%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DSaionz%26aufirst%3DK.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DPiperazine%2520sulfonamide%2520BACE1%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2837%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichau, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichau&title=Design+and+synthesis+of+5%2C5-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichau%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J.</span><span> </span><span class="NLM_article-title">Discovery of cyclic acylguanidines as highly potent and selective β-site amyloid cleaving enzyme (BACE) inhibitors: Part I. Inhibitor design and validation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901408p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=951-965&author=Z.+Zhuauthor=Z.+Sunauthor=Y.+Yeauthor=J.+Voigtauthor=C.+Stricklandauthor=E.+Smithauthor=J.+Cummingauthor=L.+Wangauthor=J.+Wongauthor=Y.+Wangauthor=D.+Wyssauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+Kennedyauthor=L.+Favreauauthor=E.+Parkerauthor=B.+McKittrickauthor=A.+Stamfordauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=J.+Hunter&title=Discovery+of+cyclic+acylguanidines+as+highly+potent+and+selective+%CE%B2-site+amyloid+cleaving+enzyme+%28BACE%29+inhibitors%3A+Part+I.+Inhibitor+design+and+validation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6o&amp;dbid=16384&amp;doi=10.1021%2Fjm901408p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901408p%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DCumming%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWyss%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DHunter%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520cyclic%2520acylguanidines%2520as%2520highly%2520potent%2520and%2520selective%2520%25CE%25B2-site%2520amyloid%2520cleaving%2520enzyme%2520%2528BACE%2529%2520inhibitors%253A%2520Part%2520I.%2520Inhibitor%2520design%2520and%2520validation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D951%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Al-Tel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semreen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Qawasmeh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Awadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaarour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Agnaf, O.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Qualitative Structure–Activity Evaluations of Novel β-Secretase Inhibitors as Potential Alzheimer’s Drug Leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8873</span><span class="NLM_x">–</span> <span class="NLM_lpage">8385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8873-8385&author=T.+Al-Telauthor=M.+H.+Semreenauthor=R.+A.+Al-Qawasmehauthor=M.+F.+Schmidtauthor=R.+El-Awadiauthor=M.+Ardahauthor=R.+Zaarourauthor=S.+N.+Raoauthor=O.+El-Agnaf&title=Design%2C+Synthesis%2C+and+Qualitative+Structure%E2%80%93Activity+Evaluations+of+Novel+%CE%B2-Secretase+Inhibitors+as+Potential+Alzheimer%E2%80%99s+Drug+Leads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Tel%26aufirst%3DT.%26aulast%3DSemreen%26aufirst%3DM.%2BH.%26aulast%3DAl-Qawasmeh%26aufirst%3DR.%2BA.%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DEl-Awadi%26aufirst%3DR.%26aulast%3DArdah%26aufirst%3DM.%26aulast%3DZaarour%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DEl-Agnaf%26aufirst%3DO.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Qualitative%2520Structure%25E2%2580%2593Activity%2520Evaluations%2520of%2520Novel%2520%25CE%25B2-Secretase%2520Inhibitors%2520as%2520Potential%2520Alzheimer%25E2%2580%2599s%2520Drug%2520Leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8873%26epage%3D8385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roberds, S. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branstetter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappenman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shopp, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintrup, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijsman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span> </span><span class="NLM_article-title">BACE1 Knockout Mice Are Healthy Despite Lacking the Primary Beta-Secretase Activity in Brain: Implications for Alzheimer’s Disease Therapeutics</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1093%2Fhmg%2F10.12.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11406613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1317-1324&author=S.+L+Roberdsauthor=J.+Andersonauthor=G.+Basiauthor=M.+J.+Bienkowskiauthor=D.+G.+Branstetterauthor=K.+S.+Chenauthor=S.+Freedmanauthor=N.+L.+Frigonauthor=D.+Gamesauthor=K.+Huauthor=K.+Johnson-Woodauthor=K.+E.+Kappenmanauthor=T.+T.+Kawabeauthor=I.+Kolaauthor=R.+Kuehnauthor=M.+Leeauthor=W.+Liuauthor=R.+Motterauthor=N.+F.+Nicholsauthor=M.+Powerauthor=D.+W.+Robertsonauthor=D.+Schenkauthor=M.+Schoorauthor=G.+M.+Shoppauthor=M.+E.+Shuckauthor=S.+Sinhaauthor=K.+A.+Svenssonauthor=G.+Tatsunoauthor=H.+Tintrupauthor=J.+Wijsmanauthor=S.+Wrightauthor=L.+McConlogue&title=BACE1+Knockout+Mice+Are+Healthy+Despite+Lacking+the+Primary+Beta-Secretase+Activity+in+Brain%3A+Implications+for+Alzheimer%E2%80%99s+Disease+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics</span></div><div class="casAuthors">Roberds, Steven L.; Anderson, John; Basi, Guriqbal; Bienkowski, Michael J.; Branstetter, Daniel G.; Chen, Karen S.; Freedman, Stephen B.; Frigon, Normand L.; Games, Dora; Hu, Kang; Johnson-Wood, Kelly; Kappenman, Karl E.; Kawabe, Thomas T.; Kola, Ismail; Kuehn, Ralf; Lee, Michael; Liu, Weiqun; Motter, Ruth; Nichols, Nanette F.; Power, Michael; Robertson, David W.; Schenk, Dale; Schoor, Michael; Shopp, George M.; Shuck, Mary E.; Sinha, Sukanto; Svensson, Kjell A.; Tatsuno, Gwen; Tintrup, Hartmut; Wijsman, John; Wright, Sarah; McConlogue, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1317-1324</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain.  The major components of plaque, β-amyloid peptides (Aβs), are produced from amyloid precursor protein (APP) by the activity of β- and γ-secretases.  β-Secretase activity cleaves APP to define the N-terminus of the Aβ1-x peptides and, therefore, has been a long-sought therapeutic target for treatment of AD.  The gene encoding a β-secretase for beta-site APP cleaving enzyme (BACE) was identified recently.  However, it was not known whether BACE was the primary β-secretase in mammalian brain nor whether inhibition of β-secretase might have effects in mammals that would preclude its utility as a therapeutic target.  In the work described herein, the authors generated two lines of BACE knockout mice and characterized them for pathol., β-secretase activity and Aβ prodn.  These mice appeared to develop normally and showed no consistent phenotypic differences from their wild-type littermates, including overall normal tissue morphol. and brain histochem., normal blood and urine chemistries, normal blood-cell compn., and no overt behavioral and neuromuscular effects.  Brain and primary cortical cultures from BACE knockout mice showed no detectable β-secretase activity, and primary cortical cultures from BACE knockout mice produced much less Aβ from APP.  The findings that BACE is the primary β-secretase activity in brain and that loss of β-secretase activity produces no profound phenotypic defects with a concomitant redn. in β-amyloid peptide clearly indicate that BACE is an excellent therapeutic target for treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ78rSt6xEe7Vg90H21EOLACvtfcHk0li64MY9hMWQfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D&md5=c18a9ff9f800eebd994476badc6ec1bc</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.12.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.12.1317%26sid%3Dliteratum%253Aachs%26aulast%3DRoberds%26aufirst%3DS.%2BL%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBasi%26aufirst%3DG.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DBranstetter%26aufirst%3DD.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%26aulast%3DFrigon%26aufirst%3DN.%2BL.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DKappenman%26aufirst%3DK.%2BE.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DKola%26aufirst%3DI.%26aulast%3DKuehn%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DNichols%26aufirst%3DN.%2BF.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DD.%2BW.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSchoor%26aufirst%3DM.%26aulast%3DShopp%26aufirst%3DG.%2BM.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTintrup%26aufirst%3DH.%26aulast%3DWijsman%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DMcConlogue%26aufirst%3DL.%26atitle%3DBACE1%2520Knockout%2520Mice%2520Are%2520Healthy%2520Despite%2520Lacking%2520the%2520Primary%2520Beta-Secretase%2520Activity%2520in%2520Brain%253A%2520Implications%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Therapeutics%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1317%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Mice Deficient in BACE1, the Alzheimer’s Beta-Secretase, Have Normal Phenotype and Abolished β-Amyloid Generation</span> <span class="citation_source-journal">Nature Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1038%2F85059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11224535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=231-232&author=Y.+Luoauthor=B.+Bolonauthor=S.+Kahnauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=P.+Denisauthor=W.+Fanauthor=H.+Khaauthor=J.+Zhangauthor=Y.+Gongauthor=L.+Martinauthor=J.-C.+Louisauthor=Q.+Yanauthor=W.+Richardsauthor=M.+Citronauthor=R.+Vassar&title=Mice+Deficient+in+BACE1%2C+the+Alzheimer%E2%80%99s+Beta-Secretase%2C+Have+Normal+Phenotype+and+Abolished+%CE%B2-Amyloid+Generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Kahn, Steve; Bennett, Brian D.; Babu-Khan, Safura; Denis, Paul; Fan, Wei; Kha, Hue; Zhang, Jianhua; Gong, Yunhua; Martin, Laura; Louis, Jean-Claude; Yan, Qiao; Richards, William G.; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Mice deficient in beta-site APP-cleaving enzyme 1 (BACE1) lack Aβ- and β-secretase-cleaved APP C-terminal fragments (CTFs) in the brain.  Moreover, BACE1-/- mice are normal in appearance and behavior and are healthy and fertile.  These results provide validation of BACE1 as the major β-secretase in vivo and indicated that BACE2 is not significant in β-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9Z5X-KkqkbVg90H21EOLACvtfcHk0ljNNRzVxZ4z7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D&md5=f733e8c48464c6521ce302be48c76b12</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2F85059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85059%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DKha%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DRichards%26aufirst%3DW.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DMice%2520Deficient%2520in%2520BACE1%252C%2520the%2520Alzheimer%25E2%2580%2599s%2520Beta-Secretase%252C%2520Have%2520Normal%2520Phenotype%2520and%2520Abolished%2520%25CE%25B2-Amyloid%2520Generation%26jtitle%3DNature%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">BACE1 is the Major Beta-secretase for Generation of Aβ Peptides by Neurons</span> <span class="citation_source-journal">Nature Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1038%2F85064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11224536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=233-234&author=H.+Caiauthor=Y.+Wangauthor=D.+McCarthyauthor=H.+Wenauthor=D.+R.+Borcheltauthor=D.+L.+Priceauthor=P.+C.+Wong&title=BACE1+is+the+Major+Beta-secretase+for+Generation+of+A%CE%B2+Peptides+by+Neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 is the major β-secretase for generation of Aβ peptides by neurons</span></div><div class="casAuthors">Cai, Huaibin; Wang, Yanshu; McCarthy, Diane; Wen, Hongjin; Borchelt, David R.; Price, Donald L.; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-234</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Secretion of Alzheimer's disease (AD) Aβ peptides (Aβ1-40/42 and Aβ11-40) is abolished in cultures of BACE1-deficient cortical neurons; BACE1-deficient is one of the two β-secretases involved in generating AD Aβ peptides.  This study also establishes that BACE1-deficient is the principal neuronal protease required to cleave amyloid precursor protein (APP) at the +1 and +11 sites that generate N-termini of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvJeMWCAU69rVg90H21EOLACvtfcHk0lgihtmm8vjnHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbc%253D&md5=fd3d6b77770735ed2b12687281fc511e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1038%2F85064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85064%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMcCarthy%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DH.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DBACE1%2520is%2520the%2520Major%2520Beta-secretase%2520for%2520Generation%2520of%2520A%25CE%25B2%2520Peptides%2520by%2520Neurons%26jtitle%3DNature%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D233%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span> </span><span class="NLM_article-title">Inhibition of BACE1 for Therapeutic Use in Alzheimer’s Disease</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=20661410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFagtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=618-628&author=X.+Luoauthor=R.+Yan&title=Inhibition+of+BACE1+for+Therapeutic+Use+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BACE1 for therapeutic use in Alzheimer's disease</span></div><div class="casAuthors">Luo, Xiaoyang; Yan, Riqiang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-628</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Since BACE1 was reported as the β-secretase in Alzheimer's disease (AD) over ten years ago, encouraging progress has been made toward understanding the cellular functions of BACE1.  Genetic studies have further confirmed that BACE1 is essential for processing amyloid precursor protein (APP) at the β-secretase site.  Only after this cleavage can the membrane-bound APP C-terminal fragment be subsequently cleaved by γ-secretase to release so-called AD-causing Aβ peptides.  Hence, in the past decade, a wide variety of BACE1 inhibitors have been developed for AD therapy.  This review will summarize the major historical events during the evolution of BACE1 inhibitors designed through different strategies of drug discovery.  Although BACE1 inhibitors are expected to be safe in general, careful titrn. of drug dosage to avoid undesirable side effects in BACE1-directed AD therapy is also emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUFz1x-AF9XbVg90H21EOLACvtfcHk0lgihtmm8vjnHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFagtbo%253D&md5=0cf2745b97b31229b1de6b7db04911e2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520BACE1%2520for%2520Therapeutic%2520Use%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2010%26volume%3D3%26spage%3D618%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kaller, M. R.; Harried, S. S.; Albrecht, B.; Amarante, P.; Babu-Khan, S.; Bartberger, M. D.; Brown, J.; Brown, R.; Chen, K.; Cheng, Y.; Citron, M.; Croghan, M. D.; Dunn, R.; Graceffa, R.; Hickman, D.; Judd, T.; Kreiman, C.; La, D.; Lopez, P.; Luo, Y.; Masse, C.; Monenschein, H.; Nguyen, T.; Pennington, L. D.; San Miguel, T.; Wahl, R. C.; Weiss, M. M.; Wen, P. H.; Williamson, T.; Wood, S.; Xue, M.; Yang, B.; Zhang, J.; Patel, V.; Zhong, W.; Hitchcock, S.</span><span> </span><span class="NLM_article-title">A Potent and Orally Efficacious, Hydroxyethylamine Based Inhibitor of Beta-Secretase</span>.  <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>doi <span class="refDoi"> DOI: 10.1021/ml3000148</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/ml3000148" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+R.+Kaller&author=S.+S.+Harried&author=B.+Albrecht&author=P.+Amarante&author=S.+Babu-Khan&author=M.+D.+Bartberger&author=J.+Brown&author=R.+Brown&author=K.+Chen&author=Y.+Cheng&author=M.+Citron&author=M.+D.+Croghan&author=R.+Dunn&author=R.+Graceffa&author=D.+Hickman&author=T.+Judd&author=C.+Kreiman&author=D.+La&author=P.+Lopez&author=Y.+Luo&author=C.+Masse&author=H.+Monenschein&author=T.+Nguyen&author=L.+D.+Pennington&author=T.+San+Miguel&author=R.+C.+Wahl&author=M.+M.+Weiss&author=P.+H.+Wen&author=T.+Williamson&author=S.+Wood&author=M.+Xue&author=B.+Yang&author=J.+Zhang&author=V.+Patel&author=W.+Zhong&author=S.+Hitchcock&title=A+Potent+and+Orally+Efficacious%2C+Hydroxyethylamine+Based+Inhibitor+of+Beta-Secretase&doi=10.1021%2Fml3000148"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fml3000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000148%26sid%3Dliteratum%253Aachs%26aulast%3DKaller%26aufirst%3DM.%2BR.%26atitle%3DA%2520Potent%2520and%2520Orally%2520Efficacious%252C%2520Hydroxyethylamine%2520Based%2520Inhibitor%2520of%2520Beta-Secretase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26doi%3D10.1021%2Fml3000148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Weiss, M. M.; Williamson, T.; Babu-Khan, S.; Bartberger, M. D.; Brown, J.; Chen, K.; Cheng, Y.; Citron, M.; Croghan, M. D.; Dineen, T. A.; Esmay, J.; Graceffa, R. F.; Harried, S. S.; Hickman, D.; Hitchcock, S. A.; Horne, D. B.; Huang, H.; Imbeah-Ampiah, R.; Judd, T.; Kaller, M. R.; Kreiman, C. R.; La, D. S.; Li, V.; Lopez, P.; Louie, S.; Monenschein, H.; Nguyen, T. T.; Pennington, L. D.; Rattan, C.; San Miguel, T.; Sickmier, E. A.; Wahl, R. C.; Wen, P. H.; Wood, S.; Xue, Q.; Yang, B. H.; Patel, V. F.; Zhong, W.</span><span> </span><span class="NLM_article-title">Design and Preparation of a Potent Series of Hydroxy Ethylamine Containing β-secretase Inhibitors that Demonstrate Robust Reduction of Central β-amyloid</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>doi <span class="refDoi"> DOI: 10.1021/jm300119p</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm300119p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+M.+Weiss&author=T.+Williamson&author=S.+Babu-Khan&author=M.+D.+Bartberger&author=J.+Brown&author=K.+Chen&author=Y.+Cheng&author=M.+Citron&author=M.+D.+Croghan&author=T.+A.+Dineen&author=J.+Esmay&author=R.+F.+Graceffa&author=S.+S.+Harried&author=D.+Hickman&author=S.+A.+Hitchcock&author=D.+B.+Horne&author=H.+Huang&author=R.+Imbeah-Ampiah&author=T.+Judd&author=M.+R.+Kaller&author=C.+R.+Kreiman&author=D.+S.+La&author=V.+Li&author=P.+Lopez&author=S.+Louie&author=H.+Monenschein&author=T.+T.+Nguyen&author=L.+D.+Pennington&author=C.+Rattan&author=T.+San+Miguel&author=E.+A.+Sickmier&author=R.+C.+Wahl&author=P.+H.+Wen&author=S.+Wood&author=Q.+Xue&author=B.+H.+Yang&author=V.+F.+Patel&author=W.+Zhong&title=Design+and+Preparation+of+a+Potent+Series+of+Hydroxy+Ethylamine+Containing+%CE%B2-secretase+Inhibitors+that+Demonstrate+Robust+Reduction+of+Central+%CE%B2-amyloid&doi=10.1021%2Fjm300119p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DDesign%2520and%2520Preparation%2520of%2520a%2520Potent%2520Series%2520of%2520Hydroxy%2520Ethylamine%2520Containing%2520%25CE%25B2-secretase%2520Inhibitors%2520that%2520Demonstrate%2520Robust%2520Reduction%2520of%2520Central%2520%25CE%25B2-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26doi%3D10.1021%2Fjm300119p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hollenberg, P. F.</span><span> </span><span class="NLM_article-title">Characteristic and Common Properties of Inhibitors, Inducers, and Activators of CYP Enzymes</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1081%2FDMR-120001387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11996009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1KgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=17-35&author=P.+F.+Hollenberg&title=Characteristic+and+Common+Properties+of+Inhibitors%2C+Inducers%2C+and+Activators+of+CYP+Enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics and common properties of inhibitors, inducers, and activators of CYP [cytochrome P 450] enzymes</span></div><div class="casAuthors">Hollenberg, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">17-35</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1tGuvyvnmSLVg90H21EOLACvtfcHk0lgB90uhi0OBwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1KgsL0%253D&md5=b20e7498802e30d66ffb15f807f77262</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1081%2FDMR-120001387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120001387%26sid%3Dliteratum%253Aachs%26aulast%3DHollenberg%26aufirst%3DP.%2BF.%26atitle%3DCharacteristic%2520and%2520Common%2520Properties%2520of%2520Inhibitors%252C%2520Inducers%252C%2520and%2520Activators%2520of%2520CYP%2520Enzymes%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2002%26volume%3D34%26spage%3D17%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lewis, D. F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickins, M.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationship For Human Cytochrome P450 Substrates and Inhibitors</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1081%2FDMR-120001391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=11996013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1KgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=69-82&author=D.+F.+V.+Lewisauthor=S.+Modiauthor=M.+Dickins&title=Structure%E2%80%93Activity+Relationship+For+Human+Cytochrome+P450+Substrates+and+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship for human cytochrome P450 substrates and inhibitors</span></div><div class="casAuthors">Lewis, David F. V.; Modi, Sandeep; Dickins, Maurice</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">69-82</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  Criteria governing the avidity of substrate binding to human hepatic cytochromes P 450 (CYP) assocd. with Phase 1 metab. of drugs are described.  The results of extensive quant. structure-activity relationship (QSAR) analyses are reported for substrates of human P450s: CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4, representing the enzymes exhibiting major involvement in the metab. of drug substrates in Homo sapiens.  In particular, it is shown that hydrogen bond properties in each class of enzyme-substrate complex are esp. important factors in detg. substrate binding affinity towards those human P450s which are involved in drug metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolHlRucex0d7Vg90H21EOLACvtfcHk0lgB90uhi0OBwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1KgsLk%253D&md5=b8783a098d7b48259d940b1d58e50415</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1081%2FDMR-120001391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120001391%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BF.%2BV.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DDickins%26aufirst%3DM.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationship%2520For%2520Human%2520Cytochrome%2520P450%2520Substrates%2520and%2520Inhibitors%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2002%26volume%3D34%26spage%3D69%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhou, S.-F.</span><span> </span><span class="NLM_article-title">Drugs Behave as Substrates, Inhibitors, and Inducers of Human Cytochrome P450 3A4</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.2174%2F138920008784220664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=18473749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1aitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=310-322&author=S.-F.+Zhou&title=Drugs+Behave+as+Substrates%2C+Inhibitors%2C+and+Inducers+of+Human+Cytochrome+P450+3A4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4</span></div><div class="casAuthors">Zhou, Shu-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">310-322</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human cytochrome P 450 (CYP) 3A4 is the most abundant hepatic and intestinal phase I enzyme that metabolizes approx. 50% marketed drugs.  The crystal structure of bound and unbound CYP3A4 has been recently constructed, and a small active site and a peripheral binding site are identified.  A recent study indicates that CYP3A4 undergoes dramatic conformational changes upon binding to ketoconazole or erythromycin with a differential but substantial (>80%) increase in the active site vol., providing a structural basis for ligand promiscuity of CYP3A4.  A no. of important drugs have been identified as substrates, inducers and/or inhibitors of CYP3A4.  The ability of drugs to act as inducers, inhibitors, or substrates for CYP3A is predictive of whether concurrent administration of these compds. with a known CYP3A substrate might lead to altered drug disposition, efficacy or toxicity.  The substrates of CYP3A4 considerably overlap with those of P-glycoprotein (P-gp).  To date, the identified clin. important CYP3A4 inhibitors mainly include macrolide antibiotics (e.g., clarithromycin, and erythromycin), anti-HIV agents (e.g., ritonavir and delavirdine), antidepressants (E.g. fluoxetine and fluvoxamine), calcium channel blockers (e.g. verapamil and diltiazem), steroids and their modulators (e.g., gestodene and mifepristone), and several herbal and dietary components.  Many of these drugs are also mechanism-based inhibitors of CYP3A4, which involves formation of reactive metabolites, binding to CYP3A4 and irreversible enzyme inactivation.  A small no. of drugs such as rifampin, phenytoin and ritonavir are identified as inducers of CYP3A4.  The orphan nuclear receptor, pregnane X receptor (PXR), have been found to play a crit. role in the induction of CYP3A4.  The inhibition or induction of CYP3A4 by drugs often causes unfavorable and long-lasting drug-drug interactions and probably fatal toxicity, depending on many factors assocd. with the enzyme, drugs and the patients.  The study of interactions of newly synthesized compds. with CYP3A4 has been incorporated into drug development and detection of possible CYP3A4 inhibitors and inducers during the early stages of drug development is crit. in preventing potential drug-drug interactions and side effects.  Clinicians are encouraged to have a sound knowledge on drugs that behave as substrates, inhibitors or inducers of CYP3A4, and take proper cautions and close monitoring for potential drug interactions when using drugs that are CYP3A4 inhibitors or inducers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv7PWdiHlenbVg90H21EOLACvtfcHk0ljHKsgfzYclpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1aitLY%253D&md5=df7e7825fd46cd35b8937245771cb972</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.2174%2F138920008784220664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008784220664%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.-F.%26atitle%3DDrugs%2520Behave%2520as%2520Substrates%252C%2520Inhibitors%252C%2520and%2520Inducers%2520of%2520Human%2520Cytochrome%2520P450%25203A4%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D310%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span> </span><span class="NLM_article-title">Stereoselective Synthesis <i>anti</i>-<i>N</i>-Protected 3-Amino-1,2-epoxides by Nucleophilic Addition to <i>N</i>-<i>tert</i>-Butanesulfinyl Imine of a Glyceraldehyde Synthon</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">5975</span><span class="NLM_x">–</span> <span class="NLM_lpage">5982</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo900643b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=5975-5982&author=S.+S.+Harriedauthor=M.+D.+Croghanauthor=M.+R.+Kallerauthor=P.+Lopezauthor=W.+Zhongauthor=R.+Hungateauthor=P.+J.+Reider&title=Stereoselective+Synthesis+anti-N-Protected+3-Amino-1%2C2-epoxides+by+Nucleophilic+Addition+to+N-tert-Butanesulfinyl+Imine+of+a+Glyceraldehyde+Synthon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjo900643b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900643b%26sid%3Dliteratum%253Aachs%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26atitle%3DStereoselective%2520Synthesis%2520anti-N-Protected%25203-Amino-1%252C2-epoxides%2520by%2520Nucleophilic%2520Addition%2520to%2520N-tert-Butanesulfinyl%2520Imine%2520of%2520a%2520Glyceraldehyde%2520Synthon%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D5975%26epage%3D5982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Dess, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">Readily Accessible 12-I-5 Oxidant for the Conversion of Primary and Secondary Alcohols to Aldehydes and Ketones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4155</span><span class="NLM_x">–</span> <span class="NLM_lpage">4156</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00170a070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaL3sXlslCqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=4155-4156&author=D.+B.+Dessauthor=J.+C.+Martin&title=Readily+Accessible+12-I-5+Oxidant+for+the+Conversion+of+Primary+and+Secondary+Alcohols+to+Aldehydes+and+Ketones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones</span></div><div class="casAuthors">Dess, D. B.; Martin, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4155-6</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Oxidn. of 2-IC6H4CO2H with KBrO3 in aq. H2SO4, followed by treatment of the oxidn. product with Ac2O gave 87% periodinane I, a 10-I-5 species (i.e., 10 valence electrons are formally involved in binding 5 ligands to the central iodine atom).  I reacted rapidly with primary or secondary alcs. at room temp. to give the corresponding aldehydes or ketones in high yield.  Excess I does not further oxidize the aldehyde or ketone under the reaction conditions.  The reaction is strongly catalyzed by excess alc. or strong acid, but is unaffected by pyridine.  I oxidizes benzylic alcs. selectively in the presence of satd. alcs.  Procedures for sepg. the carbonyl product from the reaction mixt. are mild and simple.  Cryst. I is stable at room temp. in the absence of moisture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAtQbosBW467Vg90H21EOLACvtfcHk0ljHKsgfzYclpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXlslCqsro%253D&md5=31b4835cd94c04773221d921e76231d1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjo00170a070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00170a070%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DReadily%2520Accessible%252012-I-5%2520Oxidant%2520for%2520the%2520Conversion%2520of%2520Primary%2520and%2520Secondary%2520Alcohols%2520to%2520Aldehydes%2520and%2520Ketones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26spage%3D4155%26epage%3D4156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okukado, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negishi, E.-I.</span><span> </span><span class="NLM_article-title">Highly General Stereo-, Regio-, and Chemo-selective Synthesis of Terminal and Internal Conjugated Enynes by the Pd-catalysed Reaction of Alkynylzinc Reagents with Alkenyl Halides</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1039%2Fc39770000683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaE1cXht1SmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1977&pages=683-684&author=A.+O.+Kingauthor=N.+Okukadoauthor=E.-I.+Negishi&title=Highly+General+Stereo-%2C+Regio-%2C+and+Chemo-selective+Synthesis+of+Terminal+and+Internal+Conjugated+Enynes+by+the+Pd-catalysed+Reaction+of+Alkynylzinc+Reagents+with+Alkenyl+Halides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Highly general stereo-, regio-, and chemo-selective synthesis of terminal and internal conjugated enynes by the palladium-catalyzed reaction of alkynylzinc reagents with alkenyl halides</span></div><div class="casAuthors">King, Anthony O.; Okukado, Nobuhisa; Negishi, Eiichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Chemical Communications</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">683-4</span>CODEN:
                <span class="NLM_cas:coden">JCCCAT</span>;
        ISSN:<span class="NLM_cas:issn">0022-4936</span>.
    </div><div class="casAbstract">RC≡CZnCl [R = H, Bu, (CH2)4Me], prepd. by reaction of RC≡CLi with ZnCl2, underwent palladium phosphine complex-catalyzed condensation with R1CR2:CHR3 (R1 = H, R2 = Bu, R3 = I; R1 = Bu, R2 = H, Et, R3 = I; R1 = CO2Me, R1 = Me, R3 = Br) to give ≥65% R1CR2:CHC≡CR, the stereospecificity of the reaction being ≥97%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp24Kxv9jQNqbVg90H21EOLACvtfcHk0ljHKsgfzYclpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXht1SmsLc%253D&md5=b235d8eaaede6ef4d5d4fded38433b2c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fc39770000683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39770000683%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DOkukado%26aufirst%3DN.%26aulast%3DNegishi%26aufirst%3DE.-I.%26atitle%3DHighly%2520General%2520Stereo-%252C%2520Regio-%252C%2520and%2520Chemo-selective%2520Synthesis%2520of%2520Terminal%2520and%2520Internal%2520Conjugated%2520Enynes%2520by%2520the%2520Pd-catalysed%2520Reaction%2520of%2520Alkynylzinc%2520Reagents%2520with%2520Alkenyl%2520Halides%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1977%26spage%3D683%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a Surrogate for Assessing CNS Exposure: An Industrial Perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+Surrogate+for+Assessing+CNS+Exposure%3A+An+Industrial+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0lg036jWIfViig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520Surrogate%2520for%2520Assessing%2520CNS%2520Exposure%253A%2520An%2520Industrial%2520Perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+Drug+Concentration+in+Brain+Homogenate+and+Cerebral+Spinal+Fluid+at+Steady+State+as+a+Surrogate+for+Unbound+Concentration+in+Brain+Interstitial+Fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0lg036jWIfViig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520Drug%2520Concentration%2520in%2520Brain%2520Homogenate%2520and%2520Cerebral%2520Spinal%2520Fluid%2520at%2520Steady%2520State%2520as%2520a%2520Surrogate%2520for%2520Unbound%2520Concentration%2520in%2520Brain%2520Interstitial%2520Fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Coordinates for the complex of BACE1 with inhibitor <b>37</b> have been deposited in the Protein Data Bank under PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DI2">4DI2</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mahar Doan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Passive Permeability and P-glycoprotein Mediated Efflux Differentiate CNS and Non-CNS Marketed Drugs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=K.+M.+Mahar+Doanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkinsonauthor=J.+W.+Polli&title=Passive+Permeability+and+P-glycoprotein+Mediated+Efflux+Differentiate+CNS+and+Non-CNS+Marketed+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Mahar Doan Kelly M; Humphreys Joan E; Webster Lindsey O; Wring Stephen A; Shampine Larry J; Serabjit-Singh Cosette J; Adkison Kimberly K; Polli Joseph W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-37</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to determine whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochemical properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compounds for drug development.  Apparent permeability (P(app)) and Pgp substrate profiles for 93 CNS (n = 48) and non-CNS (n = 45) drugs were determined by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were positive in the calcein-AM assay when tested at 100 microM.  The CNS drug set (n = 7 of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (n = 19 of 45, 42.2%).  Analysis of 18 physicochemical properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer positive charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group (p < 0.05), properties that enhance membrane permeability.  This study on a large, diverse set of marketed compounds clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochemical properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B --> A/A --> B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_HiV1Xqt18Vf1XRtfYM0dfW6udTcc2eaEW9FhyKZHarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D&md5=b841902aa8502de47c1e1603c80e09fb</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DMahar%2BDoan%26aufirst%3DK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520Permeability%2520and%2520P-glycoprotein%2520Mediated%2520Efflux%2520Differentiate%2520CNS%2520and%2520Non-CNS%2520Marketed%2520Drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–Brain Exposure Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93Brain+Exposure+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593Brain%2520Exposure%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Turner, R. T.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanheira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Subsite specificity of memapsin (β-secretase): implications for inhibitor design</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10001</span><span class="NLM_x">–</span> <span class="NLM_lpage">10006</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi015546s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10001-10006&author=R.+T.+Turnerauthor=G.+Koelschauthor=L.+Hongauthor=P.+Castanheiraauthor=A.+Ghoshauthor=J.+Tang&title=Subsite+specificity+of+memapsin+%28%CE%B2-secretase%29%3A+implications+for+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi015546s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi015546s%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BT.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DCastanheira%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DSubsite%2520specificity%2520of%2520memapsin%2520%2528%25CE%25B2-secretase%2529%253A%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10001%26epage%3D10006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Haniu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span> </span><span class="NLM_article-title">Characterization of Alzheimer’s beta-secretase protein BACE1. A pepsin family member with unusual properties</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">21099</span><span class="NLM_x">–</span> <span class="NLM_lpage">21106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=21099-21106&author=M.+Haniuauthor=P.+Denisauthor=Y.+Youngauthor=E.+A.+Mendiazauthor=J.+Fullerauthor=J.+O.+Huiauthor=B.+D.+Bennettauthor=S.+Kahnauthor=S.+Rossauthor=T.+Burgess&title=Characterization+of+Alzheimer%E2%80%99s+beta-secretase+protein+BACE1.+A+pepsin+family+member+with+unusual+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaniu%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DY.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DHui%26aufirst%3DJ.%2BO.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520Alzheimer%25E2%2580%2599s%2520beta-secretase%2520protein%2520BACE1.%2520A%2520pepsin%2520family%2520member%2520with%2520unusual%2520properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D21099%26epage%3D21106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Schinkel, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deemter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span> </span><span class="NLM_article-title">Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">–</span> <span class="NLM_lpage">1705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1995&pages=1698-1705&author=A.+H.+Schinkelauthor=E.+Wagenaarauthor=L.+van+Deemterauthor=C.+A.+A.+M.+Molauthor=P.+Borst&title=Absence+of+the+mdr1a+P-glycoprotein+in+mice+affects+tissue+distribution+and+pharmacokinetics+of+dexamethasone%2C+digoxin%2C+and+cyclosporin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3Dvan%2BDeemter%26aufirst%3DL.%26aulast%3DMol%26aufirst%3DC.%2BA.%2BA.%2BM.%26aulast%3DBorst%26aufirst%3DP.%26atitle%3DAbsence%2520of%2520the%2520mdr1a%2520P-glycoprotein%2520in%2520mice%2520affects%2520tissue%2520distribution%2520and%2520pharmacokinetics%2520of%2520dexamethasone%252C%2520digoxin%252C%2520and%2520cyclosporin%2520A%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1995%26volume%3D96%26spage%3D1698%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Booth-Genthe, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlini, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leake, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhandler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rushmore, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, M.</span><span> </span><span class="NLM_article-title">Development and characterization of LLC-PK1 cells containing Sprague–Dawley rat <i>Abcb</i>1a (<i>Mdr</i>1a): Comparison of rat P-glycoprotein transport to human and mouse</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1016%2Fj.vascn.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=16545584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFSkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=78-89&author=C.+L.+Booth-Gentheauthor=S.+W.+Louieauthor=E.+J.+Carliniauthor=B.+Liauthor=B.+F.+Leakeauthor=R.+Eisenhandlerauthor=J.+H.+Hochmanauthor=Q.+Meiauthor=R.+B.+Kimauthor=T.+H.+Rushmoreauthor=M.+Yamazaki&title=Development+and+characterization+of+LLC-PK1+cells+containing+Sprague%E2%80%93Dawley+rat+Abcb1a+%28Mdr1a%29%3A+Comparison+of+rat+P-glycoprotein+transport+to+human+and+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): Comparison of rat P-glycoprotein transport to human and mouse</span></div><div class="casAuthors">Booth-Genthe, Catherine L.; Louie, Steven W.; Carlini, Edward J.; Li, Bing; Leake, Brenda F.; Eisenhandler, Roy; Hochman, Jerome H.; Mei, Qin; Kim, Richard B.; Rushmore, Thomas H.; Yamazaki, Masayo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-89</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">P-glycoprotein is localized in numerous tissues throughout the body and plays an important role in the disposition of many xenobiotics.  The contribution of P-glycoprotein-mediated drug transport is being evaluated in early drug discovery stages, particularly for compds. targeted to the central nervous system, using in vitro tools including cell lines expressing P-glycoprotein.  Previous work in our lab. suggests there are species differences in P-glycoprotein transport activity between humans and animals.  The rat Abcb1a form of P-glycoprotein (formerly known as Mdr1a), the predominate isoform in the brain, has not been described in a functional cell system.  Here, we describe the development and characterization of LLC-PK1 cells expressing rat Abcb1.  We cloned rat Abcb1a and generated a stable LLC-PK1 cell line.  Expression and function of the cells were evaluated by immunoblot anal., cytotoxicity anal., cellular accumulation assays, and transcellular transport of probe substrates.  The transport ratios of structurally diverse compds. obtained from parental cells or cells stably transfected with human ABCB1, mouse Abcb1a or rat Abcb1a were compared.  Two forms of rat Abcb1a were cloned from Sprague-Dawley cDNA that differ by six amino acids and a base pair deletion.  The intact form was stably transfected in LLC-PK1 cells.  Immunoblot anal. demonstrated expression of the protein.  The cells demonstrated P-glycoprotein-mediated function by directional transport of dexamethasone, ritonavir, and vinblastine in a transwell assay that was inhibited in the presence of cyclosporin A, verapamil, or quinidine.  Likewise, the cells showed reduced cellular accumulation of Rh123 by FACS anal. that was reversed in the presence of cyclosporin A.  These cells showed ≥ 350-fold resistance to colchicine, doxorubicin, vinblastine, and taxol and were sensitized in the presence of verapamil or cyclosporin A.  Of 179 chem. diverse compds. evaluated, ∼20% of the compds. evaluated were predicted to be substrates in one species but not in other species.  Taken together, these data suggest these cells will be useful for evaluation of rat Abcb1a-mediated transport and for evaluation of species-specific P-glycoprotein-mediated transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTnY-e_sTc7LVg90H21EOLACvtfcHk0lh3Ub6u88gdfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFSkuro%253D&md5=3390b072631084f62434e147269b6c13</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBooth-Genthe%26aufirst%3DC.%2BL.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DCarlini%26aufirst%3DE.%2BJ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLeake%26aufirst%3DB.%2BF.%26aulast%3DEisenhandler%26aufirst%3DR.%26aulast%3DHochman%26aufirst%3DJ.%2BH.%26aulast%3DMei%26aufirst%3DQ.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DRushmore%26aufirst%3DT.%2BH.%26aulast%3DYamazaki%26aufirst%3DM.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520LLC-PK1%2520cells%2520containing%2520Sprague%25E2%2580%2593Dawley%2520rat%2520Abcb1a%2520%2528Mdr1a%2529%253A%2520Comparison%2520of%2520rat%2520P-glycoprotein%2520transport%2520to%2520human%2520and%2520mouse%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D78%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE1 (β-secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE1+%28%CE%B2-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE1%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0liRsY6I9t97YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300118s&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0liRsY6I9t97YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ligpJRXvqNUGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title"><i>Coot</i>: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">D60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300118s&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300118s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ligpJRXvqNUGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3DD60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DI2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DI2','PDB','4DI2'); return false;">PDB: 4DI2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DUY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DUY','PDB','3DUY'); return false;">PDB: 3DUY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i90"><a href="/doi/suppl/10.1021/jm300118s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33130"></div></div></div></div></div><hr /></hr><p class="last">General information, experimentals and characterization, X-ray crystal structure information.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300118s/suppl_file/jm300118s_si_001.pdf">jm300118s_si_001.pdf (121.92 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300118s&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm300118s%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-21%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300118s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679984cafcac24fd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
